date generated: 2026-11-06

Background

Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch

Input profiles

Here is the first few lines of the input profile.

The profiling data being passed to mitch
rna k9a k36a
NR4A3 68.07237 10.7310010 -0.9023055
HSPA1B 47.19114 18.8135155 0.8337179
DNAJB1 35.12799 2.4326983 0.1386114
MIR133A1HG -27.36199 8.9061967 2.1092761
HSPH1 25.83750 10.8922577 1.1905878
CXCL2 24.76570 0.8459414 0.0037016

Here are some metrics about the input data profile:

Profiling data metrics
Profile metrics
num_genes_in_profile 12944
duplicated_genes_present 0
num_profile_genes_in_sets 6772
num_profile_genes_not_in_sets 6172

Here is a plot of the input profiles. Note the dynamic ranges.

Here is the contour plot of the profile including all detected genes.

Input genesets

Here are some metrics about the gene sets used:

GMT file of genesets:
Gene set metrics
Gene sets metrics
num_genesets 2785
num_genesets_excluded 1357
num_genesets_included 1428
Genes by sector
rna k9a k36a Count
-1 -1 -1 990
1 -1 -1 758
-1 0 -1 1
-1 1 -1 3237
1 1 -1 3173
-1 -1 1 356
1 -1 1 348
-1 1 1 1704
0 1 1 1
1 1 1 2376
Number of significant gene sets (FDR<0.05)= 700

Gene sets by sector


Gene sets by sector
s.rna s.k9a s.k36a Count
-1 -1 -1 11
1 -1 -1 41
-1 1 -1 149
1 1 -1 294
-1 -1 1 1
1 -1 1 11
-1 1 1 58
1 1 1 135

Interactive enrichment scatterplot

All sets with FDR<0.05. Try hovering over the points.

Top N sets irrespective of FDR. Try hovering over the points.

A heatmap of S values for top results


A plot of effect size versus significance


Significance is the -log2(p.adjustMANOVA) and effect size is the s.dist which is the hypotenuse of the s scores.

Results table

Top N= 10 gene sets
set setSize pMANOVA p.adjustMANOVA s.dist s.rna s.k9a s.k36a p.rna p.k9a p.k36a
FOXO-mediated transcription of cell cycle genes 15 1.29e-05 7.40e-05 0.851 0.5080 0.607 0.3120 6.52e-04 4.66e-05 0.0364
Dectin-2 family 10 7.25e-04 2.68e-03 0.810 -0.0541 -0.740 -0.3260 7.67e-01 5.10e-05 0.0740
NGF-stimulated transcription 28 4.63e-09 6.01e-08 0.769 0.6420 0.374 0.2000 4.12e-09 6.13e-04 0.0668
NFE2L2 regulating tumorigenic genes 10 2.61e-03 7.94e-03 0.750 0.6260 0.369 0.1820 6.03e-04 4.33e-02 0.3190
MET activates RAP1 and RAC1 10 5.69e-03 1.53e-02 0.749 0.4010 0.521 0.3590 2.81e-02 4.31e-03 0.0493
Regulation of localization of FOXO transcription factors 11 2.12e-03 6.62e-03 0.729 0.4860 0.519 0.1610 5.23e-03 2.87e-03 0.3550
Phosphorylation and nuclear translocation of the CRY:PER:kinase complex 12 2.34e-04 9.85e-04 0.727 0.4620 0.556 -0.0765 5.57e-03 8.60e-04 0.6460
Antigen processing: Ub, ATP-independent proteasomal degradation 16 6.09e-06 3.75e-05 0.705 -0.6460 0.283 -0.0171 7.73e-06 4.99e-02 0.9060
Signaling by FLT3 fusion proteins 18 1.17e-05 6.80e-05 0.703 0.5560 0.429 -0.0270 4.42e-05 1.64e-03 0.8430
FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes 22 4.97e-05 2.48e-04 0.684 0.3300 0.454 0.3910 7.30e-03 2.27e-04 0.0015


Results (complete table)


Click HERE to show results for all gene sets

Complete results
set setSize pMANOVA p.adjustMANOVA s.dist s.rna s.k9a s.k36a p.rna p.k9a p.k36a
FOXO-mediated transcription of cell cycle genes 15 1.29e-05 7.40e-05 0.8510 0.508000 6.07e-01 0.312000 6.52e-04 4.66e-05 0.036400
Dectin-2 family 10 7.25e-04 2.68e-03 0.8100 -0.054100 -7.40e-01 -0.326000 7.67e-01 5.10e-05 0.074000
NGF-stimulated transcription 28 4.63e-09 6.01e-08 0.7690 0.642000 3.74e-01 0.200000 4.12e-09 6.13e-04 0.066800
NFE2L2 regulating tumorigenic genes 10 2.61e-03 7.94e-03 0.7500 0.626000 3.69e-01 0.182000 6.03e-04 4.33e-02 0.319000
MET activates RAP1 and RAC1 10 5.69e-03 1.53e-02 0.7490 0.401000 5.21e-01 0.359000 2.81e-02 4.31e-03 0.049300
Regulation of localization of FOXO transcription factors 11 2.12e-03 6.62e-03 0.7290 0.486000 5.19e-01 0.161000 5.23e-03 2.87e-03 0.355000
Phosphorylation and nuclear translocation of the CRY:PER:kinase complex 12 2.34e-04 9.85e-04 0.7270 0.462000 5.56e-01 -0.076500 5.57e-03 8.60e-04 0.646000
Antigen processing: Ub, ATP-independent proteasomal degradation 16 6.09e-06 3.75e-05 0.7050 -0.646000 2.83e-01 -0.017100 7.73e-06 4.99e-02 0.906000
Signaling by FLT3 fusion proteins 18 1.17e-05 6.80e-05 0.7030 0.556000 4.29e-01 -0.027000 4.42e-05 1.64e-03 0.843000
FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes 22 4.97e-05 2.48e-04 0.6840 0.330000 4.54e-01 0.391000 7.30e-03 2.27e-04 0.001500
Viral mRNA Translation 58 1.98e-18 1.35e-16 0.6820 -0.676000 9.05e-02 -0.012000 4.99e-19 2.34e-01 0.875000
ALK mutants bind TKIs 10 1.08e-02 2.54e-02 0.6790 0.535000 2.52e-01 0.335000 3.41e-03 1.68e-01 0.066800
SARS-CoV-1 targets host intracellular signalling and regulatory pathways 14 4.32e-04 1.68e-03 0.6780 0.393000 5.52e-01 0.036200 1.09e-02 3.51e-04 0.815000
MECP2 regulates neuronal receptors and channels 11 4.90e-03 1.34e-02 0.6750 0.593000 2.71e-01 0.174000 6.63e-04 1.20e-01 0.318000
The NLRP3 inflammasome 11 7.80e-03 1.94e-02 0.6740 0.469000 2.47e-01 0.417000 7.05e-03 1.57e-01 0.016700
Peptide chain elongation 59 3.29e-18 2.14e-16 0.6710 -0.663000 1.02e-01 -0.027600 1.21e-18 1.76e-01 0.714000
Attenuation phase 17 1.93e-04 8.47e-04 0.6680 0.515000 4.13e-01 0.099700 2.37e-04 3.20e-03 0.477000
EGR2 and SOX10-mediated initiation of Schwann cell myelination 18 2.89e-04 1.18e-03 0.6630 0.506000 2.65e-01 0.338000 2.03e-04 5.18e-02 0.013100
Protein hydroxylation 14 1.02e-04 4.74e-04 0.6590 -0.487000 4.40e-01 0.051600 1.59e-03 4.36e-03 0.738000
FOXO-mediated transcription of cell death genes 12 6.27e-03 1.64e-02 0.6570 0.327000 5.24e-01 0.226000 5.00e-02 1.68e-03 0.176000
Glycogen synthesis 12 3.65e-03 1.04e-02 0.6530 -0.088600 5.59e-01 0.325000 5.95e-01 7.97e-04 0.051600
Eukaryotic Translation Elongation 62 5.30e-18 3.29e-16 0.6520 -0.643000 9.95e-02 -0.044200 2.01e-18 1.76e-01 0.548000
Signaling by FLT3 ITD and TKD mutants 14 5.70e-04 2.14e-03 0.6510 0.579000 2.92e-01 -0.052500 1.75e-04 5.88e-02 0.734000
FOXO-mediated transcription 51 9.49e-11 1.76e-09 0.6500 0.331000 4.94e-01 0.262000 4.26e-05 1.05e-09 0.001220
Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters 11 6.50e-03 1.68e-02 0.6490 0.407000 4.98e-01 0.086200 1.93e-02 4.23e-03 0.621000
Interleukin-6 signaling 10 6.77e-03 1.73e-02 0.6450 0.567000 3.06e-01 -0.044900 1.92e-03 9.41e-02 0.806000
AKT phosphorylates targets in the nucleus 10 1.48e-02 3.31e-02 0.6420 0.478000 4.11e-01 0.125000 8.87e-03 2.45e-02 0.494000
SARS-CoV-2 targets host intracellular signalling and regulatory pathways 11 3.42e-03 9.76e-03 0.6410 0.338000 5.44e-01 -0.033800 5.24e-02 1.79e-03 0.846000
Signaling by Hippo 19 3.16e-04 1.27e-03 0.6410 0.482000 3.63e-01 0.215000 2.75e-04 6.17e-03 0.104000
Selenocysteine synthesis 62 2.51e-17 1.22e-15 0.6400 -0.634000 8.44e-02 -0.014400 5.46e-18 2.51e-01 0.845000
Adenylate cyclase inhibitory pathway 12 1.63e-03 5.26e-03 0.6370 0.402000 -2.54e-01 -0.424000 1.58e-02 1.28e-01 0.010900
Signaling by PDGFRA extracellular domain mutants 11 3.84e-03 1.08e-02 0.6330 0.548000 3.01e-01 -0.097400 1.65e-03 8.38e-02 0.576000
Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants 11 3.84e-03 1.08e-02 0.6330 0.548000 3.01e-01 -0.097400 1.65e-03 8.38e-02 0.576000
Estrogen-dependent nuclear events downstream of ESR-membrane signaling 20 2.35e-04 9.85e-04 0.6270 0.391000 4.62e-01 0.163000 2.45e-03 3.50e-04 0.207000
SARS-CoV-1 modulates host translation machinery 24 1.64e-06 1.15e-05 0.6200 -0.606000 1.20e-01 -0.050700 2.70e-07 3.07e-01 0.667000
Respiratory syncytial virus (RSV) genome replication, transcription and translation 14 2.71e-03 8.19e-03 0.6170 0.255000 5.49e-01 0.120000 9.85e-02 3.73e-04 0.436000
Inflammasomes 15 3.40e-03 9.74e-03 0.6170 0.408000 2.14e-01 0.411000 6.21e-03 1.51e-01 0.005890
Gluconeogenesis 14 4.88e-04 1.86e-03 0.6170 -0.530000 1.73e-01 -0.265000 5.95e-04 2.63e-01 0.085700
Eukaryotic Translation Termination 62 3.14e-16 1.28e-14 0.6150 -0.605000 1.09e-01 0.024200 1.76e-16 1.39e-01 0.742000
Crosslinking of collagen fibrils 16 8.26e-04 3.00e-03 0.6140 0.036000 -5.75e-01 -0.212000 8.03e-01 6.89e-05 0.142000
Regulation of PTEN mRNA translation 12 1.04e-02 2.47e-02 0.6110 0.405000 4.38e-01 0.134000 1.51e-02 8.67e-03 0.423000
Assembly of active LPL and LIPC lipase complexes 10 8.64e-03 2.12e-02 0.6100 0.407000 -2.87e-01 -0.353000 2.58e-02 1.16e-01 0.053200
Nuclear Events (kinase and transcription factor activation) 48 3.49e-10 5.86e-09 0.6100 0.474000 3.76e-01 0.078300 1.31e-08 6.71e-06 0.348000
PECAM1 interactions 10 9.02e-03 2.21e-02 0.6100 0.381000 -2.57e-01 -0.402000 3.71e-02 1.60e-01 0.027800
Response of EIF2AK1 (HRI) to heme deficiency 12 1.89e-02 4.04e-02 0.6100 0.306000 3.12e-01 0.426000 6.64e-02 6.17e-02 0.010700
Formation of a pool of free 40S subunits 69 1.38e-17 7.58e-16 0.6100 -0.599000 1.03e-01 -0.053300 7.82e-18 1.39e-01 0.444000
NFE2L2 regulating anti-oxidant/detoxification enzymes 14 8.27e-03 2.05e-02 0.6070 0.205000 4.86e-01 0.299000 1.85e-01 1.63e-03 0.052800
CLEC7A (Dectin-1) induces NFAT activation 11 1.76e-02 3.82e-02 0.6040 0.023600 5.33e-01 0.284000 8.92e-01 2.21e-03 0.104000
TGFBR3 expression 22 3.36e-04 1.33e-03 0.6000 0.313000 4.62e-01 0.221000 1.12e-02 1.76e-04 0.072200
FLT3 signaling in disease 25 7.93e-06 4.76e-05 0.5980 0.443000 4.00e-01 -0.044400 1.28e-04 5.32e-04 0.701000
Activation of BAD and translocation to mitochondria 13 4.56e-03 1.25e-02 0.5970 0.296000 5.17e-01 0.044500 6.46e-02 1.25e-03 0.781000
Complex I biogenesis 44 3.04e-11 6.29e-10 0.5910 -0.522000 2.73e-01 0.051900 2.11e-09 1.77e-03 0.552000
The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex 14 2.81e-03 8.37e-03 0.5880 0.382000 4.46e-01 -0.018400 1.33e-02 3.88e-03 0.905000
RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression 23 1.03e-04 4.76e-04 0.5860 0.319000 4.84e-01 0.081100 8.02e-03 5.89e-05 0.501000
Downregulation of TGF-beta receptor signaling 25 1.01e-04 4.73e-04 0.5830 0.342000 4.49e-01 0.146000 3.09e-03 1.01e-04 0.208000
Mucopolysaccharidoses 11 3.69e-02 6.92e-02 0.5820 -0.353000 -2.61e-01 -0.382000 4.27e-02 1.33e-01 0.028500
SARS-CoV-2 modulates host translation machinery 33 6.52e-08 5.93e-07 0.5790 -0.558000 1.56e-01 -0.013800 2.94e-08 1.21e-01 0.891000
SRP-dependent cotranslational protein targeting to membrane 76 8.66e-18 5.15e-16 0.5790 -0.564000 1.31e-01 0.004730 1.81e-17 4.93e-02 0.943000
Selenoamino acid metabolism 73 9.77e-17 4.10e-15 0.5780 -0.570000 9.46e-02 -0.025100 3.78e-17 1.63e-01 0.712000
Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA 13 6.39e-03 1.67e-02 0.5750 0.241000 5.20e-01 0.040100 1.32e-01 1.16e-03 0.802000
CTNNB1 S33 mutants aren’t phosphorylated 15 2.85e-03 8.37e-03 0.5740 0.319000 4.77e-01 0.021200 3.25e-02 1.39e-03 0.887000
CTNNB1 S37 mutants aren’t phosphorylated 15 2.85e-03 8.37e-03 0.5740 0.319000 4.77e-01 0.021200 3.25e-02 1.39e-03 0.887000
CTNNB1 S45 mutants aren’t phosphorylated 15 2.85e-03 8.37e-03 0.5740 0.319000 4.77e-01 0.021200 3.25e-02 1.39e-03 0.887000
CTNNB1 T41 mutants aren’t phosphorylated 15 2.85e-03 8.37e-03 0.5740 0.319000 4.77e-01 0.021200 3.25e-02 1.39e-03 0.887000
Signaling by CTNNB1 phospho-site mutants 15 2.85e-03 8.37e-03 0.5740 0.319000 4.77e-01 0.021200 3.25e-02 1.39e-03 0.887000
Signaling by GSK3beta mutants 15 2.85e-03 8.37e-03 0.5740 0.319000 4.77e-01 0.021200 3.25e-02 1.39e-03 0.887000
Collagen chain trimerization 28 6.79e-06 4.14e-05 0.5720 -0.075600 -5.60e-01 -0.090300 4.89e-01 2.98e-07 0.409000
Activation of SMO 13 1.09e-02 2.56e-02 0.5710 0.090300 -2.94e-01 -0.481000 5.73e-01 6.64e-02 0.002660
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) 65 1.64e-14 5.32e-13 0.5670 -0.557000 1.04e-01 0.026200 7.86e-15 1.49e-01 0.715000
Adrenaline,noradrenaline inhibits insulin secretion 18 2.71e-03 8.19e-03 0.5660 0.022700 -3.45e-01 -0.448000 8.68e-01 1.12e-02 0.001010
Vif-mediated degradation of APOBEC3G 36 4.71e-09 6.01e-08 0.5620 -0.394000 3.94e-01 -0.074700 4.25e-05 4.32e-05 0.438000
Tie2 Signaling 14 1.25e-02 2.87e-02 0.5590 0.470000 2.33e-01 0.194000 2.35e-03 1.32e-01 0.208000
Phosphorylation of CD3 and TCR zeta chains 12 2.19e-03 6.81e-03 0.5570 0.254000 -4.63e-01 0.176000 1.28e-01 5.48e-03 0.292000
Downstream signal transduction 27 8.00e-06 4.78e-05 0.5570 0.509000 1.82e-01 -0.132000 4.65e-06 1.02e-01 0.236000
Response of EIF2AK4 (GCN2) to amino acid deficiency 68 1.38e-14 4.57e-13 0.5550 -0.544000 9.93e-02 0.056400 9.03e-15 1.57e-01 0.422000
Cell-extracellular matrix interactions 17 1.27e-03 4.31e-03 0.5550 0.448000 3.21e-01 -0.068400 1.38e-03 2.20e-02 0.626000
Transcriptional regulation of pluripotent stem cells 10 6.60e-02 1.10e-01 0.5550 0.209000 4.57e-01 0.237000 2.53e-01 1.24e-02 0.194000
Competing endogenous RNAs (ceRNAs) regulate PTEN translation 11 3.45e-02 6.62e-02 0.5540 0.364000 4.06e-01 0.104000 3.68e-02 1.99e-02 0.552000
Beta-catenin phosphorylation cascade 16 4.16e-03 1.15e-02 0.5530 0.300000 4.60e-01 0.067200 3.77e-02 1.45e-03 0.642000
Carnitine shuttle 13 1.02e-02 2.44e-02 0.5520 0.428000 3.49e-01 -0.010400 7.54e-03 2.96e-02 0.948000
Defective B3GALT6 causes EDSP2 and SEMDJL1 11 1.42e-02 3.17e-02 0.5520 0.386000 -2.74e-01 -0.283000 2.66e-02 1.15e-01 0.104000
Regulation of BACH1 activity 10 3.23e-02 6.30e-02 0.5510 -0.097200 5.11e-01 0.183000 5.95e-01 5.12e-03 0.318000
Glutathione conjugation 25 1.65e-05 9.34e-05 0.5510 -0.522000 1.31e-01 0.120000 6.31e-06 2.55e-01 0.300000
APC truncation mutants have impaired AXIN binding 14 5.90e-03 1.56e-02 0.5510 0.303000 4.60e-01 -0.007610 4.97e-02 2.87e-03 0.961000
AXIN missense mutants destabilize the destruction complex 14 5.90e-03 1.56e-02 0.5510 0.303000 4.60e-01 -0.007610 4.97e-02 2.87e-03 0.961000
Signaling by AMER1 mutants 14 5.90e-03 1.56e-02 0.5510 0.303000 4.60e-01 -0.007610 4.97e-02 2.87e-03 0.961000
Signaling by APC mutants 14 5.90e-03 1.56e-02 0.5510 0.303000 4.60e-01 -0.007610 4.97e-02 2.87e-03 0.961000
Signaling by AXIN mutants 14 5.90e-03 1.56e-02 0.5510 0.303000 4.60e-01 -0.007610 4.97e-02 2.87e-03 0.961000
Truncations of AMER1 destabilize the destruction complex 14 5.90e-03 1.56e-02 0.5510 0.303000 4.60e-01 -0.007610 4.97e-02 2.87e-03 0.961000
Disorders of Nervous System Development 11 6.21e-03 1.62e-02 0.5510 0.065400 5.26e-01 -0.151000 7.07e-01 2.54e-03 0.387000
Loss of function of MECP2 in Rett syndrome 11 6.21e-03 1.62e-02 0.5510 0.065400 5.26e-01 -0.151000 7.07e-01 2.54e-03 0.387000
Pervasive developmental disorders 11 6.21e-03 1.62e-02 0.5510 0.065400 5.26e-01 -0.151000 7.07e-01 2.54e-03 0.387000
Complex III assembly 17 1.31e-03 4.42e-03 0.5480 -0.499000 5.93e-02 -0.219000 3.67e-04 6.72e-01 0.118000
Constitutive Signaling by NOTCH1 HD Domain Mutants 14 1.38e-03 4.58e-03 0.5470 0.334000 1.80e-01 -0.393000 3.04e-02 2.43e-01 0.010900
Signaling by NOTCH1 HD Domain Mutants in Cancer 14 1.38e-03 4.58e-03 0.5470 0.334000 1.80e-01 -0.393000 3.04e-02 2.43e-01 0.010900
Constitutive Signaling by AKT1 E17K in Cancer 23 2.09e-04 9.09e-04 0.5470 0.418000 3.52e-01 -0.009240 5.26e-04 3.46e-03 0.939000
FBXL7 down-regulates AURKA during mitotic entry and in early mitosis 39 5.11e-09 6.46e-08 0.5430 -0.402000 3.60e-01 -0.058200 1.38e-05 1.03e-04 0.530000
Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes 21 8.31e-04 3.01e-03 0.5400 0.224000 4.84e-01 0.083700 7.51e-02 1.22e-04 0.507000
Complex IV assembly 30 2.70e-06 1.82e-05 0.5390 -0.388000 3.39e-01 0.161000 2.35e-04 1.33e-03 0.128000
L13a-mediated translational silencing of Ceruloplasmin expression 78 6.47e-16 2.57e-14 0.5390 -0.522000 1.35e-01 -0.022000 1.67e-15 3.90e-02 0.737000
Disorders of Developmental Biology 15 1.38e-03 4.58e-03 0.5390 0.143000 5.02e-01 -0.136000 3.36e-01 7.69e-04 0.361000
Cap-dependent Translation Initiation 86 2.20e-17 1.12e-15 0.5390 -0.525000 1.20e-01 -0.030800 4.06e-17 5.50e-02 0.622000
Eukaryotic Translation Initiation 86 2.20e-17 1.12e-15 0.5390 -0.525000 1.20e-01 -0.030800 4.06e-17 5.50e-02 0.622000
DARPP-32 events 21 9.56e-04 3.36e-03 0.5390 0.163000 5.00e-01 0.118000 1.96e-01 7.28e-05 0.347000
AUF1 (hnRNP D0) binds and destabilizes mRNA 39 7.57e-09 9.24e-08 0.5380 -0.337000 4.20e-01 -0.020100 2.76e-04 5.79e-06 0.828000
GTP hydrolysis and joining of the 60S ribosomal subunit 79 6.98e-16 2.62e-14 0.5380 -0.526000 1.13e-01 -0.008770 6.33e-16 8.41e-02 0.893000
Regulation of activated PAK-2p34 by proteasome mediated degradation 35 5.89e-08 5.57e-07 0.5380 -0.370000 3.89e-01 -0.033500 1.53e-04 6.93e-05 0.732000
PI-3K cascade:FGFR2 10 7.85e-02 1.27e-01 0.5370 0.370000 3.41e-01 0.186000 4.27e-02 6.17e-02 0.308000
Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A 41 3.06e-09 4.46e-08 0.5360 -0.352000 4.04e-01 -0.028400 9.74e-05 7.76e-06 0.753000
p53-Independent G1/S DNA Damage Checkpoint 41 3.06e-09 4.46e-08 0.5360 -0.352000 4.04e-01 -0.028400 9.74e-05 7.76e-06 0.753000
Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects 13 1.13e-02 2.64e-02 0.5360 0.527000 9.83e-02 -0.003230 1.00e-03 5.40e-01 0.984000
Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) 13 1.13e-02 2.64e-02 0.5360 0.527000 9.83e-02 -0.003230 1.00e-03 5.40e-01 0.984000
HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand 40 1.82e-06 1.26e-05 0.5350 0.420000 3.19e-01 0.094900 4.40e-06 4.92e-04 0.299000
Pre-NOTCH Processing in Golgi 15 4.39e-03 1.21e-02 0.5320 0.334000 -3.05e-01 -0.280000 2.52e-02 4.09e-02 0.060500
Constitutive Signaling by EGFRvIII 15 1.14e-02 2.64e-02 0.5320 0.427000 3.06e-01 0.080600 4.16e-03 4.03e-02 0.589000
Signaling by EGFRvIII in Cancer 15 1.14e-02 2.64e-02 0.5320 0.427000 3.06e-01 0.080600 4.16e-03 4.03e-02 0.589000
Signaling by BMP 26 2.68e-04 1.10e-03 0.5310 0.404000 3.35e-01 0.081200 3.60e-04 3.14e-03 0.474000
Degradation of DVL 41 5.80e-09 7.20e-08 0.5290 -0.334000 4.11e-01 -0.015500 2.20e-04 5.38e-06 0.864000
Vpu mediated degradation of CD4 37 3.19e-08 3.23e-07 0.5290 -0.370000 3.72e-01 -0.064600 1.01e-04 8.90e-05 0.497000
Fibronectin matrix formation 16 1.34e-03 4.52e-03 0.5280 0.192000 -4.92e-01 -0.004960 1.84e-01 6.51e-04 0.973000
Downregulation of SMAD2/3:SMAD4 transcriptional activity 31 6.58e-05 3.18e-04 0.5270 0.271000 4.37e-01 0.117000 8.92e-03 2.56e-05 0.261000
HDMs demethylate histones 21 7.77e-04 2.84e-03 0.5270 0.380000 3.65e-01 -0.016200 2.58e-03 3.81e-03 0.898000
Regulation of NPAS4 gene expression 12 2.32e-02 4.79e-02 0.5250 0.451000 2.68e-01 -0.020500 6.89e-03 1.08e-01 0.902000
Signaling by FGFR3 in disease 12 2.80e-02 5.59e-02 0.5240 0.394000 3.45e-01 0.022200 1.82e-02 3.83e-02 0.894000
GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 40 1.43e-08 1.56e-07 0.5240 -0.338000 4.00e-01 -0.016000 2.19e-04 1.20e-05 0.861000
Signaling by PDGFR in disease 18 4.06e-03 1.13e-02 0.5210 0.412000 3.17e-01 0.035400 2.47e-03 2.00e-02 0.795000
SHC1 events in EGFR signaling 10 6.85e-02 1.14e-01 0.5210 0.458000 2.27e-01 0.098000 1.21e-02 2.14e-01 0.592000
TICAM1, RIP1-mediated IKK complex recruitment 18 1.45e-03 4.76e-03 0.5200 0.115000 5.07e-01 -0.010300 3.96e-01 1.95e-04 0.939000
Cardiogenesis 13 1.89e-02 4.04e-02 0.5190 0.102000 5.01e-01 0.090100 5.26e-01 1.75e-03 0.574000
Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes 62 4.25e-09 5.73e-08 0.5190 0.325000 3.88e-01 0.115000 9.64e-06 1.26e-07 0.117000
Epigenetic regulation of gene expression by MLL3 and MLL4 complexes 62 4.25e-09 5.73e-08 0.5190 0.325000 3.88e-01 0.115000 9.64e-06 1.26e-07 0.117000
MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis 62 4.25e-09 5.73e-08 0.5190 0.325000 3.88e-01 0.115000 9.64e-06 1.26e-07 0.117000
Mitochondrial ribosome-associated quality control 61 4.69e-12 1.12e-10 0.5190 -0.465000 2.31e-01 0.010300 3.52e-10 1.78e-03 0.889000
GLI3 is processed to GLI3R by the proteasome 44 4.68e-09 6.01e-08 0.5170 -0.330000 3.98e-01 0.007360 1.52e-04 4.96e-06 0.933000
Formation of the canonical BAF (cBAF) complex 17 1.75e-03 5.59e-03 0.5170 0.206000 4.65e-01 -0.088100 1.41e-01 8.96e-04 0.530000
Paracetamol ADME 11 5.93e-02 1.02e-01 0.5160 -0.437000 -1.45e-01 -0.233000 1.22e-02 4.06e-01 0.181000
Hh mutants abrogate ligand secretion 39 3.65e-08 3.59e-07 0.5150 -0.332000 3.93e-01 -0.031900 3.38e-04 2.20e-05 0.730000
Hh mutants are degraded by ERAD 39 3.65e-08 3.59e-07 0.5150 -0.332000 3.93e-01 -0.031900 3.38e-04 2.20e-05 0.730000
Regulation of MITF-M-dependent genes involved in apoptosis 14 2.08e-02 4.40e-02 0.5110 0.309000 4.02e-01 0.063900 4.50e-02 9.27e-03 0.679000
Defective B3GAT3 causes JDSSDHD 12 2.19e-02 4.58e-02 0.5110 0.317000 -2.57e-01 -0.307000 5.74e-02 1.23e-01 0.065200
Ubiquitin-dependent degradation of Cyclin D 37 1.11e-07 9.68e-07 0.5110 -0.340000 3.78e-01 -0.049100 3.51e-04 6.90e-05 0.605000
Signaling by NODAL 13 3.23e-02 6.30e-02 0.5100 0.339000 3.73e-01 0.081500 3.43e-02 2.00e-02 0.611000
SCF-beta-TrCP mediated degradation of Emi1 39 5.86e-08 5.57e-07 0.5100 -0.350000 3.70e-01 -0.025300 1.54e-04 6.37e-05 0.784000
Regulation of expression of SLITs and ROBOs 114 1.85e-21 3.30e-19 0.5090 -0.462000 2.14e-01 0.004820 1.58e-17 8.26e-05 0.929000
Activation of NF-kappaB in B cells 47 1.56e-09 2.39e-08 0.5090 -0.307000 4.05e-01 -0.022100 2.71e-04 1.54e-06 0.793000
Regulation of ornithine decarboxylase (ODC) 33 9.80e-07 7.17e-06 0.5080 -0.362000 3.54e-01 -0.036100 3.15e-04 4.28e-04 0.720000
Degradation of GLI1 by the proteasome 43 1.03e-08 1.19e-07 0.5060 -0.308000 4.01e-01 -0.033500 4.84e-04 5.43e-06 0.704000
Nephrin family interactions 17 2.97e-03 8.62e-03 0.5060 0.470000 1.19e-01 -0.145000 8.05e-04 3.97e-01 0.300000
Activated NOTCH1 Transmits Signal to the Nucleus 26 3.35e-05 1.73e-04 0.5050 0.330000 4.79e-02 -0.379000 3.64e-03 6.72e-01 0.000824
RUNX3 regulates NOTCH signaling 12 3.01e-02 5.92e-02 0.5040 0.409000 2.92e-01 -0.040200 1.43e-02 8.03e-02 0.809000
Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells 27 4.63e-04 1.78e-03 0.5030 0.293000 4.01e-01 0.078400 8.47e-03 3.12e-04 0.481000
O-glycosylation of TSR domain-containing proteins 25 1.25e-03 4.26e-03 0.5030 0.009710 -4.25e-01 -0.267000 9.33e-01 2.32e-04 0.020700
Regulation of Apoptosis 38 2.50e-07 2.07e-06 0.5020 -0.309000 3.95e-01 0.024900 1.00e-03 2.55e-05 0.791000
Formation of the ternary complex, and subsequently, the 43S complex 37 1.19e-06 8.49e-06 0.5010 -0.477000 1.26e-01 -0.088800 5.07e-07 1.86e-01 0.350000
Degradation of CRY and PER proteins 46 1.22e-08 1.39e-07 0.5010 -0.224000 4.46e-01 0.033900 8.49e-03 1.65e-07 0.691000
Glycogen storage diseases 13 1.18e-02 2.70e-02 0.5010 -0.219000 4.46e-01 0.058700 1.72e-01 5.33e-03 0.714000
HSF1-dependent transactivation 26 1.83e-04 8.17e-04 0.5000 0.326000 3.76e-01 -0.055700 4.03e-03 9.19e-04 0.623000
Mitochondrial translation initiation 61 3.82e-11 7.79e-10 0.5000 -0.449000 2.19e-01 0.026000 1.33e-09 3.17e-03 0.726000
Hedgehog ligand biogenesis 42 2.05e-08 2.17e-07 0.5000 -0.342000 3.57e-01 -0.075800 1.28e-04 6.30e-05 0.396000
Downregulation of ERBB2:ERBB3 signaling 12 1.62e-02 3.60e-02 0.4980 -0.256000 1.19e-01 -0.411000 1.25e-01 4.77e-01 0.013700
WNT5A-dependent internalization of FZD4 12 6.47e-03 1.68e-02 0.4960 0.046400 3.00e-01 -0.393000 7.81e-01 7.19e-02 0.018500
Regulation of TP53 Degradation 28 8.72e-05 4.11e-04 0.4950 0.175000 4.63e-01 -0.019300 1.10e-01 2.22e-05 0.860000
Regulation of TP53 Expression and Degradation 28 8.72e-05 4.11e-04 0.4950 0.175000 4.63e-01 -0.019300 1.10e-01 2.22e-05 0.860000
Defective CFTR causes cystic fibrosis 42 5.17e-08 5.02e-07 0.4950 -0.294000 3.99e-01 -0.003100 9.95e-04 7.77e-06 0.972000
Formation of the cornified envelope 13 4.97e-02 8.80e-02 0.4950 0.021300 -2.98e-01 -0.394000 8.94e-01 6.29e-02 0.013800
Keratinization 13 4.97e-02 8.80e-02 0.4950 0.021300 -2.98e-01 -0.394000 8.94e-01 6.29e-02 0.013800
Mitochondrial translation termination 62 4.22e-11 8.48e-10 0.4940 -0.441000 2.21e-01 0.016200 1.85e-09 2.59e-03 0.826000
Degradation of GLI2 by the proteasome 44 2.29e-08 2.37e-07 0.4940 -0.319000 3.77e-01 -0.013400 2.57e-04 1.53e-05 0.878000
Expression of BMAL (ARNTL), CLOCK, and NPAS2 33 7.72e-05 3.69e-04 0.4930 0.232000 4.29e-01 0.072200 2.11e-02 1.97e-05 0.473000
Regulation of CDH1 Gene Transcription 36 5.77e-05 2.82e-04 0.4930 0.234000 4.18e-01 0.117000 1.51e-02 1.43e-05 0.225000
Regulation of glycolysis by fructose 2,6-bisphosphate metabolism 11 3.33e-02 6.45e-02 0.4930 0.172000 4.59e-01 -0.056100 3.23e-01 8.45e-03 0.747000
Rap1 signalling 13 3.60e-02 6.82e-02 0.4930 0.317000 3.75e-01 0.044600 4.82e-02 1.93e-02 0.781000
Myogenesis 25 8.12e-04 2.96e-03 0.4920 0.195000 4.47e-01 0.067900 9.18e-02 1.10e-04 0.557000
SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion 12 2.40e-02 4.91e-02 0.4920 0.291000 -1.01e-01 -0.384000 8.14e-02 5.43e-01 0.021300
Synaptic adhesion-like molecules 11 8.72e-02 1.39e-01 0.4910 -0.321000 -3.52e-01 -0.119000 6.56e-02 4.34e-02 0.493000
Autodegradation of the E3 ubiquitin ligase COP1 37 5.27e-07 4.07e-06 0.4900 -0.369000 3.18e-01 -0.051700 1.03e-04 8.22e-04 0.587000
Interleukin-4 and Interleukin-13 signaling 63 6.56e-09 8.08e-08 0.4900 0.456000 9.41e-02 0.153000 4.04e-10 1.97e-01 0.035800
Defective B4GALT7 causes EDS, progeroid type 12 3.42e-02 6.59e-02 0.4890 0.277000 -2.56e-01 -0.311000 9.64e-02 1.25e-01 0.062300
Prolonged ERK activation events 12 3.66e-02 6.89e-02 0.4880 0.200000 4.45e-01 0.006170 2.30e-01 7.61e-03 0.970000
Mitochondrial unfolded protein response (UPRmt) 13 3.94e-02 7.31e-02 0.4870 0.395000 2.83e-01 0.039300 1.37e-02 7.71e-02 0.806000
Interleukin-15 signaling 11 5.48e-02 9.56e-02 0.4870 0.363000 3.23e-01 -0.029600 3.73e-02 6.37e-02 0.865000
Interleukin-7 signaling 12 2.74e-02 5.49e-02 0.4860 0.373000 2.86e-01 -0.124000 2.54e-02 8.59e-02 0.455000
MAPK targets/ Nuclear events mediated by MAP kinases 29 3.00e-04 1.21e-03 0.4860 0.321000 3.64e-01 0.031000 2.82e-03 6.94e-04 0.773000
Activation of BH3-only proteins 24 2.24e-03 6.95e-03 0.4860 0.325000 3.51e-01 0.084800 5.79e-03 2.95e-03 0.472000
Negative regulation of NOTCH4 signaling 42 6.36e-08 5.90e-07 0.4860 -0.336000 3.44e-01 -0.067700 1.64e-04 1.16e-04 0.448000
Orc1 removal from chromatin 47 2.36e-08 2.42e-07 0.4850 -0.397000 2.79e-01 0.012800 2.49e-06 9.49e-04 0.879000
BMAL1:CLOCK,NPAS2 activates circadian expression 22 4.41e-03 1.22e-02 0.4830 0.399000 2.54e-01 0.102000 1.21e-03 3.96e-02 0.406000
APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint 51 3.31e-09 4.73e-08 0.4830 -0.342000 3.41e-01 -0.013300 2.39e-05 2.61e-05 0.869000
Cdc20:Phospho-APC/C mediated degradation of Cyclin A 51 3.31e-09 4.73e-08 0.4830 -0.342000 3.41e-01 -0.013300 2.39e-05 2.61e-05 0.869000
Mitochondrial translation elongation 60 2.95e-10 5.08e-09 0.4820 -0.419000 2.35e-01 0.040000 1.97e-08 1.64e-03 0.593000
NIK–>noncanonical NF-kB signaling 43 6.83e-08 6.17e-07 0.4820 -0.253000 4.09e-01 -0.025400 4.05e-03 3.44e-06 0.774000
APC/C:Cdc20 mediated degradation of Securin 49 8.03e-09 9.72e-08 0.4820 -0.343000 3.38e-01 -0.014600 3.33e-05 4.21e-05 0.860000
Downstream signaling of activated FGFR3 15 1.76e-02 3.82e-02 0.4820 0.404000 2.60e-01 -0.028800 6.72e-03 8.09e-02 0.847000
Anchoring fibril formation 13 2.27e-02 4.74e-02 0.4810 -0.044900 -4.79e-01 -0.016200 7.79e-01 2.79e-03 0.920000
Regulation of IFNG signaling 11 1.16e-01 1.74e-01 0.4810 0.205000 3.86e-01 0.201000 2.40e-01 2.67e-02 0.247000
Dectin-1 mediated noncanonical NF-kB signaling 44 5.34e-08 5.16e-07 0.4800 -0.252000 4.08e-01 -0.023100 3.83e-03 2.83e-06 0.791000
Downstream signaling events of B Cell Receptor (BCR) 60 2.32e-10 4.14e-09 0.4800 -0.220000 4.25e-01 0.026300 3.18e-03 1.23e-08 0.724000
Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha 47 2.10e-08 2.21e-07 0.4790 -0.285000 3.85e-01 -0.009220 7.25e-04 5.07e-06 0.913000
Regulation of RUNX1 Expression and Activity 17 5.14e-03 1.39e-02 0.4780 0.429000 1.28e-01 -0.169000 2.22e-03 3.60e-01 0.227000
Downstream signaling of activated FGFR2 17 1.70e-02 3.71e-02 0.4770 0.389000 2.69e-01 0.063000 5.51e-03 5.51e-02 0.653000
CRMPs in Sema3A signaling 13 2.93e-02 5.78e-02 0.4770 0.269000 -2.11e-01 -0.332000 9.26e-02 1.87e-01 0.038500
Cross-presentation of soluble exogenous antigens (endosomes) 34 4.45e-06 2.84e-05 0.4760 -0.371000 2.94e-01 -0.048900 1.82e-04 2.98e-03 0.622000
SCF(Skp2)-mediated degradation of p27/p21 41 2.30e-07 1.92e-06 0.4750 -0.295000 3.70e-01 -0.038800 1.09e-03 4.18e-05 0.667000
Signaling by KIT in disease 18 3.52e-03 1.00e-02 0.4740 0.416000 1.03e-01 -0.203000 2.24e-03 4.49e-01 0.136000
Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants 18 3.52e-03 1.00e-02 0.4740 0.416000 1.03e-01 -0.203000 2.24e-03 4.49e-01 0.136000
Degradation of AXIN 39 4.78e-07 3.74e-06 0.4740 -0.296000 3.68e-01 -0.048600 1.38e-03 7.17e-05 0.599000
Defective B3GALTL causes PpS 24 3.07e-03 8.86e-03 0.4740 0.039600 -4.05e-01 -0.243000 7.37e-01 6.01e-04 0.039500
Synthesis of PIPs at the early endosome membrane 16 1.58e-02 3.51e-02 0.4730 0.333000 3.36e-01 -0.015300 2.12e-02 1.99e-02 0.916000
Maturation of hRSV A proteins 11 3.80e-02 7.11e-02 0.4720 0.068300 4.62e-01 -0.062000 6.95e-01 7.91e-03 0.722000
Cellular response to hypoxia 52 8.45e-09 1.01e-07 0.4720 -0.208000 4.23e-01 0.011800 9.56e-03 1.32e-07 0.883000
TGF-beta receptor signaling activates SMADs 43 3.15e-05 1.67e-04 0.4710 0.311000 3.33e-01 0.118000 4.13e-04 1.56e-04 0.182000
RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function 29 9.67e-05 4.53e-04 0.4700 0.347000 2.83e-01 -0.143000 1.23e-03 8.35e-03 0.184000
Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells 11 7.58e-02 1.23e-01 0.4700 0.367000 2.93e-01 -0.004910 3.53e-02 9.20e-02 0.977000
RHOV GTPase cycle 32 3.89e-05 1.98e-04 0.4690 0.338000 2.98e-01 -0.130000 9.31e-04 3.56e-03 0.204000
Scavenging by Class A Receptors 11 4.35e-02 7.84e-02 0.4690 0.105000 -4.56e-01 -0.023700 5.47e-01 8.83e-03 0.892000
Autodegradation of Cdh1 by Cdh1:APC/C 50 1.40e-08 1.55e-07 0.4680 -0.335000 3.25e-01 -0.033900 4.16e-05 7.08e-05 0.679000
Mitochondrial translation 70 2.68e-11 5.80e-10 0.4670 -0.401000 2.39e-01 0.016900 6.64e-09 5.65e-04 0.807000
Heme signaling 42 7.91e-05 3.76e-04 0.4660 0.280000 3.39e-01 0.153000 1.69e-03 1.44e-04 0.086100
APC/C:Cdc20 mediated degradation of mitotic proteins 52 9.71e-09 1.13e-07 0.4650 -0.329000 3.29e-01 -0.014200 4.19e-05 4.02e-05 0.859000
Apoptotic cleavage of cellular proteins 28 2.80e-04 1.15e-03 0.4650 0.306000 3.43e-01 -0.073700 5.06e-03 1.70e-03 0.500000
PI-3K cascade:FGFR1 11 1.08e-01 1.64e-01 0.4650 0.337000 3.09e-01 0.085500 5.31e-02 7.57e-02 0.623000
Signaling by FGFR4 in disease 11 7.72e-02 1.25e-01 0.4650 0.372000 2.79e-01 -0.016900 3.27e-02 1.09e-01 0.923000
Glycogen metabolism 23 4.94e-03 1.35e-02 0.4650 -0.019300 4.10e-01 0.219000 8.73e-01 6.68e-04 0.069100
Activation of the AP-1 family of transcription factors 10 9.36e-02 1.47e-01 0.4650 0.384000 2.58e-01 -0.044800 3.53e-02 1.59e-01 0.806000
Assembly of collagen fibrils and other multimeric structures 44 8.92e-06 5.28e-05 0.4650 -0.042300 -4.45e-01 -0.127000 6.28e-01 3.26e-07 0.145000
Diseases associated with O-glycosylation of proteins 40 1.39e-04 6.32e-04 0.4650 -0.037700 -3.73e-01 -0.274000 6.80e-01 4.41e-05 0.002740
Disassembly of the destruction complex and recruitment of AXIN to the membrane 25 4.26e-04 1.66e-03 0.4630 0.194000 4.10e-01 -0.093400 9.37e-02 3.83e-04 0.419000
Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA 13 3.40e-02 6.57e-02 0.4630 0.170000 4.30e-01 -0.019900 2.89e-01 7.24e-03 0.901000
Respiratory electron transport 107 7.84e-17 3.39e-15 0.4630 -0.401000 2.30e-01 0.012900 7.56e-13 4.20e-05 0.818000
Estrogen-dependent gene expression 76 1.07e-09 1.70e-08 0.4620 0.307000 3.44e-01 0.024200 3.66e-06 2.17e-07 0.716000
Signaling by SCF-KIT 34 4.14e-05 2.09e-04 0.4610 0.431000 1.17e-01 -0.117000 1.39e-05 2.38e-01 0.240000
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) 84 5.84e-13 1.64e-11 0.4610 -0.422000 1.85e-01 0.006750 2.26e-11 3.41e-03 0.915000
Nonsense-Mediated Decay (NMD) 84 5.84e-13 1.64e-11 0.4610 -0.422000 1.85e-01 0.006750 2.26e-11 3.41e-03 0.915000
Apoptotic execution phase 35 3.88e-05 1.98e-04 0.4600 0.298000 3.44e-01 -0.069100 2.28e-03 4.36e-04 0.480000
Gastrin-CREB signalling pathway via PKC and MAPK 13 4.17e-02 7.63e-02 0.4600 0.361000 2.80e-01 -0.050200 2.41e-02 8.03e-02 0.754000
Proteasome assembly 43 5.45e-07 4.15e-06 0.4590 -0.373000 2.65e-01 -0.030600 2.31e-05 2.63e-03 0.728000
Signaling by NTRK1 (TRKA) 93 2.68e-12 6.61e-11 0.4590 0.347000 2.99e-01 -0.027700 7.57e-09 6.43e-07 0.645000
Golgi Associated Vesicle Biogenesis 44 3.28e-05 1.71e-04 0.4580 0.264000 3.62e-01 0.097000 2.46e-03 3.32e-05 0.266000
RHOBTB2 GTPase cycle 21 3.12e-03 8.99e-03 0.4570 0.335000 2.98e-01 -0.091400 7.90e-03 1.82e-02 0.469000
mRNA decay by 5’ to 3’ exoribonuclease 13 2.40e-02 4.91e-02 0.4570 0.197000 3.93e-01 -0.123000 2.18e-01 1.41e-02 0.442000
rRNA processing in the mitochondrion 11 5.45e-02 9.53e-02 0.4560 -0.429000 1.55e-01 0.006430 1.38e-02 3.73e-01 0.971000
Stabilization of p53 40 1.46e-06 1.03e-05 0.4540 -0.311000 3.30e-01 -0.034700 6.78e-04 3.09e-04 0.704000
TRP channels 11 1.12e-01 1.69e-01 0.4540 0.101000 -2.66e-01 -0.354000 5.64e-01 1.27e-01 0.041800
WNT5A-dependent internalization of FZD2, FZD5 and ROR2 11 2.42e-02 4.94e-02 0.4530 -0.057300 2.83e-01 -0.350000 7.42e-01 1.05e-01 0.044500
Formation of the embryonic stem cell BAF (esBAF) complex 17 3.71e-03 1.05e-02 0.4530 0.036800 4.22e-01 -0.161000 7.93e-01 2.59e-03 0.251000
M-decay: degradation of maternal mRNAs by maternally stored factors 35 5.38e-05 2.65e-04 0.4530 0.346000 2.80e-01 -0.085400 3.96e-04 4.21e-03 0.382000
HSF1 activation 22 6.04e-03 1.59e-02 0.4530 0.247000 3.77e-01 0.040400 4.46e-02 2.19e-03 0.743000
Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins 53 1.85e-08 1.99e-07 0.4530 -0.330000 3.10e-01 -0.022600 3.35e-05 9.59e-05 0.776000
CD28 dependent PI3K/Akt signaling 16 1.06e-02 2.51e-02 0.4520 0.239000 3.62e-01 -0.128000 9.83e-02 1.21e-02 0.377000
Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) 21 1.52e-03 4.95e-03 0.4520 0.124000 4.18e-01 -0.120000 3.26e-01 9.18e-04 0.343000
Regulation of RUNX2 expression and activity 51 6.48e-08 5.93e-07 0.4500 -0.159000 4.21e-01 -0.002240 4.93e-02 1.99e-07 0.978000
Formation of apoptosome 11 4.13e-02 7.59e-02 0.4500 -0.005640 4.39e-01 -0.099300 9.74e-01 1.17e-02 0.569000
Regulation of the apoptosome activity 11 4.13e-02 7.59e-02 0.4500 -0.005640 4.39e-01 -0.099300 9.74e-01 1.17e-02 0.569000
Repression of WNT target genes 12 2.92e-02 5.77e-02 0.4500 0.223000 9.96e-02 -0.378000 1.81e-01 5.50e-01 0.023500
Maternal to zygotic transition (MZT) 49 1.02e-06 7.39e-06 0.4490 0.321000 3.06e-01 -0.073300 1.03e-04 2.15e-04 0.375000
RAF activation 34 4.03e-05 2.04e-04 0.4490 0.144000 4.20e-01 -0.070200 1.47e-01 2.30e-05 0.479000
Synthesis of glycosylphosphatidylinositol (GPI) 14 4.18e-02 7.63e-02 0.4470 -0.429000 -1.25e-01 0.012400 5.42e-03 4.17e-01 0.936000
Purine salvage 13 3.63e-02 6.84e-02 0.4470 -0.348000 2.40e-01 0.145000 2.97e-02 1.33e-01 0.366000
Formation of the beta-catenin:TCF transactivating complex 26 8.50e-04 3.07e-03 0.4470 0.294000 3.24e-01 -0.089900 9.44e-03 4.21e-03 0.428000
Keratan sulfate biosynthesis 19 1.03e-02 2.45e-02 0.4460 0.409000 -1.84e-02 0.177000 2.02e-03 8.89e-01 0.181000
Regulation of KIT signaling 14 2.69e-02 5.40e-02 0.4460 0.387000 -8.73e-02 -0.205000 1.22e-02 5.72e-01 0.184000
CDK-mediated phosphorylation and removal of Cdc6 51 5.69e-08 5.45e-07 0.4450 -0.317000 3.10e-01 -0.040900 8.92e-05 1.31e-04 0.614000
Co-inhibition by PD-1 13 2.38e-02 4.89e-02 0.4450 0.240000 -3.73e-01 0.039500 1.34e-01 1.99e-02 0.805000
Ephrin signaling 15 1.68e-02 3.68e-02 0.4450 0.326000 2.48e-01 -0.176000 2.91e-02 9.67e-02 0.239000
FCERI mediated NF-kB activation 60 3.02e-09 4.46e-08 0.4450 -0.179000 4.07e-01 -0.021100 1.66e-02 5.21e-08 0.778000
Regulation of CDH11 Expression and Function 25 2.35e-03 7.23e-03 0.4430 0.291000 3.33e-01 -0.024600 1.18e-02 3.97e-03 0.832000
Circadian clock 99 6.27e-13 1.72e-11 0.4410 0.059600 4.37e-01 0.020300 3.07e-01 6.13e-14 0.728000
IKK complex recruitment mediated by RIP1 20 7.22e-03 1.82e-02 0.4410 0.176000 4.04e-01 -0.021200 1.73e-01 1.77e-03 0.870000
Signaling by EGFR in Cancer 21 1.61e-02 3.57e-02 0.4400 0.308000 3.03e-01 0.087700 1.46e-02 1.64e-02 0.487000
Transcriptional regulation of brown and beige adipocyte differentiation 25 1.78e-03 5.68e-03 0.4400 0.302000 3.13e-01 -0.068000 8.88e-03 6.80e-03 0.556000
Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 25 1.78e-03 5.68e-03 0.4400 0.302000 3.13e-01 -0.068000 8.88e-03 6.80e-03 0.556000
ABC transporters in lipid homeostasis 11 1.76e-01 2.41e-01 0.4400 -0.304000 -1.90e-01 -0.256000 8.12e-02 2.74e-01 0.142000
Metabolism of polyamines 40 2.70e-06 1.82e-05 0.4400 -0.314000 2.95e-01 -0.088600 5.90e-04 1.24e-03 0.332000
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer 49 2.54e-05 1.37e-04 0.4400 0.243000 3.54e-01 0.097100 3.33e-03 1.86e-05 0.240000
Processing of SMDT1 14 2.23e-02 4.66e-02 0.4390 -0.364000 2.17e-01 -0.115000 1.84e-02 1.60e-01 0.457000
Erythropoietin activates RAS 12 5.56e-02 9.67e-02 0.4390 0.394000 1.15e-01 -0.155000 1.82e-02 4.89e-01 0.354000
Integrin cell surface interactions 58 7.55e-08 6.69e-07 0.4390 0.185000 -3.86e-01 -0.093700 1.49e-02 3.63e-07 0.218000
Regulation of PTEN stability and activity 51 1.91e-07 1.62e-06 0.4380 -0.165000 4.06e-01 0.010300 4.19e-02 5.36e-07 0.899000
Cell recruitment (pro-inflammatory response) 17 1.87e-02 4.01e-02 0.4380 0.358000 -4.30e-02 0.248000 1.06e-02 7.59e-01 0.076300
Purinergic signaling in leishmaniasis infection 17 1.87e-02 4.01e-02 0.4380 0.358000 -4.30e-02 0.248000 1.06e-02 7.59e-01 0.076300
SUMOylation of intracellular receptors 26 6.67e-03 1.71e-02 0.4380 0.292000 3.06e-01 0.113000 9.99e-03 6.98e-03 0.319000
TICAM1,TRAF6-dependent induction of TAK1 complex 11 8.06e-02 1.30e-01 0.4370 0.019900 4.36e-01 0.014500 9.09e-01 1.23e-02 0.934000
Downstream signaling of activated FGFR4 17 2.29e-02 4.77e-02 0.4360 0.385000 2.01e-01 -0.037500 5.96e-03 1.51e-01 0.789000
Sensory perception of taste 10 1.32e-01 1.92e-01 0.4360 -0.319000 8.38e-03 -0.298000 8.11e-02 9.63e-01 0.103000
Amino acid transport across the plasma membrane 21 1.03e-02 2.44e-02 0.4360 -0.154000 3.40e-01 0.225000 2.23e-01 7.05e-03 0.074000
FRS-mediated FGFR3 signaling 10 8.95e-02 1.42e-01 0.4360 0.361000 1.25e-01 -0.208000 4.80e-02 4.92e-01 0.254000
Somitogenesis 37 1.00e-05 5.89e-05 0.4350 -0.290000 3.16e-01 -0.070000 2.25e-03 8.76e-04 0.462000
RHO GTPases activate PKNs 30 8.56e-04 3.08e-03 0.4340 0.327000 2.84e-01 -0.030400 1.93e-03 7.12e-03 0.774000
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 52 1.37e-07 1.16e-06 0.4310 -0.314000 2.95e-01 -0.031100 9.25e-05 2.39e-04 0.698000
ERKs are inactivated 12 2.87e-02 5.72e-02 0.4310 0.027800 3.72e-01 -0.215000 8.68e-01 2.56e-02 0.197000
Signaling by TGF-beta Receptor Complex 84 1.94e-08 2.07e-07 0.4310 0.284000 3.09e-01 0.098300 7.15e-06 9.92e-07 0.120000
Regulation of Expression and Function of Type II Classical Cadherins 26 2.30e-03 7.12e-03 0.4300 0.317000 2.86e-01 -0.050000 5.13e-03 1.15e-02 0.659000
RET signaling 27 8.03e-04 2.93e-03 0.4300 0.365000 1.47e-01 -0.173000 1.02e-03 1.88e-01 0.121000
RMTs methylate histone arginines 26 8.51e-04 3.07e-03 0.4290 0.035700 4.25e-01 -0.052100 7.53e-01 1.78e-04 0.646000
PI-3K cascade:FGFR4 10 1.64e-01 2.26e-01 0.4290 0.364000 2.26e-01 0.015200 4.62e-02 2.15e-01 0.934000
Regulation of APC/C activators between G1/S and early anaphase 58 2.91e-08 2.97e-07 0.4280 -0.298000 3.08e-01 -0.011300 8.83e-05 5.14e-05 0.881000
Formation of the polybromo-BAF (pBAF) complex 18 6.64e-03 1.71e-02 0.4280 0.005820 4.16e-01 -0.100000 9.66e-01 2.24e-03 0.462000
Translation 205 2.88e-27 1.03e-24 0.4280 -0.386000 1.84e-01 -0.021800 2.00e-21 6.14e-06 0.591000
ERK/MAPK targets 20 6.67e-03 1.71e-02 0.4270 0.220000 3.53e-01 -0.098900 8.88e-02 6.33e-03 0.444000
Mitochondrial calcium ion transport 21 2.85e-03 8.37e-03 0.4260 -0.322000 2.48e-01 -0.127000 1.05e-02 4.94e-02 0.312000
IRS-mediated signalling 26 2.51e-03 7.67e-03 0.4260 0.273000 3.24e-01 -0.042000 1.58e-02 4.23e-03 0.711000
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants 52 4.16e-07 3.30e-06 0.4260 0.228000 3.37e-01 -0.127000 4.48e-03 2.69e-05 0.113000
Constitutive Signaling by NOTCH1 PEST Domain Mutants 52 4.16e-07 3.30e-06 0.4260 0.228000 3.37e-01 -0.127000 4.48e-03 2.69e-05 0.113000
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer 52 4.16e-07 3.30e-06 0.4260 0.228000 3.37e-01 -0.127000 4.48e-03 2.69e-05 0.113000
Signaling by NOTCH1 PEST Domain Mutants in Cancer 52 4.16e-07 3.30e-06 0.4260 0.228000 3.37e-01 -0.127000 4.48e-03 2.69e-05 0.113000
Signaling by NOTCH1 in Cancer 52 4.16e-07 3.30e-06 0.4260 0.228000 3.37e-01 -0.127000 4.48e-03 2.69e-05 0.113000
Elastic fibre formation 35 1.97e-04 8.62e-04 0.4260 0.248000 -2.95e-01 -0.182000 1.12e-02 2.56e-03 0.062700
Signaling by TGFBR3 38 4.86e-04 1.86e-03 0.4250 0.313000 2.80e-01 0.064800 8.45e-04 2.83e-03 0.490000
Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) 33 3.23e-05 1.70e-04 0.4250 0.162000 3.04e-01 -0.248000 1.07e-01 2.50e-03 0.013600
Signaling by ERBB2 ECD mutants 15 5.85e-02 1.01e-01 0.4250 0.312000 2.87e-01 0.018000 3.63e-02 5.42e-02 0.904000
Signaling by FGFR1 in disease 30 1.62e-03 5.23e-03 0.4240 0.320000 2.78e-01 -0.001660 2.42e-03 8.41e-03 0.987000
Switching of origins to a post-replicative state 65 8.36e-09 1.00e-07 0.4230 -0.336000 2.58e-01 0.007960 2.94e-06 3.34e-04 0.912000
RIP-mediated NFkB activation via ZBP1 13 7.91e-02 1.28e-01 0.4230 0.298000 2.99e-01 -0.021900 6.30e-02 6.20e-02 0.891000
Translation initiation complex formation 43 9.59e-06 5.66e-05 0.4220 -0.385000 1.64e-01 -0.055600 1.26e-05 6.30e-02 0.528000
Collagen biosynthesis and modifying enzymes 44 2.03e-04 8.87e-04 0.4220 -0.042400 -3.78e-01 -0.183000 6.27e-01 1.46e-05 0.036100
Glycogen breakdown (glycogenolysis) 13 1.25e-01 1.84e-01 0.4220 -0.003080 3.54e-01 0.229000 9.85e-01 2.73e-02 0.152000
NOTCH1 Intracellular Domain Regulates Transcription 45 1.26e-05 7.23e-05 0.4210 0.199000 3.67e-01 -0.052800 2.09e-02 2.02e-05 0.540000
Z-decay: degradation of maternal mRNAs by zygotically expressed factors 11 1.07e-01 1.64e-01 0.4210 0.244000 3.38e-01 -0.055000 1.61e-01 5.20e-02 0.752000
Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S 44 7.49e-06 4.51e-05 0.4200 -0.380000 1.69e-01 -0.062100 1.31e-05 5.27e-02 0.476000
Epigenetic regulation by WDR5-containing histone modifying complexes 91 2.78e-09 4.18e-08 0.4190 0.212000 3.57e-01 0.059200 4.74e-04 4.24e-09 0.330000
Membrane binding and targetting of GAG proteins 12 5.91e-02 1.02e-01 0.4190 -0.155000 3.89e-01 -0.003930 3.52e-01 1.96e-02 0.981000
Synthesis And Processing Of GAG, GAGPOL Polyproteins 12 5.91e-02 1.02e-01 0.4190 -0.155000 3.89e-01 -0.003930 3.52e-01 1.96e-02 0.981000
Uptake and actions of bacterial toxins 22 6.43e-03 1.67e-02 0.4190 0.356000 1.92e-01 -0.107000 3.82e-03 1.19e-01 0.383000
Attachment and Entry 9694614 11 8.46e-02 1.35e-01 0.4190 0.301000 6.96e-04 -0.291000 8.38e-02 9.97e-01 0.094700
Platelet Adhesion to exposed collagen 10 1.10e-01 1.67e-01 0.4190 0.216000 -3.56e-01 -0.038400 2.37e-01 5.11e-02 0.834000
HS-GAG degradation 13 1.68e-01 2.30e-01 0.4180 -0.110000 -2.70e-01 -0.300000 4.92e-01 9.14e-02 0.061600
NCAM1 interactions 25 8.66e-03 2.12e-02 0.4180 -0.021500 -3.91e-01 -0.146000 8.52e-01 7.10e-04 0.206000
Transcriptional activation of mitochondrial biogenesis 49 3.25e-05 1.70e-04 0.4180 0.232000 3.45e-01 0.038800 4.91e-03 2.89e-05 0.639000
Frs2-mediated activation 10 1.06e-01 1.62e-01 0.4180 0.047900 4.10e-01 -0.063400 7.93e-01 2.47e-02 0.728000
Signalling to RAS 17 1.36e-02 3.08e-02 0.4180 0.215000 5.21e-02 -0.355000 1.26e-01 7.10e-01 0.011400
Regulation of mRNA stability by proteins that bind AU-rich elements 68 4.11e-09 5.70e-08 0.4180 -0.077600 4.09e-01 -0.030400 2.69e-01 5.47e-09 0.665000
Formation of annular gap junctions 11 6.96e-02 1.14e-01 0.4170 0.273000 1.88e-01 -0.254000 1.17e-01 2.81e-01 0.145000
IRS-related events triggered by IGF1R 29 1.30e-03 4.39e-03 0.4170 0.274000 3.08e-01 -0.064700 1.07e-02 4.15e-03 0.547000
Signaling by NOTCH1 66 1.18e-08 1.35e-07 0.4170 0.279000 2.64e-01 -0.163000 9.24e-05 2.10e-04 0.022500
Regulation of RUNX3 expression and activity 40 1.07e-05 6.28e-05 0.4170 -0.244000 3.33e-01 -0.056700 7.57e-03 2.71e-04 0.535000
Integrin signaling 20 1.20e-02 2.76e-02 0.4170 0.401000 6.92e-02 -0.091000 1.93e-03 5.92e-01 0.481000
Interleukin-10 signaling 15 4.25e-02 7.70e-02 0.4160 0.412000 1.32e-02 -0.062000 5.79e-03 9.30e-01 0.678000
Activation of GABAB receptors 25 7.49e-03 1.87e-02 0.4160 0.148000 -2.58e-01 -0.291000 2.02e-01 2.55e-02 0.011800
GABA B receptor activation 25 7.49e-03 1.87e-02 0.4160 0.148000 -2.58e-01 -0.291000 2.02e-01 2.55e-02 0.011800
Transcriptional Regulation by NPAS4 28 2.87e-03 8.41e-03 0.4150 0.338000 2.39e-01 -0.024500 1.94e-03 2.84e-02 0.822000
Regulation of MECP2 expression and activity 28 7.20e-04 2.66e-03 0.4150 0.189000 3.47e-01 -0.127000 8.31e-02 1.49e-03 0.246000
IGF1R signaling cascade 30 1.21e-03 4.15e-03 0.4150 0.284000 2.98e-01 -0.056400 7.19e-03 4.80e-03 0.593000
PI3K Cascade 22 1.02e-02 2.43e-02 0.4150 0.224000 3.49e-01 -0.016500 6.90e-02 4.65e-03 0.894000
Ubiquinol biosynthesis 11 1.17e-01 1.74e-01 0.4140 -0.263000 2.61e-01 0.186000 1.32e-01 1.34e-01 0.286000
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) 31 9.90e-04 3.47e-03 0.4140 0.284000 2.96e-01 -0.055400 6.18e-03 4.38e-03 0.594000
Nuclear events mediated by NFE2L2 74 4.70e-09 6.01e-08 0.4140 -0.082700 4.04e-01 0.033800 2.19e-01 1.87e-09 0.616000
Collagen degradation 36 4.24e-04 1.66e-03 0.4130 0.050700 -3.95e-01 -0.110000 5.99e-01 4.06e-05 0.255000
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer’s disease models 17 4.18e-02 7.63e-02 0.4130 0.205000 3.58e-01 0.025600 1.44e-01 1.06e-02 0.855000
Neurodegenerative Diseases 17 4.18e-02 7.63e-02 0.4130 0.205000 3.58e-01 0.025600 1.44e-01 1.06e-02 0.855000
Downstream signaling of activated FGFR1 21 1.85e-02 3.98e-02 0.4130 0.352000 2.17e-01 0.008340 5.30e-03 8.55e-02 0.947000
RUNX1 regulates transcription of genes involved in differentiation of HSCs 52 4.80e-07 3.74e-06 0.4120 -0.201000 3.58e-01 -0.030700 1.22e-02 7.83e-06 0.702000
Ribosomal scanning and start codon recognition 43 2.25e-05 1.22e-04 0.4120 -0.388000 1.32e-01 -0.039000 1.07e-05 1.34e-01 0.658000
Cytochrome c-mediated apoptotic response 13 6.96e-02 1.14e-01 0.4120 0.033300 4.10e-01 0.008510 8.35e-01 1.04e-02 0.958000
NOTCH3 Intracellular Domain Regulates Transcription 18 4.90e-02 8.71e-02 0.4110 0.347000 2.06e-01 0.079400 1.08e-02 1.31e-01 0.560000
Transcriptional regulation of white adipocyte differentiation 68 5.69e-06 3.54e-05 0.4110 0.240000 3.03e-01 0.140000 6.41e-04 1.54e-05 0.045800
Transcriptional regulation of granulopoiesis 22 9.80e-03 2.36e-02 0.4110 0.363000 1.79e-01 -0.071000 3.23e-03 1.46e-01 0.565000
Meiotic synapsis 22 1.88e-02 4.03e-02 0.4110 0.206000 3.50e-01 0.057800 9.43e-02 4.45e-03 0.639000
IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation 13 1.18e-01 1.76e-01 0.4100 0.143000 3.76e-01 0.081100 3.72e-01 1.90e-02 0.613000
G1/S DNA Damage Checkpoints 52 5.22e-07 4.05e-06 0.4100 -0.223000 3.42e-01 -0.036400 5.35e-03 2.02e-05 0.650000
Other semaphorin interactions 15 4.23e-02 7.70e-02 0.4090 0.277000 -2.74e-01 -0.125000 6.32e-02 6.64e-02 0.400000
Generation of second messenger molecules 19 9.96e-03 2.39e-02 0.4080 0.308000 -2.66e-01 0.031800 2.01e-02 4.48e-02 0.811000
Asymmetric localization of PCP proteins 46 1.83e-06 1.26e-05 0.4070 -0.230000 3.13e-01 -0.121000 6.97e-03 2.37e-04 0.157000
GAB1 signalosome 13 1.61e-01 2.23e-01 0.4070 0.284000 2.61e-01 0.129000 7.63e-02 1.03e-01 0.422000
Nuclear Receptor transcription pathway 41 1.02e-03 3.56e-03 0.4060 0.204000 3.25e-01 0.130000 2.36e-02 3.16e-04 0.150000
Signaling by FGFR3 29 9.13e-04 3.24e-03 0.4050 0.242000 2.95e-01 -0.136000 2.40e-02 5.96e-03 0.205000
Signaling by TGFB family members 136 1.63e-12 4.22e-11 0.4050 0.293000 2.74e-01 0.054300 3.82e-09 3.83e-08 0.275000
AKT phosphorylates targets in the cytosol 13 7.59e-02 1.23e-01 0.4040 0.313000 2.30e-01 -0.111000 5.06e-02 1.51e-01 0.490000
p53-Dependent G1 DNA Damage Response 45 5.72e-06 3.54e-05 0.4040 -0.246000 3.17e-01 -0.050100 4.40e-03 2.40e-04 0.561000
p53-Dependent G1/S DNA damage checkpoint 45 5.72e-06 3.54e-05 0.4040 -0.246000 3.17e-01 -0.050100 4.40e-03 2.40e-04 0.561000
Protein methylation 14 4.97e-02 8.80e-02 0.4030 -0.172000 3.64e-01 0.028500 2.66e-01 1.84e-02 0.854000
Activation of HOX genes during differentiation 45 1.78e-05 9.90e-05 0.4010 0.219000 3.16e-01 -0.115000 1.12e-02 2.51e-04 0.181000
Activation of anterior HOX genes in hindbrain development during early embryogenesis 45 1.78e-05 9.90e-05 0.4010 0.219000 3.16e-01 -0.115000 1.12e-02 2.51e-04 0.181000
KSRP (KHSRP) binds and destabilizes mRNA 13 4.54e-02 8.15e-02 0.4010 0.148000 3.19e-01 -0.193000 3.57e-01 4.65e-02 0.229000
NOTCH4 Intracellular Domain Regulates Transcription 17 4.57e-02 8.19e-02 0.4000 0.349000 1.94e-01 -0.032900 1.28e-02 1.66e-01 0.814000
IRAK2 mediated activation of TAK1 complex 10 1.52e-01 2.13e-01 0.4000 0.014600 4.00e-01 -0.004160 9.36e-01 2.85e-02 0.982000
Insulin receptor signalling cascade 31 1.37e-03 4.57e-03 0.4000 0.253000 3.03e-01 -0.065800 1.49e-02 3.56e-03 0.526000
Degradation of CDH1 48 3.51e-06 2.28e-05 0.3990 -0.241000 3.16e-01 -0.040800 3.92e-03 1.54e-04 0.625000
COPI-independent Golgi-to-ER retrograde traffic 37 1.17e-04 5.37e-04 0.3990 0.262000 2.51e-01 -0.167000 5.85e-03 8.37e-03 0.078600
Plasma lipoprotein remodeling 17 5.31e-02 9.32e-02 0.3990 0.162000 -2.26e-01 -0.286000 2.46e-01 1.06e-01 0.041400
Signaling by PDGF 48 1.70e-05 9.55e-05 0.3990 0.385000 -8.17e-02 -0.064900 3.96e-06 3.28e-01 0.437000
Signaling by NTRKs 106 1.02e-10 1.86e-09 0.3980 0.303000 2.57e-01 -0.034700 7.66e-08 5.11e-06 0.538000
CLEC7A (Dectin-1) signaling 76 5.38e-09 6.75e-08 0.3980 -0.107000 3.83e-01 0.005950 1.07e-01 7.62e-09 0.929000
Retrograde neurotrophin signalling 10 9.44e-02 1.47e-01 0.3980 0.063700 1.82e-01 -0.348000 7.27e-01 3.18e-01 0.056700
Signaling by Erythropoietin 21 1.40e-02 3.15e-02 0.3980 0.366000 1.14e-01 -0.108000 3.72e-03 3.65e-01 0.393000
Assembly of the pre-replicative complex 64 8.82e-08 7.77e-07 0.3980 -0.290000 2.72e-01 0.003820 6.01e-05 1.68e-04 0.958000
VEGFR2 mediated vascular permeability 21 1.25e-02 2.87e-02 0.3980 0.184000 3.47e-01 -0.065400 1.44e-01 5.98e-03 0.604000
Signaling by NOTCH2 27 2.88e-03 8.42e-03 0.3970 0.303000 2.28e-01 -0.120000 6.53e-03 4.04e-02 0.282000
FRS-mediated FGFR4 signaling 12 9.40e-02 1.47e-01 0.3970 0.342000 6.41e-02 -0.191000 4.05e-02 7.01e-01 0.252000
Intra-Golgi traffic 35 1.35e-03 4.52e-03 0.3960 0.131000 3.71e-01 0.045300 1.80e-01 1.44e-04 0.643000
p38MAPK events 13 5.34e-02 9.36e-02 0.3960 0.154000 9.72e-02 -0.352000 3.36e-01 5.44e-01 0.028200
Infection with Enterobacteria 19 7.18e-03 1.82e-02 0.3960 0.145000 -3.22e-01 0.178000 2.74e-01 1.51e-02 0.180000
APC/C-mediated degradation of cell cycle proteins 60 2.84e-07 2.33e-06 0.3950 -0.259000 2.98e-01 0.000973 5.18e-04 6.45e-05 0.990000
Regulation of mitotic cell cycle 60 2.84e-07 2.33e-06 0.3950 -0.259000 2.98e-01 0.000973 5.18e-04 6.45e-05 0.990000
BBSome-mediated cargo-targeting to cilium 18 1.93e-02 4.13e-02 0.3950 -0.294000 -6.78e-02 0.255000 3.08e-02 6.18e-01 0.061100
ABC transporter disorders 54 1.36e-06 9.63e-06 0.3950 -0.241000 3.12e-01 -0.006110 2.20e-03 7.24e-05 0.938000
Co-stimulation by CD28 33 6.97e-04 2.59e-03 0.3940 0.185000 3.39e-01 -0.077900 6.58e-02 7.44e-04 0.439000
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants 19 4.26e-02 7.70e-02 0.3940 0.251000 3.03e-01 0.020800 5.88e-02 2.22e-02 0.876000
Signaling by Ligand-Responsive EGFR Variants in Cancer 19 4.26e-02 7.70e-02 0.3940 0.251000 3.03e-01 0.020800 5.88e-02 2.22e-02 0.876000
Influenza Viral RNA Transcription and Replication 99 1.17e-10 2.11e-09 0.3940 -0.374000 8.65e-02 -0.088500 1.36e-10 1.38e-01 0.129000
TRAF3-dependent IRF activation pathway 11 1.18e-01 1.76e-01 0.3930 0.285000 1.06e-02 -0.271000 1.02e-01 9.51e-01 0.119000
Diseases of hemostasis 12 1.29e-01 1.89e-01 0.3930 0.017300 -3.88e-01 -0.063200 9.18e-01 2.01e-02 0.705000
Sema4D induced cell migration and growth-cone collapse 19 1.40e-02 3.15e-02 0.3920 0.215000 6.11e-02 -0.323000 1.06e-01 6.45e-01 0.014800
Spry regulation of FGF signaling 16 1.87e-02 4.01e-02 0.3910 0.109000 2.58e-01 -0.273000 4.50e-01 7.45e-02 0.058300
TP53 Regulates Metabolic Genes 67 1.51e-06 1.06e-05 0.3910 -0.047400 3.73e-01 0.107000 5.03e-01 1.36e-07 0.129000
Regulation of CDH1 Function 54 1.02e-06 7.39e-06 0.3900 -0.208000 3.25e-01 -0.058000 8.24e-03 3.70e-05 0.462000
Degradation of beta-catenin by the destruction complex 67 3.34e-08 3.34e-07 0.3900 -0.102000 3.71e-01 -0.060800 1.51e-01 1.50e-07 0.390000
ESR-mediated signaling 130 4.13e-12 1.00e-10 0.3900 0.278000 2.72e-01 -0.006160 4.39e-08 8.49e-08 0.904000
mTORC1-mediated signalling 22 2.50e-02 5.08e-02 0.3900 -0.062300 3.54e-01 0.149000 6.13e-01 4.02e-03 0.226000
RHOBTB GTPase Cycle 32 6.01e-03 1.58e-02 0.3890 0.243000 2.96e-01 0.071200 1.76e-02 3.76e-03 0.486000
Assembly Of The HIV Virion 14 5.29e-02 9.31e-02 0.3890 -0.120000 3.69e-01 -0.033500 4.37e-01 1.69e-02 0.828000
PERK regulates gene expression 23 3.41e-02 6.58e-02 0.3890 0.067700 3.49e-01 0.158000 5.74e-01 3.77e-03 0.189000
EGFR downregulation 25 2.32e-02 4.79e-02 0.3890 0.205000 3.17e-01 0.093300 7.55e-02 6.10e-03 0.420000
Platelet Aggregation (Plug Formation) 25 5.97e-03 1.58e-02 0.3890 0.352000 -4.29e-02 -0.159000 2.30e-03 7.10e-01 0.169000
Gap junction degradation 12 8.14e-02 1.31e-01 0.3890 0.249000 1.91e-01 -0.230000 1.35e-01 2.52e-01 0.168000
Mechanical load activates signaling by PIEZO1 and integrins in osteocytes 13 8.31e-02 1.33e-01 0.3880 0.272000 -1.95e-02 -0.277000 8.98e-02 9.03e-01 0.084000
Uptake and function of anthrax toxins 11 1.23e-01 1.82e-01 0.3870 0.296000 1.66e-01 -0.186000 8.88e-02 3.41e-01 0.285000
NOTCH2 Activation and Transmission of Signal to the Nucleus 20 1.33e-02 3.04e-02 0.3870 0.282000 1.53e-01 -0.216000 2.93e-02 2.35e-01 0.094000
ATF4 activates genes in response to endoplasmic reticulum stress 19 6.94e-02 1.14e-01 0.3860 0.100000 3.47e-01 0.136000 4.50e-01 8.83e-03 0.305000
SHC-mediated cascade:FGFR4 10 1.75e-01 2.40e-01 0.3850 0.344000 2.18e-02 -0.172000 5.95e-02 9.05e-01 0.345000
Transcriptional Regulation by MECP2 44 1.12e-04 5.18e-04 0.3850 0.218000 3.11e-01 -0.064200 1.23e-02 3.60e-04 0.461000
Translocation of SLC2A4 (GLUT4) to the plasma membrane 57 3.29e-05 1.71e-04 0.3850 0.178000 3.39e-01 0.038400 2.01e-02 9.73e-06 0.616000
FRS-mediated FGFR2 signaling 12 1.48e-01 2.09e-01 0.3850 0.347000 1.60e-01 -0.048600 3.77e-02 3.38e-01 0.771000
Synthesis of PIPs at the late endosome membrane 11 2.72e-01 3.45e-01 0.3820 0.309000 1.58e-01 0.159000 7.57e-02 3.63e-01 0.361000
Negative regulation of FGFR3 signaling 19 1.15e-02 2.65e-02 0.3820 0.134000 2.73e-01 -0.231000 3.14e-01 3.91e-02 0.081300
DNA Replication Pre-Initiation 74 3.34e-08 3.34e-07 0.3820 -0.294000 2.43e-01 0.009040 1.23e-05 2.97e-04 0.893000
Cellular response to starvation 107 5.71e-11 1.12e-09 0.3820 -0.369000 9.56e-02 0.024800 4.51e-11 8.81e-02 0.658000
RHOBTB1 GTPase cycle 22 2.89e-02 5.72e-02 0.3810 0.155000 3.46e-01 0.036700 2.08e-01 4.93e-03 0.766000
Deactivation of the beta-catenin transactivating complex 36 3.02e-04 1.21e-03 0.3800 0.209000 2.76e-01 -0.158000 3.00e-02 4.21e-03 0.101000
ATP-dependent chromatin remodelers 27 2.80e-03 8.37e-03 0.3800 0.095500 3.54e-01 -0.101000 3.91e-01 1.46e-03 0.362000
SWI/SNF chromatin remodelers 27 2.80e-03 8.37e-03 0.3800 0.095500 3.54e-01 -0.101000 3.91e-01 1.46e-03 0.362000
Signaling by cytosolic FGFR1 fusion mutants 17 6.23e-02 1.06e-01 0.3800 0.232000 3.01e-01 -0.021900 9.77e-02 3.19e-02 0.876000
Intrinsic Pathway for Apoptosis 46 2.08e-04 9.05e-04 0.3800 0.152000 3.49e-01 0.012200 7.56e-02 4.36e-05 0.887000
Signaling by FGFR4 31 1.47e-03 4.82e-03 0.3800 0.242000 2.60e-01 -0.134000 1.95e-02 1.21e-02 0.197000
Syndecan interactions 22 1.11e-02 2.59e-02 0.3800 0.250000 -2.85e-01 -0.019600 4.20e-02 2.08e-02 0.874000
TNFR1-induced NF-kappa-B signaling pathway 31 1.74e-03 5.59e-03 0.3800 0.099500 3.62e-01 -0.055200 3.38e-01 4.85e-04 0.595000
Metabolism of porphyrins 18 6.91e-02 1.14e-01 0.3790 -0.200000 -5.28e-02 -0.318000 1.42e-01 6.98e-01 0.019400
Signaling by ALK 20 3.33e-02 6.45e-02 0.3790 0.339000 1.61e-01 -0.056000 8.78e-03 2.12e-01 0.664000
Co-inhibition by CTLA4 17 3.47e-02 6.64e-02 0.3790 0.263000 2.10e-01 -0.173000 6.06e-02 1.34e-01 0.216000
Adipogenesis 88 4.26e-07 3.36e-06 0.3780 0.231000 2.92e-01 0.066200 1.78e-04 2.23e-06 0.284000
MAPK6/MAPK4 signaling 65 8.00e-07 5.89e-06 0.3770 -0.054700 3.73e-01 0.005190 4.46e-01 2.01e-07 0.942000
Collagen formation 61 5.87e-05 2.86e-04 0.3770 -0.022900 -3.43e-01 -0.155000 7.57e-01 3.70e-06 0.036500
STING mediated induction of host immune responses 11 2.85e-01 3.58e-01 0.3770 0.007300 -2.32e-01 -0.296000 9.67e-01 1.82e-01 0.088900
Response of Mtb to phagocytosis 22 6.75e-03 1.73e-02 0.3760 -0.148000 1.81e-01 -0.295000 2.31e-01 1.42e-01 0.016500
SHC-mediated cascade:FGFR2 10 2.55e-01 3.28e-01 0.3760 0.350000 1.37e-01 -0.001490 5.52e-02 4.54e-01 0.993000
Signalling to ERKs 30 1.54e-03 4.99e-03 0.3750 0.235000 2.27e-01 -0.185000 2.62e-02 3.16e-02 0.079800
Aspirin ADME 11 2.96e-01 3.70e-01 0.3750 -0.077100 -3.22e-01 -0.176000 6.58e-01 6.42e-02 0.313000
Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors 25 1.66e-02 3.66e-02 0.3750 0.240000 2.88e-01 -0.011300 3.78e-02 1.27e-02 0.922000
G beta:gamma signalling through PLC beta 12 2.85e-01 3.58e-01 0.3750 -0.084900 -2.35e-01 -0.279000 6.11e-01 1.58e-01 0.094100
Presynaptic function of Kainate receptors 12 2.85e-01 3.58e-01 0.3750 -0.084900 -2.35e-01 -0.279000 6.11e-01 1.58e-01 0.094100
GABA receptor activation 27 1.66e-02 3.66e-02 0.3740 0.098600 -2.01e-01 -0.300000 3.75e-01 7.04e-02 0.006980
PI3K events in ERBB2 signaling 12 1.36e-01 1.96e-01 0.3740 -0.024400 3.73e-01 0.010200 8.84e-01 2.52e-02 0.951000
Negative Regulation of CDH1 Gene Transcription 28 7.63e-03 1.90e-02 0.3740 0.108000 3.58e-01 0.008390 3.21e-01 1.05e-03 0.939000
activated TAK1 mediates p38 MAPK activation 22 1.35e-02 3.06e-02 0.3740 0.127000 3.41e-01 -0.086600 3.04e-01 5.65e-03 0.482000
CD209 (DC-SIGN) signaling 16 8.94e-02 1.42e-01 0.3730 0.284000 2.40e-01 -0.024800 4.91e-02 9.67e-02 0.864000
Activation of RAC1 10 3.49e-01 4.20e-01 0.3720 0.092400 3.18e-01 0.170000 6.13e-01 8.14e-02 0.352000
Molecules associated with elastic fibres 28 5.79e-03 1.55e-02 0.3720 0.246000 -2.51e-01 -0.121000 2.42e-02 2.14e-02 0.267000
Signaling by FGFR1 40 3.54e-04 1.40e-03 0.3720 0.272000 2.22e-01 -0.121000 2.94e-03 1.50e-02 0.184000
FRS-mediated FGFR1 signaling 13 1.21e-01 1.79e-01 0.3710 0.320000 1.47e-01 -0.116000 4.56e-02 3.60e-01 0.470000
Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation 10 2.54e-01 3.26e-01 0.3700 -0.052500 3.54e-01 0.095100 7.74e-01 5.26e-02 0.603000
ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression 16 5.04e-02 8.91e-02 0.3700 0.125000 3.58e-02 -0.346000 3.86e-01 8.04e-01 0.016600
Transcriptional and post-translational regulation of MITF-M expression and activity 36 7.45e-03 1.87e-02 0.3690 0.239000 2.63e-01 0.099800 1.31e-02 6.27e-03 0.301000
EPH-ephrin mediated repulsion of cells 33 9.22e-04 3.27e-03 0.3690 0.196000 6.58e-02 -0.306000 5.15e-02 5.13e-01 0.002350
Formation of paraxial mesoderm 48 1.19e-05 6.89e-05 0.3690 -0.181000 3.01e-01 -0.114000 3.06e-02 3.06e-04 0.172000
RHOJ GTPase cycle 48 1.16e-03 3.98e-03 0.3690 0.221000 2.78e-01 0.101000 8.07e-03 8.74e-04 0.226000
VLDLR internalisation and degradation 15 3.68e-02 6.91e-02 0.3690 -0.100000 2.78e-01 -0.221000 5.01e-01 6.25e-02 0.138000
Nucleotide salvage 18 3.94e-02 7.31e-02 0.3690 -0.312000 1.94e-01 0.037500 2.20e-02 1.55e-01 0.783000
Cellular hexose transport 10 3.65e-01 4.35e-01 0.3690 -0.270000 -2.00e-01 -0.152000 1.39e-01 2.74e-01 0.406000
Chaperone Mediated Autophagy 18 1.25e-01 1.84e-01 0.3680 0.082900 3.10e-01 0.180000 5.43e-01 2.27e-02 0.185000
RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known 34 5.64e-03 1.52e-02 0.3680 0.184000 3.16e-01 0.043500 6.39e-02 1.42e-03 0.661000
Other interleukin signaling 16 6.56e-02 1.09e-01 0.3680 0.216000 -2.88e-01 -0.077000 1.34e-01 4.61e-02 0.594000
Gap junction trafficking and regulation 26 6.93e-03 1.77e-02 0.3680 0.265000 9.44e-03 -0.255000 1.95e-02 9.34e-01 0.024500
PRC2 methylates histones and DNA 12 1.10e-01 1.67e-01 0.3670 0.157000 2.91e-01 -0.159000 3.47e-01 8.10e-02 0.340000
Aerobic respiration and respiratory electron transport 172 5.42e-17 2.42e-15 0.3670 -0.261000 2.55e-01 0.039000 3.96e-09 9.00e-09 0.379000
MAP kinase activation 60 3.70e-05 1.89e-04 0.3660 0.193000 3.11e-01 0.007740 9.75e-03 3.06e-05 0.918000
Signaling by high-kinase activity BRAF mutants 29 2.65e-03 8.05e-03 0.3660 0.250000 1.53e-01 -0.219000 1.97e-02 1.53e-01 0.041400
NOTCH3 Activation and Transmission of Signal to the Nucleus 23 7.47e-03 1.87e-02 0.3640 0.162000 2.25e-01 -0.236000 1.79e-01 6.19e-02 0.050200
RNA Polymerase III Transcription Termination 18 4.18e-02 7.63e-02 0.3640 0.000817 3.63e-01 -0.028800 9.95e-01 7.70e-03 0.833000
Deadenylation of mRNA 24 2.10e-02 4.43e-02 0.3640 0.240000 2.70e-01 -0.044100 4.16e-02 2.22e-02 0.708000
Mitochondrial protein import 43 9.15e-05 4.30e-04 0.3640 -0.187000 3.07e-01 -0.056400 3.41e-02 4.97e-04 0.523000
Attachment of bacteria to epithelial cells 18 2.30e-02 4.77e-02 0.3640 0.148000 -3.00e-01 0.143000 2.78e-01 2.76e-02 0.293000
Biofilm formation 18 2.30e-02 4.77e-02 0.3640 0.148000 -3.00e-01 0.143000 2.78e-01 2.76e-02 0.293000
Thrombin signalling through proteinase activated receptors (PARs) 18 7.42e-02 1.21e-01 0.3630 0.060400 -1.03e-01 -0.343000 6.57e-01 4.51e-01 0.011700
Recycling pathway of L1 33 1.94e-03 6.09e-03 0.3630 0.303000 4.00e-02 -0.196000 2.58e-03 6.91e-01 0.051400
RUNX2 regulates bone development 26 1.10e-02 2.58e-02 0.3630 0.224000 2.75e-01 -0.079100 4.85e-02 1.54e-02 0.485000
Golgi Cisternae Pericentriolar Stack Reorganization 10 2.19e-01 2.87e-01 0.3630 0.035800 5.95e-03 -0.361000 8.45e-01 9.74e-01 0.048100
Regulation of RAS by GAPs 51 1.74e-05 9.72e-05 0.3620 -0.169000 3.17e-01 -0.046100 3.73e-02 9.17e-05 0.569000
Cytoprotection by HMOX1 45 4.59e-04 1.77e-03 0.3620 0.002840 3.58e-01 0.050400 9.74e-01 3.25e-05 0.559000
Signaling by ROBO receptors 152 7.88e-15 2.81e-13 0.3610 -0.295000 2.09e-01 -0.003220 3.74e-10 9.24e-06 0.946000
APC-Cdc20 mediated degradation of Nek2A 21 2.14e-02 4.50e-02 0.3610 -0.249000 2.61e-01 0.001520 4.87e-02 3.82e-02 0.990000
Signaling by EGFR 43 1.92e-03 6.07e-03 0.3600 0.234000 2.71e-01 0.040500 7.86e-03 2.14e-03 0.646000
Synthesis of DNA 89 1.46e-08 1.57e-07 0.3600 -0.321000 1.63e-01 -0.011200 1.71e-07 7.77e-03 0.856000
KEAP1-NFE2L2 pathway 97 9.37e-09 1.11e-07 0.3600 0.009020 3.60e-01 0.013100 8.78e-01 9.67e-10 0.824000
Negative regulation of MAPK pathway 41 3.33e-04 1.32e-03 0.3590 0.056500 3.49e-01 -0.064500 5.32e-01 1.12e-04 0.475000
Diseases of carbohydrate metabolism 27 6.51e-03 1.68e-02 0.3590 -0.262000 1.33e-01 -0.205000 1.84e-02 2.31e-01 0.064900
Activation of the pre-replicative complex 21 3.03e-02 5.95e-02 0.3580 -0.326000 -6.90e-03 0.149000 9.70e-03 9.56e-01 0.238000
Synthesis of active ubiquitin: roles of E1 and E2 enzymes 29 4.48e-03 1.23e-02 0.3580 -0.048000 3.54e-01 -0.025100 6.54e-01 9.65e-04 0.815000
Striated Muscle Contraction 32 1.93e-03 6.08e-03 0.3580 -0.133000 3.31e-01 -0.026900 1.92e-01 1.19e-03 0.792000
Translesion synthesis by POLI 17 6.42e-02 1.08e-01 0.3570 -0.307000 1.68e-01 0.070200 2.83e-02 2.30e-01 0.616000
Detoxification of Reactive Oxygen Species 23 2.32e-02 4.79e-02 0.3570 -0.251000 2.25e-01 0.119000 3.73e-02 6.23e-02 0.325000
Unblocking of NMDA receptors, glutamate binding and activation 12 1.85e-01 2.52e-01 0.3570 -0.243000 2.04e-01 0.164000 1.45e-01 2.22e-01 0.326000
Evasion by RSV of host interferon responses 17 3.19e-02 6.24e-02 0.3560 0.049900 1.84e-01 -0.301000 7.22e-01 1.89e-01 0.031700
Signaling by the B Cell Receptor (BCR) 81 9.89e-08 8.67e-07 0.3560 -0.195000 2.96e-01 0.026000 2.46e-03 4.06e-06 0.687000
Pausing and recovery of Tat-mediated HIV elongation 22 1.67e-02 3.66e-02 0.3550 -0.010200 8.30e-02 -0.345000 9.34e-01 5.01e-01 0.005060
Tat-mediated HIV elongation arrest and recovery 22 1.67e-02 3.66e-02 0.3550 -0.010200 8.30e-02 -0.345000 9.34e-01 5.01e-01 0.005060
mRNA Splicing 179 6.29e-19 4.73e-17 0.3550 -0.145000 3.04e-01 -0.111000 8.46e-04 2.40e-12 0.010400
Signaling by Activin 15 1.33e-01 1.92e-01 0.3550 0.209000 2.86e-01 -0.015200 1.60e-01 5.49e-02 0.919000
Host Interactions of HIV factors 102 6.76e-11 1.29e-09 0.3540 -0.179000 2.74e-01 -0.135000 1.84e-03 1.74e-06 0.018700
Signaling by ERBB2 in Cancer 21 6.53e-02 1.09e-01 0.3540 0.193000 2.95e-01 0.033500 1.26e-01 1.94e-02 0.791000
FGFR1 mutant receptor activation 23 3.40e-02 6.57e-02 0.3540 0.262000 2.34e-01 -0.042100 2.97e-02 5.26e-02 0.727000
Oncogenic MAPK signaling 71 3.91e-06 2.53e-05 0.3530 0.248000 2.42e-01 -0.067500 2.98e-04 4.32e-04 0.326000
Termination of O-glycan biosynthesis 13 2.16e-01 2.85e-01 0.3530 0.024200 -3.28e-01 -0.127000 8.80e-01 4.05e-02 0.428000
Respiratory syncytial virus (RSV) attachment and entry 17 7.12e-02 1.17e-01 0.3530 0.317000 6.94e-03 -0.155000 2.38e-02 9.61e-01 0.270000
ER-Phagosome pathway 61 4.57e-06 2.90e-05 0.3520 -0.196000 2.92e-01 -0.024700 8.11e-03 8.27e-05 0.739000
Interaction between L1 and Ankyrins 18 9.40e-02 1.47e-01 0.3520 0.315000 1.57e-01 -0.006750 2.06e-02 2.49e-01 0.960000
SHC-mediated cascade:FGFR1 11 2.30e-01 2.99e-01 0.3520 0.319000 1.23e-01 -0.085000 6.72e-02 4.79e-01 0.626000
Glutamate Neurotransmitter Release Cycle 14 1.09e-01 1.66e-01 0.3510 0.026400 3.55e-02 -0.349000 8.64e-01 8.18e-01 0.024000
RHOU GTPase cycle 36 2.72e-03 8.19e-03 0.3510 0.291000 1.73e-01 -0.091600 2.54e-03 7.28e-02 0.342000
Regulation of beta-cell development 17 1.01e-01 1.57e-01 0.3500 0.260000 2.32e-01 -0.033400 6.32e-02 9.74e-02 0.811000
FLT3 Signaling 32 8.91e-03 2.18e-02 0.3500 0.314000 1.50e-01 -0.033500 2.10e-03 1.43e-01 0.743000
Formation of Incision Complex in GG-NER 39 4.77e-04 1.83e-03 0.3500 -0.140000 3.16e-01 -0.053700 1.31e-01 6.42e-04 0.562000
Interleukin-3, Interleukin-5 and GM-CSF signaling 33 3.98e-03 1.11e-02 0.3490 0.286000 1.60e-01 -0.121000 4.46e-03 1.13e-01 0.230000
ECM proteoglycans 51 5.31e-05 2.64e-04 0.3490 0.228000 -2.63e-01 0.020900 4.79e-03 1.17e-03 0.797000
Diseases associated with glycosylation precursor biosynthesis 13 1.02e-01 1.58e-01 0.3490 -0.110000 1.60e-01 -0.290000 4.91e-01 3.19e-01 0.070200
tRNA modification in the nucleus and cytosol 29 9.08e-03 2.21e-02 0.3490 -0.334000 9.24e-02 0.040600 1.86e-03 3.89e-01 0.705000
Synthesis of PIPs at the Golgi membrane 15 9.95e-02 1.54e-01 0.3480 0.280000 1.31e-01 -0.160000 6.01e-02 3.78e-01 0.285000
Constitutive Signaling by Overexpressed ERBB2 10 2.70e-01 3.42e-01 0.3480 0.316000 1.01e-01 -0.107000 8.39e-02 5.80e-01 0.558000
Signaling by RAF1 mutants 34 1.30e-03 4.39e-03 0.3480 0.173000 2.31e-01 -0.194000 8.10e-02 1.96e-02 0.050400
Signaling by NOTCH3 40 1.14e-03 3.93e-03 0.3480 0.232000 2.41e-01 -0.094700 1.11e-02 8.32e-03 0.300000
mRNA Splicing - Major Pathway 174 9.84e-18 5.62e-16 0.3480 -0.133000 3.01e-01 -0.114000 2.61e-03 8.52e-12 0.009950
RHOH GTPase cycle 31 1.68e-02 3.68e-02 0.3480 0.121000 3.20e-01 0.060100 2.44e-01 2.03e-03 0.563000
RAF-independent MAPK1/3 activation 21 4.34e-02 7.84e-02 0.3470 0.276000 1.91e-01 -0.089000 2.84e-02 1.30e-01 0.480000
Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters 16 4.56e-02 8.18e-02 0.3470 -0.028800 2.13e-01 -0.273000 8.42e-01 1.41e-01 0.059100
ABC-family proteins mediated transport 72 5.47e-07 4.15e-06 0.3470 -0.233000 2.52e-01 -0.053200 6.40e-04 2.26e-04 0.436000
Negative regulation of FGFR1 signaling 22 1.73e-02 3.76e-02 0.3470 0.140000 2.66e-01 -0.173000 2.55e-01 3.09e-02 0.160000
TP53 Regulates Transcription of Death Receptors and Ligands 10 2.49e-01 3.21e-01 0.3470 0.286000 -1.93e-01 -0.033500 1.17e-01 2.90e-01 0.854000
Diseases associated with the TLR signaling cascade 19 1.55e-01 2.16e-01 0.3460 0.195000 2.51e-01 0.139000 1.42e-01 5.85e-02 0.294000
Diseases of Immune System 19 1.55e-01 2.16e-01 0.3460 0.195000 2.51e-01 0.139000 1.42e-01 5.85e-02 0.294000
Transcriptional regulation by RUNX2 88 6.11e-08 5.74e-07 0.3460 0.033800 3.42e-01 -0.044500 5.84e-01 3.12e-08 0.471000
Processing and activation of SUMO 10 3.55e-01 4.27e-01 0.3460 0.129000 3.15e-01 0.059400 4.79e-01 8.44e-02 0.745000
Negative regulation of FGFR4 signaling 21 1.98e-02 4.22e-02 0.3450 0.144000 2.24e-01 -0.219000 2.54e-01 7.53e-02 0.082600
Intrinsic Pathway of Fibrin Clot Formation 12 1.31e-01 1.91e-01 0.3450 0.021600 -3.20e-01 0.125000 8.97e-01 5.46e-02 0.452000
TNFR2 non-canonical NF-kB pathway 55 2.06e-05 1.13e-04 0.3450 -0.174000 2.93e-01 -0.051600 2.56e-02 1.71e-04 0.509000
PCP/CE pathway 67 6.86e-07 5.08e-06 0.3440 -0.159000 2.75e-01 -0.132000 2.44e-02 1.02e-04 0.061300
Negative regulation of FGFR2 signaling 21 2.73e-02 5.47e-02 0.3440 0.147000 2.79e-01 -0.137000 2.44e-01 2.69e-02 0.276000
Regulation of signaling by CBL 18 6.53e-02 1.09e-01 0.3430 0.262000 1.77e-01 -0.133000 5.42e-02 1.93e-01 0.329000
PPARA activates gene expression 95 3.12e-06 2.05e-05 0.3430 0.192000 2.75e-01 0.073400 1.27e-03 3.65e-06 0.217000
Glycosaminoglycan-protein linkage region biosynthesis 18 9.32e-02 1.47e-01 0.3430 0.193000 -1.65e-01 -0.231000 1.57e-01 2.25e-01 0.090300
Initiation of Nuclear Envelope (NE) Reformation 16 1.16e-01 1.74e-01 0.3420 0.223000 2.53e-01 -0.058300 1.23e-01 7.95e-02 0.686000
Signaling by NOTCH4 65 3.05e-06 2.02e-05 0.3420 -0.091700 3.24e-01 -0.058500 2.01e-01 6.15e-06 0.415000
rRNA processing 146 2.50e-12 6.26e-11 0.3420 -0.303000 1.10e-01 -0.114000 2.68e-10 2.23e-02 0.017600
Triglyceride catabolism 16 1.58e-01 2.20e-01 0.3420 -0.097800 2.78e-01 0.174000 4.99e-01 5.44e-02 0.228000
Peptide ligand-binding receptors 38 9.54e-04 3.36e-03 0.3420 0.179000 -2.89e-01 0.035600 5.59e-02 2.05e-03 0.704000
G alpha (z) signalling events 30 9.90e-03 2.38e-02 0.3420 0.208000 -7.46e-02 -0.261000 4.90e-02 4.80e-01 0.013300
B-WICH complex positively regulates rRNA expression 24 4.45e-02 8.00e-02 0.3420 0.255000 2.28e-01 -0.012100 3.08e-02 5.37e-02 0.918000
Role of LAT2/NTAL/LAB on calcium mobilization 12 2.28e-01 2.98e-01 0.3420 0.307000 1.36e-01 -0.064800 6.57e-02 4.15e-01 0.698000
PI3K/AKT Signaling in Cancer 69 6.32e-05 3.07e-04 0.3420 0.272000 2.07e-01 0.016200 9.75e-05 2.98e-03 0.816000
Energy dependent regulation of mTOR by LKB1-AMPK 26 2.39e-02 4.90e-02 0.3410 0.002140 3.39e-01 0.032200 9.85e-01 2.75e-03 0.776000
EPHA-mediated growth cone collapse 18 7.75e-02 1.26e-01 0.3410 0.261000 -8.49e-02 -0.202000 5.55e-02 5.33e-01 0.137000
ADP signalling through P2Y purinoceptor 1 14 1.86e-01 2.53e-01 0.3410 0.107000 -1.10e-01 -0.304000 4.88e-01 4.76e-01 0.048900
Formation of WDR5-containing histone-modifying complexes 37 2.45e-03 7.52e-03 0.3400 0.088400 3.26e-01 -0.044000 3.52e-01 6.07e-04 0.643000
Ub-specific processing proteases 133 2.40e-10 4.24e-09 0.3400 0.099900 3.25e-01 -0.008230 4.72e-02 1.05e-10 0.870000
Signal regulatory protein family interactions 11 3.17e-01 3.90e-01 0.3400 0.122000 -2.37e-01 -0.210000 4.83e-01 1.73e-01 0.228000
Extra-nuclear estrogen signaling 57 3.02e-04 1.21e-03 0.3400 0.276000 1.97e-01 -0.010900 3.09e-04 1.01e-02 0.887000
trans-Golgi Network Vesicle Budding 58 6.22e-04 2.32e-03 0.3390 0.185000 2.77e-01 0.062700 1.48e-02 2.61e-04 0.410000
ERBB2 Regulates Cell Motility 11 1.62e-01 2.23e-01 0.3390 -0.136000 2.67e-01 -0.158000 4.35e-01 1.25e-01 0.363000
RHOBTB3 ATPase cycle 10 3.85e-01 4.53e-01 0.3390 0.003490 3.13e-01 0.131000 9.85e-01 8.68e-02 0.474000
TRAF6-mediated induction of TAK1 complex within TLR4 complex 14 2.06e-01 2.74e-01 0.3390 0.153000 3.02e-01 0.023900 3.21e-01 5.08e-02 0.877000
Interleukin receptor SHC signaling 15 1.15e-01 1.73e-01 0.3390 0.277000 1.09e-01 -0.162000 6.33e-02 4.65e-01 0.278000
Transcriptional regulation by RUNX3 76 4.42e-06 2.83e-05 0.3390 0.068500 3.32e-01 -0.003880 3.02e-01 5.84e-07 0.953000
GPER1 signaling 34 6.59e-03 1.70e-02 0.3390 0.220000 -1.30e-01 -0.222000 2.62e-02 1.91e-01 0.025100
Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function 16 6.17e-02 1.05e-01 0.3390 0.013800 -1.51e-01 0.303000 9.24e-01 2.95e-01 0.036200
Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function 16 6.17e-02 1.05e-01 0.3390 0.013800 -1.51e-01 0.303000 9.24e-01 2.95e-01 0.036200
Defective homologous recombination repair (HRR) due to BRCA1 loss of function 16 6.17e-02 1.05e-01 0.3390 0.013800 -1.51e-01 0.303000 9.24e-01 2.95e-01 0.036200
Defective homologous recombination repair (HRR) due to PALB2 loss of function 16 6.17e-02 1.05e-01 0.3390 0.013800 -1.51e-01 0.303000 9.24e-01 2.95e-01 0.036200
Impaired BRCA2 binding to PALB2 16 6.17e-02 1.05e-01 0.3390 0.013800 -1.51e-01 0.303000 9.24e-01 2.95e-01 0.036200
Mitotic Telophase/Cytokinesis 10 4.54e-01 5.17e-01 0.3380 0.079200 2.70e-01 0.188000 6.65e-01 1.39e-01 0.303000
Cellular response to chemical stress 153 2.30e-12 5.87e-11 0.3380 -0.058200 3.32e-01 0.023600 2.15e-01 1.42e-12 0.615000
Mitochondrial biogenesis 67 3.38e-05 1.74e-04 0.3380 0.140000 3.08e-01 -0.011900 4.80e-02 1.36e-05 0.866000
Developmental Lineage of Pancreatic Ductal Cells 19 6.52e-02 1.09e-01 0.3380 -0.074500 -3.28e-01 0.034300 5.74e-01 1.34e-02 0.796000
Paradoxical activation of RAF signaling by kinase inactive BRAF 38 8.84e-04 3.15e-03 0.3380 0.180000 2.02e-01 -0.202000 5.45e-02 3.13e-02 0.031200
Signaling by RAS mutants 38 8.84e-04 3.15e-03 0.3380 0.180000 2.02e-01 -0.202000 5.45e-02 3.13e-02 0.031200
Signaling by moderate kinase activity BRAF mutants 38 8.84e-04 3.15e-03 0.3380 0.180000 2.02e-01 -0.202000 5.45e-02 3.13e-02 0.031200
Signaling downstream of RAS mutants 38 8.84e-04 3.15e-03 0.3380 0.180000 2.02e-01 -0.202000 5.45e-02 3.13e-02 0.031200
Negative regulation of NMDA receptor-mediated neuronal transmission 12 1.88e-01 2.55e-01 0.3380 -0.205000 2.67e-01 0.018900 2.18e-01 1.09e-01 0.910000
Translesion synthesis by REV1 16 1.06e-01 1.62e-01 0.3370 -0.278000 1.79e-01 0.063100 5.39e-02 2.14e-01 0.662000
Notch-HLH transcription pathway 28 1.01e-02 2.42e-02 0.3370 0.247000 1.46e-01 -0.177000 2.39e-02 1.83e-01 0.104000
Diseases of signal transduction by growth factor receptors and second messengers 356 8.25e-26 1.68e-23 0.3370 0.207000 2.64e-01 -0.030800 2.43e-11 1.66e-17 0.320000
Degradation of the extracellular matrix 80 6.84e-06 4.16e-05 0.3370 0.137000 -2.70e-01 -0.147000 3.43e-02 2.97e-05 0.023400
Base-Excision Repair, AP Site Formation 15 1.61e-01 2.23e-01 0.3370 -0.289000 2.76e-02 -0.171000 5.30e-02 8.53e-01 0.251000
Formation of Fibrin Clot (Clotting Cascade) 16 6.39e-02 1.08e-01 0.3360 0.094400 -2.96e-01 0.129000 5.14e-01 4.02e-02 0.374000
Condensation of Prophase Chromosomes 11 2.19e-01 2.87e-01 0.3360 0.086700 -3.25e-01 0.018700 6.19e-01 6.24e-02 0.915000
PTEN Regulation 119 4.01e-10 6.65e-09 0.3360 0.039600 3.30e-01 -0.051100 4.56e-01 5.38e-10 0.337000
Post-chaperonin tubulin folding pathway 15 2.13e-01 2.82e-01 0.3360 -0.079700 -9.19e-02 -0.313000 5.93e-01 5.38e-01 0.035800
Regulation of lipid metabolism by PPARalpha 97 2.91e-06 1.93e-05 0.3360 0.193000 2.70e-01 0.055300 1.07e-03 4.56e-06 0.347000
Voltage gated Potassium channels 10 3.05e-01 3.80e-01 0.3360 0.254000 -1.53e-01 -0.158000 1.64e-01 4.03e-01 0.388000
Signaling by ALK fusions and activated point mutants 76 1.22e-05 7.03e-05 0.3350 0.256000 2.14e-01 -0.036100 1.18e-04 1.27e-03 0.586000
Signaling by ALK in cancer 76 1.22e-05 7.03e-05 0.3350 0.256000 2.14e-01 -0.036100 1.18e-04 1.27e-03 0.586000
NPAS4 regulates expression of target genes 16 1.50e-01 2.11e-01 0.3350 0.254000 2.17e-01 -0.027500 7.89e-02 1.32e-01 0.849000
Signaling by CSF1 (M-CSF) in myeloid cells 29 1.14e-02 2.64e-02 0.3350 0.278000 1.77e-02 -0.187000 9.70e-03 8.69e-01 0.081800
rRNA processing in the nucleus and cytosol 135 6.02e-11 1.16e-09 0.3350 -0.292000 1.06e-01 -0.124000 4.68e-09 3.40e-02 0.013200
GRB2 events in ERBB2 signaling 12 1.91e-01 2.57e-01 0.3340 0.105000 3.06e-01 -0.085400 5.28e-01 6.67e-02 0.609000
Phase II - Conjugation of compounds 46 7.70e-04 2.83e-03 0.3340 -0.244000 2.05e-01 0.102000 4.26e-03 1.61e-02 0.234000
Azathioprine ADME 13 1.90e-01 2.57e-01 0.3340 -0.289000 9.11e-02 0.141000 7.15e-02 5.70e-01 0.378000
SHC1 events in ERBB4 signaling 10 3.34e-01 4.06e-01 0.3340 0.233000 2.35e-01 -0.042200 2.02e-01 1.97e-01 0.817000
Cyclin E associated events during G1/S transition 62 2.02e-05 1.11e-04 0.3340 -0.125000 3.09e-01 -0.006640 8.88e-02 2.54e-05 0.928000
TNFR1-induced proapoptotic signaling 23 5.42e-02 9.49e-02 0.3340 0.165000 2.90e-01 -0.007290 1.71e-01 1.61e-02 0.952000
Major pathway of rRNA processing in the nucleolus and cytosol 129 3.20e-10 5.44e-09 0.3340 -0.299000 9.31e-02 -0.116000 4.94e-09 6.86e-02 0.023400
Telomere Extension By Telomerase 15 9.79e-02 1.52e-01 0.3330 -0.111000 3.08e-01 -0.063200 4.59e-01 3.89e-02 0.672000
NRAGE signals death through JNK 44 9.44e-04 3.34e-03 0.3330 0.288000 4.28e-03 -0.168000 9.63e-04 9.61e-01 0.053800
DNA strand elongation 28 4.05e-02 7.49e-02 0.3330 -0.307000 -1.03e-01 -0.077000 4.89e-03 3.45e-01 0.481000
Inactivation of APC/C via direct inhibition of the APC/C complex 17 9.36e-02 1.47e-01 0.3330 -0.210000 2.54e-01 0.049800 1.35e-01 7.01e-02 0.722000
Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components 17 9.36e-02 1.47e-01 0.3330 -0.210000 2.54e-01 0.049800 1.35e-01 7.01e-02 0.722000
Metalloprotease DUBs 16 1.30e-01 1.90e-01 0.3330 -0.032600 3.29e-01 0.033900 8.22e-01 2.27e-02 0.815000
PINK1-PRKN Mediated Mitophagy 26 3.49e-02 6.66e-02 0.3320 -0.074000 3.11e-01 0.091800 5.14e-01 6.14e-03 0.418000
Signal amplification 20 6.38e-02 1.08e-01 0.3320 0.220000 -5.70e-02 -0.242000 8.88e-02 6.59e-01 0.060900
Binding and Uptake of Ligands by Scavenger Receptors 24 2.83e-02 5.64e-02 0.3320 0.178000 -2.78e-01 -0.031700 1.31e-01 1.84e-02 0.788000
Caspase-mediated cleavage of cytoskeletal proteins 11 2.43e-01 3.15e-01 0.3320 0.200000 2.40e-01 -0.111000 2.51e-01 1.68e-01 0.526000
Toll Like Receptor 9 (TLR9) Cascade 92 8.67e-06 5.16e-05 0.3310 0.219000 2.44e-01 0.050400 2.95e-04 5.36e-05 0.404000
MyD88-independent TLR4 cascade 95 2.91e-06 1.93e-05 0.3310 0.211000 2.55e-01 0.023600 3.96e-04 1.82e-05 0.691000
TRIF (TICAM1)-mediated TLR4 signaling 95 2.91e-06 1.93e-05 0.3310 0.211000 2.55e-01 0.023600 3.96e-04 1.82e-05 0.691000
Gap junction assembly 13 1.89e-01 2.56e-01 0.3310 0.274000 -2.32e-02 -0.184000 8.68e-02 8.85e-01 0.251000
Formation of the non-canonical BAF (ncBAF) complex 17 5.28e-02 9.31e-02 0.3300 0.031300 2.58e-01 -0.204000 8.23e-01 6.53e-02 0.146000
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell 40 4.21e-03 1.16e-02 0.3300 0.025700 -3.23e-01 -0.062200 7.79e-01 4.03e-04 0.496000
Toll Like Receptor 3 (TLR3) Cascade 93 3.95e-06 2.54e-05 0.3300 0.193000 2.67e-01 0.023300 1.34e-03 9.11e-06 0.698000
Maturation of TCA enzymes and regulation of TCA cycle 15 1.06e-01 1.62e-01 0.3290 -0.150000 2.89e-01 -0.053200 3.16e-01 5.30e-02 0.722000
MTOR signalling 38 4.00e-03 1.12e-02 0.3290 0.000954 3.29e-01 0.012100 9.92e-01 4.49e-04 0.898000
Fc epsilon receptor (FCERI) signaling 102 6.89e-08 6.18e-07 0.3290 -0.013100 3.29e-01 0.007770 8.19e-01 9.84e-09 0.892000
G alpha (12/13) signalling events 56 1.52e-04 6.86e-04 0.3290 0.260000 -3.62e-02 -0.198000 7.61e-04 6.40e-01 0.010300
Meiosis 38 2.28e-02 4.76e-02 0.3290 0.094500 2.74e-01 0.156000 3.14e-01 3.54e-03 0.095900
Signaling by ERBB2 KD Mutants 20 9.86e-02 1.53e-01 0.3280 0.172000 2.80e-01 0.001620 1.84e-01 3.04e-02 0.990000
Signaling by FGFR2 51 2.28e-04 9.65e-04 0.3280 0.149000 2.74e-01 -0.103000 6.57e-02 7.31e-04 0.202000
Gap junction trafficking 24 2.65e-02 5.33e-02 0.3280 0.232000 6.31e-02 -0.223000 4.90e-02 5.93e-01 0.058500
Apoptosis 133 2.93e-10 5.08e-09 0.3280 0.052000 3.23e-01 -0.025800 3.02e-01 1.37e-10 0.608000
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways 48 4.16e-03 1.15e-02 0.3270 0.223000 2.33e-01 0.055200 7.49e-03 5.24e-03 0.509000
Chromatin modifying enzymes 180 2.19e-14 6.95e-13 0.3270 0.159000 2.66e-01 -0.102000 2.46e-04 7.65e-10 0.018000
Semaphorin interactions 55 2.12e-04 9.17e-04 0.3260 0.269000 -3.12e-02 -0.182000 5.62e-04 6.89e-01 0.019500
Interleukin-17 signaling 63 1.86e-04 8.29e-04 0.3260 0.177000 2.74e-01 -0.008560 1.50e-02 1.73e-04 0.907000
HS-GAG biosynthesis 18 9.23e-02 1.45e-01 0.3260 0.112000 -1.58e-02 -0.306000 4.09e-01 9.08e-01 0.024700
Post-translational modification: synthesis of GPI-anchored proteins 41 1.39e-02 3.13e-02 0.3260 -0.208000 -2.35e-01 -0.088100 2.12e-02 9.17e-03 0.330000
Citric acid cycle (TCA cycle) 29 9.35e-03 2.26e-02 0.3260 -0.124000 2.98e-01 -0.047300 2.47e-01 5.52e-03 0.659000
VEGFR2 mediated cell proliferation 17 1.46e-01 2.08e-01 0.3260 0.274000 1.73e-01 -0.035400 5.06e-02 2.17e-01 0.801000
Cyclin D associated events in G1 39 9.10e-03 2.21e-02 0.3260 0.138000 2.93e-01 0.035300 1.37e-01 1.54e-03 0.703000
G1 Phase 39 9.10e-03 2.21e-02 0.3260 0.138000 2.93e-01 0.035300 1.37e-01 1.54e-03 0.703000
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription 34 2.35e-02 4.83e-02 0.3260 0.186000 2.63e-01 0.049800 6.13e-02 8.00e-03 0.615000
Regulation of pyruvate metabolism 31 3.30e-02 6.42e-02 0.3260 0.096500 3.02e-01 0.076000 3.53e-01 3.68e-03 0.464000
PKA activation 16 1.38e-01 1.98e-01 0.3250 0.260000 -8.70e-02 -0.175000 7.21e-02 5.47e-01 0.227000
Activation of gene expression by SREBF (SREBP) 37 1.39e-02 3.13e-02 0.3250 0.219000 2.38e-01 0.022400 2.12e-02 1.21e-02 0.814000
Keratan sulfate/keratin metabolism 24 4.24e-02 7.70e-02 0.3240 0.301000 -7.62e-02 0.093000 1.07e-02 5.19e-01 0.430000
RHOQ GTPase cycle 54 6.04e-04 2.27e-03 0.3240 0.228000 2.25e-01 -0.045500 3.71e-03 4.30e-03 0.563000
Signaling by Nuclear Receptors 184 1.73e-11 3.80e-10 0.3240 0.202000 2.52e-01 0.014900 2.36e-06 4.03e-09 0.728000
Regulation of MITF-M-dependent genes involved in pigmentation 34 9.46e-03 2.29e-02 0.3230 0.104000 3.05e-01 -0.028900 2.93e-01 2.12e-03 0.771000
NRIF signals cell death from the nucleus 12 2.94e-01 3.68e-01 0.3230 -0.028900 3.13e-01 0.076100 8.62e-01 6.07e-02 0.648000
PKA activation in glucagon signalling 15 1.81e-01 2.47e-01 0.3230 0.187000 -1.13e-01 -0.238000 2.09e-01 4.47e-01 0.111000
Regulation of PTEN gene transcription 56 1.55e-04 6.97e-04 0.3230 0.169000 2.57e-01 -0.098200 2.88e-02 8.77e-04 0.204000
Josephin domain DUBs 11 1.87e-01 2.54e-01 0.3230 -0.010200 2.54e-01 -0.200000 9.53e-01 1.45e-01 0.252000
Activation of G protein gated Potassium channels 13 3.75e-01 4.44e-01 0.3230 -0.087700 -2.62e-01 -0.167000 5.84e-01 1.02e-01 0.296000
G protein gated Potassium channels 13 3.75e-01 4.44e-01 0.3230 -0.087700 -2.62e-01 -0.167000 5.84e-01 1.02e-01 0.296000
Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits 13 3.75e-01 4.44e-01 0.3230 -0.087700 -2.62e-01 -0.167000 5.84e-01 1.02e-01 0.296000
HIV elongation arrest and recovery 24 2.88e-02 5.72e-02 0.3220 0.023800 5.65e-02 -0.317000 8.40e-01 6.32e-01 0.007280
Pausing and recovery of HIV elongation 24 2.88e-02 5.72e-02 0.3220 0.023800 5.65e-02 -0.317000 8.40e-01 6.32e-01 0.007280
Class A/1 (Rhodopsin-like receptors) 63 4.78e-05 2.40e-04 0.3220 0.180000 -2.66e-01 -0.024300 1.35e-02 2.60e-04 0.739000
EPH-Ephrin signaling 68 6.52e-06 4.00e-05 0.3220 0.177000 1.34e-01 -0.234000 1.19e-02 5.66e-02 0.000878
LDL clearance 16 8.55e-02 1.36e-01 0.3210 0.112000 1.69e-01 -0.249000 4.36e-01 2.43e-01 0.085100
Potential therapeutics for SARS 78 1.32e-05 7.50e-05 0.3210 0.161000 2.74e-01 -0.040900 1.42e-02 2.85e-05 0.533000
Infection with Mycobacterium tuberculosis 25 2.10e-02 4.43e-02 0.3200 -0.129000 1.30e-01 -0.263000 2.64e-01 2.62e-01 0.022900
Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 11 4.25e-01 4.90e-01 0.3200 0.057400 2.86e-01 0.130000 7.42e-01 1.00e-01 0.455000
EPHB-mediated forward signaling 34 4.66e-03 1.28e-02 0.3190 0.170000 9.36e-02 -0.253000 8.59e-02 3.45e-01 0.010600
SHC1 events in ERBB2 signaling 18 1.14e-01 1.72e-01 0.3190 0.171000 2.63e-01 -0.058000 2.10e-01 5.32e-02 0.670000
Cyclin A:Cdk2-associated events at S phase entry 64 2.77e-05 1.48e-04 0.3190 -0.133000 2.88e-01 -0.030100 6.58e-02 6.74e-05 0.678000
Drug ADME 40 9.31e-03 2.26e-02 0.3190 -0.309000 -4.60e-02 -0.063300 7.31e-04 6.15e-01 0.489000
Sphingolipid de novo biosynthesis 27 1.28e-02 2.93e-02 0.3180 0.131000 2.08e-01 -0.202000 2.37e-01 6.14e-02 0.069500
Sema4D in semaphorin signaling 23 3.10e-02 6.10e-02 0.3180 0.174000 1.29e-01 -0.233000 1.48e-01 2.83e-01 0.053500
Chromatin organization 192 9.55e-15 3.26e-13 0.3180 0.146000 2.62e-01 -0.106000 5.15e-04 4.28e-10 0.011500
ZBP1(DAI) mediated induction of type I IFNs 16 1.58e-01 2.20e-01 0.3170 0.268000 1.45e-01 -0.089000 6.36e-02 3.15e-01 0.538000
Toll Like Receptor 7/8 (TLR7/8) Cascade 89 3.05e-05 1.62e-04 0.3170 0.214000 2.31e-01 0.037800 5.06e-04 1.68e-04 0.538000
Alpha-protein kinase 1 signaling pathway 11 3.07e-01 3.81e-01 0.3170 -0.140000 2.77e-01 0.062800 4.20e-01 1.12e-01 0.718000
DNA Replication 100 1.25e-07 1.07e-06 0.3160 -0.268000 1.61e-01 -0.047100 3.75e-06 5.51e-03 0.416000
HDACs deacetylate histones 31 4.94e-03 1.35e-02 0.3160 0.037200 2.09e-01 -0.234000 7.20e-01 4.39e-02 0.024400
TCF dependent signaling in response to WNT 126 1.41e-09 2.19e-08 0.3150 0.038200 3.07e-01 -0.059200 4.60e-01 2.83e-09 0.252000
MAP2K and MAPK activation 32 1.05e-02 2.48e-02 0.3150 0.233000 1.33e-01 -0.164000 2.26e-02 1.93e-01 0.108000
G-protein activation 12 4.00e-01 4.68e-01 0.3140 -0.083600 -1.16e-01 -0.280000 6.16e-01 4.87e-01 0.093200
Regulation of CDH1 Expression and Function 125 4.40e-09 5.82e-08 0.3140 -0.015700 3.13e-01 -0.013800 7.63e-01 1.53e-09 0.790000
Regulation of Expression and Function of Type I Classical Cadherins 125 4.40e-09 5.82e-08 0.3140 -0.015700 3.13e-01 -0.013800 7.63e-01 1.53e-09 0.790000
Endogenous sterols 16 1.31e-01 1.91e-01 0.3140 0.235000 -1.28e-01 0.164000 1.04e-01 3.75e-01 0.257000
Signaling by ERBB2 41 1.93e-03 6.08e-03 0.3140 0.162000 2.27e-01 -0.143000 7.30e-02 1.18e-02 0.113000
Regulation of innate immune responses to cytosolic DNA 10 4.80e-01 5.39e-01 0.3140 -0.242000 -8.16e-02 -0.182000 1.85e-01 6.55e-01 0.320000
Transcriptional regulation by RUNX1 134 3.43e-09 4.80e-08 0.3130 0.119000 2.87e-01 -0.037100 1.75e-02 9.74e-09 0.459000
Deadenylation-dependent mRNA decay 46 1.40e-03 4.62e-03 0.3130 0.152000 2.59e-01 -0.088600 7.54e-02 2.38e-03 0.299000
Nucleotide biosynthesis 14 3.29e-01 4.02e-01 0.3130 -0.249000 -8.65e-02 -0.169000 1.07e-01 5.76e-01 0.274000
SUMOylation of transcription factors 15 1.40e-01 2.01e-01 0.3130 0.195000 1.52e-01 -0.191000 1.91e-01 3.07e-01 0.199000
Cristae formation 10 3.21e-01 3.94e-01 0.3130 -0.221000 1.21e-01 -0.185000 2.26e-01 5.09e-01 0.310000
Early Phase of HIV Life Cycle 13 2.39e-01 3.11e-01 0.3130 -0.188000 5.96e-02 -0.243000 2.40e-01 7.10e-01 0.130000
Suppression of phagosomal maturation 13 1.96e-01 2.63e-01 0.3130 -0.201000 1.38e-01 -0.196000 2.09e-01 3.90e-01 0.222000
Regulation of CDH11 function 10 3.98e-01 4.67e-01 0.3120 0.154000 2.71e-01 -0.015000 4.00e-01 1.37e-01 0.935000
Meiotic recombination 17 2.40e-01 3.11e-01 0.3120 -0.011700 1.55e-01 0.271000 9.34e-01 2.70e-01 0.053300
NCAM signaling for neurite out-growth 44 8.65e-03 2.12e-02 0.3120 0.101000 -1.91e-01 -0.225000 2.47e-01 2.85e-02 0.009990
PKA-mediated phosphorylation of CREB 18 1.27e-01 1.86e-01 0.3110 0.270000 -9.80e-02 -0.119000 4.74e-02 4.72e-01 0.381000
RUNX2 regulates osteoblast differentiation 20 1.29e-01 1.89e-01 0.3110 0.193000 2.43e-01 -0.011300 1.34e-01 6.01e-02 0.930000
DNA Damage Recognition in GG-NER 34 5.40e-03 1.46e-02 0.3100 -0.191000 2.03e-01 -0.136000 5.39e-02 4.04e-02 0.171000
Downstream TCR signaling 69 8.42e-05 4.00e-04 0.3100 -0.067800 3.00e-01 0.036500 3.30e-01 1.64e-05 0.600000
Influenza Infection 116 4.41e-08 4.31e-07 0.3100 -0.282000 9.95e-02 -0.082800 1.68e-07 6.45e-02 0.124000
Thromboxane signalling through TP receptor 14 3.24e-01 3.97e-01 0.3100 0.040200 -1.64e-01 -0.259000 7.95e-01 2.88e-01 0.092900
The role of GTSE1 in G2/M progression after G2 checkpoint 51 4.50e-04 1.75e-03 0.3090 -0.177000 2.51e-01 -0.036000 2.89e-02 1.97e-03 0.657000
Transcriptional Regulation by E2F6 31 5.67e-02 9.83e-02 0.3090 0.260000 1.51e-01 0.069400 1.22e-02 1.46e-01 0.504000
Vasopressin regulates renal water homeostasis via Aquaporins 30 3.84e-02 7.16e-02 0.3080 0.156000 -1.60e-01 -0.211000 1.39e-01 1.28e-01 0.045300
Signaling by BRAF and RAF1 fusions 56 4.63e-04 1.78e-03 0.3080 0.195000 2.18e-01 -0.094100 1.15e-02 4.75e-03 0.224000
Signaling by NTRK2 (TRKB) 19 1.41e-01 2.02e-01 0.3070 0.255000 1.65e-01 -0.046400 5.43e-02 2.13e-01 0.726000
APC/C:Cdc20 mediated degradation of Cyclin B 20 8.20e-02 1.31e-01 0.3070 -0.211000 2.23e-01 -0.002980 1.03e-01 8.41e-02 0.982000
Interleukin-12 family signaling 35 1.37e-02 3.11e-02 0.3070 0.093000 2.91e-01 -0.026800 3.42e-01 2.90e-03 0.784000
MAP3K8 (TPL2)-dependent MAPK1/3 activation 16 1.57e-01 2.19e-01 0.3060 -0.134000 2.75e-01 0.011300 3.54e-01 5.72e-02 0.938000
Apoptotic factor-mediated response 18 9.01e-02 1.43e-01 0.3060 -0.098200 2.79e-01 -0.077400 4.71e-01 4.07e-02 0.570000
Laminin interactions 26 3.57e-02 6.77e-02 0.3050 0.237000 -1.92e-01 0.009810 3.62e-02 9.08e-02 0.931000
ROS and RNS production in phagocytes 22 1.40e-01 2.01e-01 0.3050 0.070900 -2.41e-01 -0.173000 5.65e-01 5.03e-02 0.160000
Dopamine Neurotransmitter Release Cycle 12 3.96e-01 4.65e-01 0.3050 0.063500 -1.61e-01 -0.251000 7.03e-01 3.36e-01 0.132000
eNOS activation 13 2.08e-01 2.77e-01 0.3050 0.098100 2.62e-01 -0.121000 5.40e-01 1.02e-01 0.449000
Processing of Capped Intron-Containing Pre-mRNA 239 8.05e-19 5.74e-17 0.3050 -0.121000 2.54e-01 -0.117000 1.35e-03 1.52e-11 0.001990
MyD88 dependent cascade initiated on endosome 88 7.00e-05 3.37e-04 0.3040 0.205000 2.23e-01 0.027400 8.84e-04 3.10e-04 0.657000
Downregulation of ERBB2 signaling 22 3.79e-02 7.09e-02 0.3040 -0.059000 2.47e-01 -0.167000 6.32e-01 4.48e-02 0.176000
Trafficking of GluR2-containing AMPA receptors 12 3.71e-01 4.41e-01 0.3040 -0.119000 2.18e-01 0.174000 4.75e-01 1.91e-01 0.296000
Defective Intrinsic Pathway for Apoptosis 19 1.41e-01 2.02e-01 0.3030 0.122000 2.77e-01 -0.019700 3.58e-01 3.67e-02 0.882000
Translesion synthesis by POLK 17 1.52e-01 2.13e-01 0.3030 -0.227000 1.94e-01 0.050500 1.05e-01 1.66e-01 0.719000
G beta:gamma signalling through PI3Kgamma 14 2.85e-01 3.58e-01 0.3030 0.006810 -5.96e-02 -0.297000 9.65e-01 7.00e-01 0.054400
Antigen processing: Ubiquitination & Proteasome degradation 251 2.79e-14 8.65e-13 0.3030 0.080000 2.90e-01 0.029800 2.98e-02 2.76e-15 0.418000
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation 87 1.07e-04 4.94e-04 0.3020 0.201000 2.23e-01 0.037400 1.21e-03 3.32e-04 0.547000
Retrograde transport at the Trans-Golgi-Network 44 1.39e-02 3.13e-02 0.3020 0.040800 2.84e-01 0.095600 6.40e-01 1.13e-03 0.273000
RHO GTPases Activate WASPs and WAVEs 31 1.14e-02 2.64e-02 0.3020 0.135000 1.95e-01 -0.187000 1.92e-01 6.04e-02 0.071700
SARS-CoV-1-host interactions 71 4.61e-05 2.32e-04 0.3020 -0.059700 2.95e-01 -0.017300 3.85e-01 1.71e-05 0.802000
Programmed Cell Death 155 6.57e-10 1.07e-08 0.3020 0.093300 2.85e-01 -0.031700 4.55e-02 9.67e-10 0.497000
Class I peroxisomal membrane protein import 14 1.50e-01 2.11e-01 0.3020 -0.067500 2.07e-01 -0.209000 6.62e-01 1.81e-01 0.176000
Regulation of cholesterol biosynthesis by SREBP (SREBF) 49 4.95e-03 1.35e-02 0.3020 0.224000 2.01e-01 -0.012700 6.64e-03 1.49e-02 0.878000
Ion homeostasis 44 1.07e-02 2.52e-02 0.3010 0.025100 2.91e-01 0.073800 7.73e-01 8.37e-04 0.397000
Cleavage of the damaged pyrimidine 13 2.62e-01 3.33e-01 0.3010 -0.267000 1.04e-01 -0.092800 9.59e-02 5.16e-01 0.562000
Depyrimidination 13 2.62e-01 3.33e-01 0.3010 -0.267000 1.04e-01 -0.092800 9.59e-02 5.16e-01 0.562000
Recognition and association of DNA glycosylase with site containing an affected pyrimidine 13 2.62e-01 3.33e-01 0.3010 -0.267000 1.04e-01 -0.092800 9.59e-02 5.16e-01 0.562000
Interconversion of nucleotide di- and triphosphates 20 1.24e-01 1.83e-01 0.3010 -0.185000 2.12e-01 0.107000 1.52e-01 1.01e-01 0.406000
CS/DS degradation 13 4.00e-01 4.68e-01 0.3000 -0.064900 -2.72e-01 -0.110000 6.85e-01 8.99e-02 0.493000
Inhibition of DNA recombination at telomere 15 1.31e-01 1.91e-01 0.3000 -0.019000 1.82e-01 -0.238000 8.99e-01 2.22e-01 0.111000
Interleukin-6 family signaling 18 1.99e-01 2.67e-01 0.3000 0.248000 1.69e-01 -0.011800 6.90e-02 2.15e-01 0.931000
NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux 31 2.12e-02 4.46e-02 0.2990 0.104000 2.71e-01 -0.073200 3.17e-01 9.01e-03 0.481000
Cargo concentration in the ER 23 1.62e-01 2.23e-01 0.2990 0.244000 1.55e-01 0.079300 4.31e-02 1.99e-01 0.510000
RHOC GTPase cycle 63 1.65e-04 7.39e-04 0.2990 0.219000 7.89e-02 -0.187000 2.63e-03 2.79e-01 0.010200
GPVI-mediated activation cascade 21 1.02e-01 1.57e-01 0.2990 0.248000 -4.69e-02 -0.160000 4.91e-02 7.10e-01 0.204000
Signaling by FGFR 62 1.72e-04 7.71e-04 0.2990 0.167000 2.12e-01 -0.128000 2.30e-02 3.87e-03 0.082600
Deubiquitination 199 1.59e-11 3.56e-10 0.2990 0.116000 2.75e-01 -0.004500 4.78e-03 2.58e-11 0.913000
Budding and maturation of HIV virion 23 7.60e-02 1.23e-01 0.2980 -0.101000 2.79e-01 0.027600 4.03e-01 2.04e-02 0.819000
UCH proteinases 67 7.49e-05 3.60e-04 0.2980 -0.159000 2.50e-01 -0.025300 2.43e-02 3.96e-04 0.720000
Signaling by CSF3 (G-CSF) 24 6.00e-02 1.03e-01 0.2960 0.176000 2.10e-01 -0.112000 1.37e-01 7.46e-02 0.342000
Chemokine receptors bind chemokines 12 2.51e-01 3.23e-01 0.2960 0.175000 -1.86e-01 0.149000 2.94e-01 2.65e-01 0.371000
CS-GAG biosynthesis 15 2.39e-01 3.11e-01 0.2960 0.288000 -5.89e-02 0.032300 5.34e-02 6.93e-01 0.828000
Prolactin receptor signaling 10 4.17e-01 4.83e-01 0.2960 0.035600 2.94e-01 -0.004380 8.45e-01 1.08e-01 0.981000
MyD88 cascade initiated on plasma membrane 85 1.92e-04 8.47e-04 0.2950 0.193000 2.21e-01 0.032400 2.09e-03 4.32e-04 0.606000
Toll Like Receptor 10 (TLR10) Cascade 85 1.92e-04 8.47e-04 0.2950 0.193000 2.21e-01 0.032400 2.09e-03 4.32e-04 0.606000
Toll Like Receptor 5 (TLR5) Cascade 85 1.92e-04 8.47e-04 0.2950 0.193000 2.21e-01 0.032400 2.09e-03 4.32e-04 0.606000
COPI-mediated anterograde transport 79 4.88e-06 3.07e-05 0.2950 0.073700 2.36e-01 -0.160000 2.58e-01 2.84e-04 0.013900
Signaling by WNT in cancer 27 6.41e-02 1.08e-01 0.2940 0.169000 2.38e-01 -0.034500 1.28e-01 3.22e-02 0.756000
Depolymerization of the Nuclear Lamina 12 3.17e-01 3.90e-01 0.2940 0.235000 1.30e-01 -0.120000 1.58e-01 4.36e-01 0.473000
C-type lectin receptors (CLRs) 95 1.83e-06 1.26e-05 0.2940 -0.050900 2.88e-01 -0.032400 3.92e-01 1.29e-06 0.586000
Regulation of TP53 Activity through Acetylation 29 2.48e-02 5.05e-02 0.2940 0.158000 8.18e-02 -0.234000 1.41e-01 4.46e-01 0.029200
Signaling by WNT 193 9.04e-13 2.44e-11 0.2940 0.063300 2.77e-01 -0.072500 1.31e-01 3.38e-11 0.083400
Class B/2 (Secretin family receptors) 39 5.50e-02 9.58e-02 0.2920 -0.186000 -1.31e-01 -0.183000 4.44e-02 1.57e-01 0.047700
Regulation of Homotypic Cell-Cell Adhesion 136 1.28e-08 1.44e-07 0.2920 0.005000 2.91e-01 -0.024800 9.20e-01 4.98e-09 0.618000
PIP3 activates AKT signaling 210 7.20e-12 1.66e-10 0.2920 0.111000 2.69e-01 -0.014500 5.72e-03 1.94e-11 0.718000
MAPK family signaling cascades 229 4.12e-13 1.20e-11 0.2910 0.145000 2.50e-01 -0.035800 1.69e-04 7.49e-11 0.352000
Abortive elongation of HIV-1 transcript in the absence of Tat 18 2.10e-01 2.79e-01 0.2910 -0.043700 -3.51e-02 -0.285000 7.49e-01 7.97e-01 0.036100
FCGR3A-mediated phagocytosis 48 2.35e-03 7.23e-03 0.2910 0.204000 5.49e-02 -0.200000 1.45e-02 5.11e-01 0.016900
Leishmania phagocytosis 48 2.35e-03 7.23e-03 0.2910 0.204000 5.49e-02 -0.200000 1.45e-02 5.11e-01 0.016900
Parasite infection 48 2.35e-03 7.23e-03 0.2910 0.204000 5.49e-02 -0.200000 1.45e-02 5.11e-01 0.016900
Processive synthesis on the lagging strand 15 3.22e-01 3.94e-01 0.2900 -0.233000 -2.61e-02 -0.171000 1.18e-01 8.61e-01 0.251000
NOD1/2 Signaling Pathway 34 1.82e-02 3.93e-02 0.2900 0.157000 2.24e-01 -0.098100 1.14e-01 2.39e-02 0.322000
Nitric oxide stimulates guanylate cyclase 16 2.60e-01 3.33e-01 0.2900 0.099600 -2.51e-01 -0.108000 4.91e-01 8.27e-02 0.455000
Neddylation 193 7.42e-11 1.39e-09 0.2900 0.020100 2.89e-01 0.021500 6.31e-01 4.99e-12 0.608000
SUMOylation of transcription cofactors 39 9.71e-03 2.34e-02 0.2900 0.172000 2.11e-01 -0.100000 6.31e-02 2.25e-02 0.278000
Glucagon-type ligand receptors 14 4.56e-01 5.19e-01 0.2900 -0.148000 -1.55e-01 -0.196000 3.39e-01 3.15e-01 0.205000
Insertion of tail-anchored proteins into the endoplasmic reticulum membrane 16 1.47e-01 2.08e-01 0.2900 0.050100 1.22e-01 -0.259000 7.29e-01 4.00e-01 0.073500
Oncogene Induced Senescence 30 6.22e-02 1.06e-01 0.2890 0.164000 2.38e-01 -0.003190 1.20e-01 2.40e-02 0.976000
Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation 24 9.24e-02 1.46e-01 0.2890 0.069500 2.81e-01 -0.012000 5.56e-01 1.74e-02 0.919000
Smooth Muscle Contraction 37 2.67e-02 5.37e-02 0.2890 0.074300 2.79e-01 0.020800 4.34e-01 3.36e-03 0.827000
Pre-NOTCH Transcription and Translation 30 4.56e-02 8.18e-02 0.2890 0.265000 8.17e-02 -0.081700 1.21e-02 4.39e-01 0.439000
PKMTs methylate histone lysines 34 1.64e-02 3.63e-02 0.2890 0.184000 1.72e-01 -0.141000 6.41e-02 8.22e-02 0.154000
mRNA Splicing - Minor Pathway 38 6.99e-03 1.78e-02 0.2880 -0.144000 2.38e-01 -0.072500 1.24e-01 1.10e-02 0.440000
SUMOylation of immune response proteins 10 3.70e-01 4.40e-01 0.2880 0.021200 2.73e-01 -0.088400 9.08e-01 1.35e-01 0.628000
Pentose phosphate pathway 11 2.81e-01 3.55e-01 0.2880 -0.007820 2.01e-01 -0.206000 9.64e-01 2.48e-01 0.238000
MyD88:MAL(TIRAP) cascade initiated on plasma membrane 90 2.26e-04 9.58e-04 0.2880 0.201000 2.01e-01 0.039600 9.69e-04 9.73e-04 0.516000
Toll Like Receptor 2 (TLR2) Cascade 90 2.26e-04 9.58e-04 0.2880 0.201000 2.01e-01 0.039600 9.69e-04 9.73e-04 0.516000
Toll Like Receptor TLR1:TLR2 Cascade 90 2.26e-04 9.58e-04 0.2880 0.201000 2.01e-01 0.039600 9.69e-04 9.73e-04 0.516000
Toll Like Receptor TLR6:TLR2 Cascade 90 2.26e-04 9.58e-04 0.2880 0.201000 2.01e-01 0.039600 9.69e-04 9.73e-04 0.516000
Pre-NOTCH Expression and Processing 43 8.47e-03 2.09e-02 0.2880 0.262000 -1.81e-02 -0.117000 2.97e-03 8.37e-01 0.184000
Retinoid metabolism and transport 23 1.47e-01 2.08e-01 0.2870 0.099300 -2.26e-01 -0.148000 4.10e-01 6.12e-02 0.220000
Regulation of pyruvate dehydrogenase (PDH) complex 14 4.71e-01 5.30e-01 0.2870 0.137000 1.89e-01 0.167000 3.74e-01 2.20e-01 0.279000
ER Quality Control Compartment (ERQC) 18 3.12e-01 3.86e-01 0.2870 0.031100 2.44e-01 0.148000 8.20e-01 7.34e-02 0.279000
Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal 59 3.97e-03 1.11e-02 0.2860 0.152000 2.41e-01 0.024800 4.31e-02 1.37e-03 0.742000
Amplification of signal from the kinetochores 59 3.97e-03 1.11e-02 0.2860 0.152000 2.41e-01 0.024800 4.31e-02 1.37e-03 0.742000
RND2 GTPase cycle 33 2.53e-02 5.13e-02 0.2860 0.128000 2.94e-03 -0.255000 2.02e-01 9.77e-01 0.011200
alpha-linolenic (omega3) and linoleic (omega6) acid metabolism 10 4.34e-01 4.99e-01 0.2860 0.028500 2.89e-03 -0.284000 8.76e-01 9.87e-01 0.120000
alpha-linolenic acid (ALA) metabolism 10 4.34e-01 4.99e-01 0.2860 0.028500 2.89e-03 -0.284000 8.76e-01 9.87e-01 0.120000
Positive epigenetic regulation of rRNA expression 39 9.19e-03 2.23e-02 0.2850 0.189000 1.52e-01 -0.151000 4.17e-02 1.01e-01 0.103000
RHO GTPases activate CIT 18 1.86e-01 2.53e-01 0.2850 0.245000 1.03e-01 -0.102000 7.22e-02 4.48e-01 0.455000
HATs acetylate histones 72 2.55e-04 1.06e-03 0.2840 0.122000 2.52e-01 -0.048400 7.43e-02 2.17e-04 0.478000
Class I MHC mediated antigen processing & presentation 301 9.59e-15 3.26e-13 0.2840 0.090100 2.68e-01 0.030800 7.44e-03 1.66e-15 0.360000
Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane 10 4.40e-01 5.03e-01 0.2840 0.233000 -2.24e-02 -0.161000 2.03e-01 9.03e-01 0.377000
Transport of connexons to the plasma membrane 10 4.40e-01 5.03e-01 0.2840 0.233000 -2.24e-02 -0.161000 2.03e-01 9.03e-01 0.377000
COPII-mediated vesicle transport 56 2.81e-03 8.37e-03 0.2840 0.194000 2.02e-01 -0.047200 1.21e-02 9.04e-03 0.541000
High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells 53 3.05e-03 8.82e-03 0.2840 0.176000 -5.68e-02 -0.215000 2.67e-02 4.75e-01 0.006750
Formation of the dystrophin-glycoprotein complex (DGC) 30 1.42e-01 2.02e-01 0.2840 0.077800 2.22e-01 0.159000 4.61e-01 3.54e-02 0.133000
TNF signaling 51 2.78e-03 8.35e-03 0.2840 0.083400 2.66e-01 -0.054700 3.03e-01 1.04e-03 0.500000
E3 ubiquitin ligases ubiquitinate target proteins 36 2.32e-02 4.79e-02 0.2840 0.097400 2.64e-01 -0.036500 3.12e-01 6.18e-03 0.705000
Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) 17 1.31e-01 1.91e-01 0.2830 0.038700 -1.65e-01 0.227000 7.82e-01 2.40e-01 0.105000
Protein ubiquitination 55 1.99e-03 6.24e-03 0.2830 0.082900 2.67e-01 -0.043400 2.88e-01 6.20e-04 0.578000
RHOD GTPase cycle 45 1.39e-02 3.13e-02 0.2820 0.255000 1.18e-01 -0.027000 3.07e-03 1.71e-01 0.754000
Regulation of TP53 Activity through Association with Co-factors 11 3.98e-01 4.67e-01 0.2820 0.214000 -2.17e-02 -0.183000 2.19e-01 9.01e-01 0.294000
Fanconi Anemia Pathway 26 4.42e-02 7.96e-02 0.2820 -0.168000 1.87e-01 -0.129000 1.38e-01 9.96e-02 0.255000
NR1H2 and NR1H3-mediated signaling 37 3.12e-02 6.12e-02 0.2820 0.133000 2.49e-01 -0.007530 1.62e-01 8.80e-03 0.937000
Kidney development 23 9.02e-02 1.43e-01 0.2820 0.186000 3.00e-02 -0.210000 1.23e-01 8.03e-01 0.081200
Metabolism of RNA 585 2.16e-37 1.54e-34 0.2820 -0.142000 2.28e-01 -0.083600 5.35e-09 9.07e-21 0.000625
Nuclear RNA decay 25 1.47e-01 2.08e-01 0.2810 0.079700 2.63e-01 0.058300 4.90e-01 2.26e-02 0.614000
ADORA2B mediated anti-inflammatory cytokines production 31 5.29e-02 9.31e-02 0.2810 0.174000 -9.94e-02 -0.198000 9.44e-02 3.38e-01 0.056900
Endosomal Sorting Complex Required For Transport (ESCRT) 26 6.11e-02 1.05e-01 0.2810 -0.098700 2.62e-01 -0.017300 3.84e-01 2.08e-02 0.879000
Platelet sensitization by LDL 15 2.11e-01 2.81e-01 0.2800 0.143000 1.77e-01 -0.163000 3.37e-01 2.35e-01 0.273000
Protein localization 118 6.17e-08 5.76e-07 0.2800 -0.134000 2.22e-01 -0.105000 1.21e-02 3.11e-05 0.049700
RHO GTPases activate IQGAPs 20 1.47e-01 2.08e-01 0.2790 0.176000 1.95e-01 -0.095500 1.74e-01 1.31e-01 0.460000
Diseases associated with N-glycosylation of proteins 17 3.17e-01 3.90e-01 0.2790 -0.209000 -1.83e-01 -0.028200 1.37e-01 1.91e-01 0.841000
Aquaporin-mediated transport 31 7.36e-02 1.21e-01 0.2790 0.128000 -1.70e-01 -0.180000 2.18e-01 1.01e-01 0.083300
Ovarian tumor domain proteases 33 6.28e-02 1.07e-01 0.2790 0.146000 2.37e-01 0.010700 1.47e-01 1.84e-02 0.915000
FCERI mediated MAPK activation 25 1.05e-01 1.61e-01 0.2780 0.269000 2.93e-02 -0.064100 1.99e-02 8.00e-01 0.579000
Gastrulation 69 1.25e-04 5.73e-04 0.2780 -0.000850 2.62e-01 -0.094500 9.90e-01 1.74e-04 0.175000
Regulation of MITF-M-dependent genes involved in cell cycle and proliferation 15 2.89e-01 3.62e-01 0.2770 0.259000 4.38e-02 -0.090700 8.31e-02 7.69e-01 0.543000
Toll Like Receptor 4 (TLR4) Cascade 114 1.91e-05 1.06e-04 0.2770 0.221000 1.67e-01 -0.000879 4.62e-05 2.10e-03 0.987000
Hedgehog ‘on’ state 64 2.17e-04 9.35e-04 0.2770 -0.147000 1.86e-01 -0.143000 4.25e-02 1.00e-02 0.047400
Resolution of Abasic Sites (AP sites) 34 6.83e-02 1.14e-01 0.2770 -0.260000 -5.53e-02 -0.076800 8.67e-03 5.77e-01 0.439000
Formation of the ureteric bud 13 3.13e-01 3.87e-01 0.2770 0.203000 7.41e-02 -0.172000 2.04e-01 6.44e-01 0.282000
Inactivation of CSF3 (G-CSF) signaling 19 1.34e-01 1.93e-01 0.2770 0.062800 2.45e-01 -0.112000 6.35e-01 6.45e-02 0.398000
Regulation of TNFR1 signaling 44 8.37e-03 2.07e-02 0.2770 0.040900 2.70e-01 -0.044600 6.39e-01 1.97e-03 0.609000
RHO GTPases activate PAKs 20 1.38e-01 1.98e-01 0.2760 0.198000 9.64e-02 -0.167000 1.26e-01 4.56e-01 0.196000
DAP12 interactions 21 1.58e-01 2.20e-01 0.2750 0.260000 -1.17e-02 -0.089000 3.89e-02 9.26e-01 0.480000
RHO GTPases Activate NADPH Oxidases 12 3.47e-01 4.20e-01 0.2750 -0.096500 8.02e-02 -0.245000 5.63e-01 6.31e-01 0.142000
TRAF6 mediated IRF7 activation 13 3.41e-01 4.13e-01 0.2750 0.232000 5.40e-02 -0.137000 1.47e-01 7.36e-01 0.394000
TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain 19 1.44e-01 2.06e-01 0.2740 0.157000 1.50e-01 -0.167000 2.36e-01 2.57e-01 0.207000
ER to Golgi Anterograde Transport 122 1.99e-07 1.67e-06 0.2740 0.108000 2.25e-01 -0.113000 4.02e-02 1.79e-05 0.031000
FGFR2 alternative splicing 20 1.04e-01 1.61e-01 0.2740 0.000820 2.35e-01 -0.141000 9.95e-01 6.88e-02 0.275000
Resolution of Sister Chromatid Cohesion 77 1.36e-03 4.54e-03 0.2740 0.167000 2.16e-01 0.026600 1.16e-02 1.06e-03 0.686000
Neurexins and neuroligins 29 6.94e-02 1.14e-01 0.2740 0.150000 -2.19e-01 -0.067900 1.62e-01 4.14e-02 0.527000
Epigenetic regulation of gene expression 216 9.16e-12 2.08e-10 0.2730 0.135000 2.26e-01 -0.071800 6.29e-04 1.07e-08 0.069900
Adherens junctions interactions 144 6.51e-08 5.93e-07 0.2730 0.004610 2.73e-01 -0.016400 9.24e-01 1.67e-08 0.735000
Glucagon signaling in metabolic regulation 23 1.88e-01 2.54e-01 0.2730 0.077700 -1.25e-01 -0.230000 5.19e-01 3.00e-01 0.056000
Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding 23 2.54e-01 3.26e-01 0.2730 -0.108000 -1.09e-01 -0.226000 3.70e-01 3.65e-01 0.061100
RHO GTPases Activate Formins 92 1.40e-04 6.37e-04 0.2720 0.175000 2.08e-01 -0.022600 3.76e-03 5.91e-04 0.708000
Interleukin-2 family signaling 26 1.06e-01 1.62e-01 0.2720 0.250000 8.17e-02 -0.070600 2.74e-02 4.71e-01 0.533000
Developmental Cell Lineages of the Exocrine Pancreas 21 1.49e-01 2.10e-01 0.2720 -0.105000 -2.43e-01 0.061900 4.05e-01 5.41e-02 0.623000
TRAF6 mediated NF-kB activation 18 3.30e-01 4.02e-01 0.2720 0.237000 1.18e-01 0.061300 8.17e-02 3.87e-01 0.653000
Cyclin A/B1/B2 associated events during G2/M transition 19 2.97e-01 3.70e-01 0.2720 -0.012200 2.44e-01 0.118000 9.27e-01 6.54e-02 0.372000
Antigen processing-Cross presentation 70 3.88e-04 1.53e-03 0.2720 -0.140000 2.33e-01 0.001450 4.25e-02 7.77e-04 0.983000
Separation of Sister Chromatids 125 1.16e-06 8.33e-06 0.2710 -0.035100 2.69e-01 0.011200 4.99e-01 2.15e-07 0.829000
Cellular response to heat stress 84 5.34e-05 2.64e-04 0.2710 0.105000 2.32e-01 -0.094800 9.63e-02 2.49e-04 0.134000
Heparan sulfate/heparin (HS-GAG) metabolism 24 2.04e-01 2.72e-01 0.2710 -0.046000 -8.97e-02 -0.252000 6.97e-01 4.47e-01 0.032700
The role of Nef in HIV-1 replication and disease pathogenesis 20 1.05e-01 1.62e-01 0.2710 -0.048500 2.11e-01 -0.162000 7.08e-01 1.02e-01 0.209000
Signal transduction by L1 17 1.61e-01 2.23e-01 0.2710 0.033200 2.08e-01 -0.170000 8.13e-01 1.37e-01 0.226000
VEGFA-VEGFR2 Pathway 80 3.32e-04 1.32e-03 0.2700 0.200000 1.70e-01 -0.063200 2.04e-03 8.53e-03 0.329000
Extracellular matrix organization 209 4.32e-10 7.09e-09 0.2700 0.162000 -1.77e-01 -0.123000 5.70e-05 1.05e-05 0.002210
RNA Polymerase II Transcription Termination 54 1.57e-03 5.08e-03 0.2700 -0.151000 2.02e-01 -0.095200 5.49e-02 1.02e-02 0.227000
Developmental Cell Lineages 22 1.12e-01 1.69e-01 0.2690 -0.063100 -2.44e-01 0.094800 6.08e-01 4.78e-02 0.441000
Cytosolic sensors of pathogen-associated DNA 47 3.78e-03 1.07e-02 0.2690 0.107000 1.79e-01 -0.170000 2.03e-01 3.42e-02 0.043900
Mitochondrial protein degradation 66 5.28e-04 2.00e-03 0.2680 -0.086200 2.51e-01 -0.039500 2.26e-01 4.24e-04 0.579000
NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 12 4.35e-01 5.00e-01 0.2680 0.033300 -2.88e-02 -0.265000 8.42e-01 8.63e-01 0.113000
DAP12 signaling 20 1.94e-01 2.61e-01 0.2680 0.249000 -2.56e-02 -0.096700 5.43e-02 8.43e-01 0.454000
Inhibition of replication initiation of damaged DNA by RB1/E2F1 12 4.34e-01 4.99e-01 0.2680 0.063900 2.60e-01 -0.008260 7.02e-01 1.19e-01 0.960000
Early SARS-CoV-2 Infection Events 23 1.24e-01 1.82e-01 0.2670 0.199000 3.44e-02 -0.176000 9.90e-02 7.76e-01 0.145000
Metabolism of amino acids and derivatives 229 4.95e-11 9.82e-10 0.2670 -0.264000 3.91e-02 -0.007410 7.12e-12 3.09e-01 0.847000
TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling 11 3.63e-01 4.35e-01 0.2660 0.069700 1.59e-01 -0.202000 6.89e-01 3.61e-01 0.246000
Interleukin-12 signaling 30 6.47e-02 1.09e-01 0.2660 0.003760 2.66e-01 -0.016300 9.72e-01 1.18e-02 0.877000
CASP8 activity is inhibited 10 6.51e-01 7.00e-01 0.2660 -0.103000 -2.15e-01 -0.117000 5.72e-01 2.38e-01 0.521000
Dimerization of procaspase-8 10 6.51e-01 7.00e-01 0.2660 -0.103000 -2.15e-01 -0.117000 5.72e-01 2.38e-01 0.521000
Regulation by c-FLIP 10 6.51e-01 7.00e-01 0.2660 -0.103000 -2.15e-01 -0.117000 5.72e-01 2.38e-01 0.521000
RNA Polymerase III Chain Elongation 13 2.82e-01 3.55e-01 0.2660 0.037100 1.89e-01 -0.183000 8.17e-01 2.39e-01 0.252000
SARS-CoV-1 activates/modulates innate immune responses 30 5.64e-02 9.80e-02 0.2660 0.059900 2.51e-01 -0.062200 5.70e-01 1.73e-02 0.556000
Effects of PIP2 hydrolysis 20 1.48e-01 2.09e-01 0.2660 -0.066800 2.51e-01 -0.057000 6.05e-01 5.24e-02 0.659000
DAG1 glycosylations 12 4.07e-01 4.75e-01 0.2650 -0.233000 1.26e-01 -0.006600 1.62e-01 4.49e-01 0.968000
TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest 13 4.11e-01 4.78e-01 0.2640 -0.164000 3.00e-02 -0.206000 3.07e-01 8.52e-01 0.199000
Regulation of Complement cascade 16 2.12e-01 2.81e-01 0.2640 0.103000 -1.55e-01 0.188000 4.77e-01 2.83e-01 0.194000
RAS processing 19 1.58e-01 2.20e-01 0.2640 -0.051100 2.45e-01 -0.084500 7.00e-01 6.46e-02 0.524000
Respiratory Syncytial Virus Infection Pathway 82 2.61e-04 1.08e-03 0.2640 0.162000 1.94e-01 -0.074600 1.13e-02 2.37e-03 0.244000
Oxidative Stress Induced Senescence 60 5.79e-03 1.55e-02 0.2640 0.128000 2.31e-01 -0.008510 8.67e-02 2.03e-03 0.909000
Phase 0 - rapid depolarisation 20 2.11e-01 2.81e-01 0.2630 -0.199000 1.44e-01 0.095000 1.23e-01 2.66e-01 0.462000
MAPK1/MAPK3 signaling 198 7.98e-10 1.28e-08 0.2630 0.114000 2.32e-01 -0.050800 5.70e-03 2.03e-08 0.219000
Negative regulation of MET activity 18 3.60e-01 4.32e-01 0.2630 0.071600 2.41e-01 0.078500 5.99e-01 7.68e-02 0.564000
Regulation of actin dynamics for phagocytic cup formation 49 6.79e-03 1.73e-02 0.2630 0.186000 1.22e-01 -0.141000 2.44e-02 1.41e-01 0.087800
Prostacyclin signalling through prostacyclin receptor 10 6.18e-01 6.72e-01 0.2630 -0.151000 -5.83e-02 -0.208000 4.10e-01 7.50e-01 0.255000
Regulation of endogenous retroelements 69 3.35e-04 1.33e-03 0.2630 0.046000 9.35e-02 -0.241000 5.09e-01 1.80e-01 0.000535
Toll-like Receptor Cascades 130 3.11e-05 1.65e-04 0.2630 0.197000 1.71e-01 0.030400 1.08e-04 7.77e-04 0.550000
Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation 44 1.65e-02 3.64e-02 0.2620 -0.210000 8.15e-02 -0.133000 1.58e-02 3.50e-01 0.127000
Plasma lipoprotein clearance 29 4.89e-02 8.70e-02 0.2620 -0.034300 1.13e-01 -0.234000 7.50e-01 2.92e-01 0.029500
G1/S Transition 94 5.43e-05 2.66e-04 0.2620 -0.139000 2.21e-01 0.013200 2.00e-02 2.12e-04 0.826000
RND1 GTPase cycle 34 3.58e-02 6.79e-02 0.2610 0.172000 1.14e-01 -0.160000 8.23e-02 2.49e-01 0.107000
Basigin interactions 17 2.28e-01 2.98e-01 0.2610 -0.030500 2.54e-01 -0.053600 8.28e-01 6.99e-02 0.702000
Signaling by FGFR in disease 44 2.57e-02 5.20e-02 0.2610 0.205000 1.55e-01 -0.047600 1.87e-02 7.62e-02 0.585000
E2F mediated regulation of DNA replication 17 4.70e-01 5.30e-01 0.2610 0.098300 1.74e-01 0.168000 4.83e-01 2.15e-01 0.230000
Diseases of glycosylation 97 1.34e-03 4.51e-03 0.2610 -0.002660 -1.83e-01 -0.186000 9.64e-01 1.88e-03 0.001560
RAF/MAP kinase cascade 193 2.39e-09 3.63e-08 0.2610 0.101000 2.37e-01 -0.042400 1.55e-02 1.56e-08 0.311000
Beta-catenin independent WNT signaling 107 1.98e-06 1.36e-05 0.2610 -0.040400 2.31e-01 -0.113000 4.71e-01 3.67e-05 0.043900
Intracellular signaling by second messengers 245 3.03e-11 6.29e-10 0.2600 0.107000 2.36e-01 -0.025600 4.09e-03 2.32e-10 0.491000
Diseases associated with glycosaminoglycan metabolism 27 1.12e-01 1.69e-01 0.2600 0.231000 -6.24e-02 -0.102000 3.78e-02 5.75e-01 0.358000
Response of endothelial cells to shear stress 74 1.02e-03 3.56e-03 0.2600 0.227000 9.70e-02 -0.082800 7.62e-04 1.49e-01 0.219000
SUMOylation 148 6.50e-07 4.84e-06 0.2590 0.178000 1.81e-01 -0.054500 1.91e-04 1.52e-04 0.253000
MITF-M-regulated melanocyte development 114 5.07e-05 2.52e-04 0.2590 0.169000 1.96e-01 -0.016000 1.92e-03 3.03e-04 0.768000
TICAM1-dependent activation of IRF3/IRF7 12 4.00e-01 4.68e-01 0.2590 0.033900 2.49e-01 -0.064400 8.39e-01 1.36e-01 0.699000
EML4 and NUDC in mitotic spindle formation 72 2.89e-03 8.42e-03 0.2590 0.175000 1.90e-01 -0.011000 1.03e-02 5.28e-03 0.872000
Aggrephagy 29 6.70e-02 1.11e-01 0.2590 0.154000 1.59e-01 -0.134000 1.51e-01 1.40e-01 0.211000
Interleukin-20 family signaling 13 4.15e-01 4.81e-01 0.2590 0.222000 -6.26e-02 -0.116000 1.65e-01 6.96e-01 0.469000
Peroxisomal lipid metabolism 20 2.62e-01 3.33e-01 0.2580 -0.257000 -9.47e-03 -0.028100 4.69e-02 9.42e-01 0.828000
RHO GTPase Effectors 184 9.56e-09 1.12e-07 0.2580 0.165000 1.86e-01 -0.069000 1.21e-04 1.38e-05 0.107000
S Phase 124 3.27e-06 2.13e-05 0.2580 -0.161000 2.00e-01 0.027800 2.04e-03 1.22e-04 0.593000
Activated NTRK2 signals through FRS2 and FRS3 10 5.34e-01 5.92e-01 0.2570 0.233000 4.41e-02 -0.100000 2.02e-01 8.09e-01 0.584000
Cellular responses to mechanical stimuli 81 5.19e-04 1.97e-03 0.2570 0.224000 8.19e-02 -0.096500 5.12e-04 2.03e-01 0.134000
GPCR ligand binding 105 3.08e-04 1.24e-03 0.2570 0.028400 -2.33e-01 -0.105000 6.16e-01 3.86e-05 0.064600
Peroxisomal protein import 48 7.72e-03 1.92e-02 0.2570 -0.158000 1.94e-01 -0.056300 5.81e-02 2.02e-02 0.500000
Resolution of D-Loop Structures 22 1.20e-01 1.78e-01 0.2560 -0.058900 -1.24e-01 0.217000 6.33e-01 3.16e-01 0.078400
Resolution of D-loop Structures through Holliday Junction Intermediates 22 1.20e-01 1.78e-01 0.2560 -0.058900 -1.24e-01 0.217000 6.33e-01 3.16e-01 0.078400
Regulation of IFNA/IFNB signaling 10 5.06e-01 5.65e-01 0.2560 0.146000 1.86e-01 -0.099400 4.23e-01 3.10e-01 0.586000
Diseases of branched-chain amino acid catabolism 10 6.87e-01 7.34e-01 0.2560 0.134000 1.84e-01 0.116000 4.63e-01 3.13e-01 0.524000
Mitotic Spindle Checkpoint 74 3.33e-03 9.54e-03 0.2560 0.082000 2.40e-01 0.030800 2.23e-01 3.54e-04 0.647000
Mitochondrial Fatty Acid Beta-Oxidation 27 9.21e-02 1.45e-01 0.2550 -0.189000 1.24e-01 -0.119000 8.96e-02 2.66e-01 0.284000
N-glycan trimming in the ER and Calnexin/Calreticulin cycle 31 8.85e-02 1.41e-01 0.2550 -0.036500 2.51e-01 0.023200 7.25e-01 1.55e-02 0.823000
Transport of Mature mRNA derived from an Intron-Containing Transcript 61 1.14e-03 3.93e-03 0.2550 -0.104000 1.58e-01 -0.171000 1.60e-01 3.30e-02 0.021100
Dual Incision in GG-NER 36 5.28e-02 9.31e-02 0.2540 -0.235000 7.24e-02 -0.066100 1.48e-02 4.52e-01 0.493000
Signaling by VEGF 88 2.59e-04 1.07e-03 0.2540 0.201000 1.21e-01 -0.097000 1.10e-03 4.97e-02 0.116000
Sema3A PAK dependent Axon repulsion 14 4.46e-01 5.09e-01 0.2530 0.239000 8.23e-02 -0.019700 1.22e-01 5.94e-01 0.898000
RHO GTPases Activate ROCKs 19 3.03e-01 3.77e-01 0.2530 0.208000 1.42e-01 -0.028600 1.17e-01 2.82e-01 0.829000
Cellular Senescence 109 2.21e-04 9.49e-04 0.2530 0.157000 1.98e-01 0.009850 4.58e-03 3.64e-04 0.859000
Signaling by Retinoic Acid 30 2.04e-01 2.73e-01 0.2530 0.019400 2.08e-01 0.143000 8.54e-01 4.88e-02 0.176000
Nuclear events stimulated by ALK signaling in cancer 26 1.37e-01 1.97e-01 0.2530 0.065700 -1.07e-02 -0.244000 5.62e-01 9.25e-01 0.031500
Translesion Synthesis by POLH 18 2.49e-01 3.21e-01 0.2530 -0.205000 1.28e-01 -0.074200 1.33e-01 3.48e-01 0.586000
Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex 10 5.44e-01 6.02e-01 0.2520 -0.092400 3.74e-02 -0.232000 6.13e-01 8.38e-01 0.205000
Receptor-type tyrosine-protein phosphatases 11 5.63e-01 6.20e-01 0.2520 0.085400 -9.32e-02 -0.218000 6.24e-01 5.92e-01 0.210000
Mitotic G1 phase and G1/S transition 108 3.25e-05 1.70e-04 0.2520 -0.095200 2.33e-01 0.012200 8.79e-02 3.01e-05 0.828000
Pyruvate metabolism 40 6.37e-02 1.08e-01 0.2510 0.030700 2.45e-01 0.046000 7.37e-01 7.30e-03 0.615000
NF-kB is activated and signals survival 11 5.72e-01 6.28e-01 0.2510 -0.058300 2.26e-01 0.093100 7.38e-01 1.94e-01 0.593000
VxPx cargo-targeting to cilium 15 3.48e-01 4.20e-01 0.2510 0.198000 4.08e-02 -0.150000 1.85e-01 7.84e-01 0.316000
Sealing of the nuclear envelope (NE) by ESCRT-III 19 2.32e-01 3.01e-01 0.2510 0.119000 2.68e-02 -0.220000 3.71e-01 8.40e-01 0.097500
Activation of kainate receptors upon glutamate binding 19 4.16e-01 4.83e-01 0.2510 -0.140000 -1.91e-01 -0.083400 2.91e-01 1.50e-01 0.529000
Formation of TC-NER Pre-Incision Complex 43 2.18e-02 4.57e-02 0.2510 -0.175000 9.52e-02 -0.153000 4.75e-02 2.80e-01 0.083400
FCGR3A-mediated IL10 synthesis 29 1.15e-01 1.73e-01 0.2510 0.198000 -1.21e-01 -0.095300 6.49e-02 2.61e-01 0.375000
Regulation of endogenous retroelements by KRAB-ZFP proteins 40 4.78e-02 8.54e-02 0.2510 0.022300 -2.54e-02 -0.248000 8.07e-01 7.81e-01 0.006590
PCNA-Dependent Long Patch Base Excision Repair 18 3.35e-01 4.07e-01 0.2500 -0.245000 -5.06e-02 0.017400 7.24e-02 7.10e-01 0.899000
RHOB GTPase cycle 58 5.78e-03 1.55e-02 0.2500 0.200000 8.29e-02 -0.124000 8.33e-03 2.75e-01 0.102000
Interleukin-37 signaling 17 3.24e-01 3.97e-01 0.2500 0.238000 -6.49e-02 -0.036000 8.89e-02 6.43e-01 0.797000
RNA Polymerase III Abortive And Retractive Initiation 34 4.25e-02 7.70e-02 0.2500 -0.018900 2.37e-01 -0.076100 8.49e-01 1.68e-02 0.443000
RNA Polymerase III Transcription 34 4.25e-02 7.70e-02 0.2500 -0.018900 2.37e-01 -0.076100 8.49e-01 1.68e-02 0.443000
HIV Infection 180 1.15e-09 1.81e-08 0.2490 -0.083000 2.12e-01 -0.101000 5.54e-02 9.84e-07 0.019500
Signaling by ERBB4 40 4.61e-02 8.24e-02 0.2490 0.113000 2.19e-01 -0.035300 2.15e-01 1.67e-02 0.699000
Cell death signalling via NRAGE, NRIF and NADE 58 7.26e-03 1.83e-02 0.2490 0.213000 7.87e-02 -0.103000 5.15e-03 3.01e-01 0.176000
Glycosphingolipid biosynthesis 14 5.18e-01 5.76e-01 0.2490 0.223000 9.39e-02 0.056300 1.48e-01 5.43e-01 0.715000
Transport to the Golgi and subsequent modification 144 5.80e-07 4.33e-06 0.2480 0.110000 2.04e-01 -0.089600 2.34e-02 2.52e-05 0.064200
Metabolism of fat-soluble vitamins 26 2.03e-01 2.71e-01 0.2480 0.098500 -1.89e-01 -0.126000 3.85e-01 9.49e-02 0.265000
DNA Double Strand Break Response 40 2.82e-02 5.63e-02 0.2480 0.126000 1.81e-01 -0.114000 1.68e-01 4.83e-02 0.213000
Long-term potentiation 13 5.03e-01 5.62e-01 0.2480 -0.072700 2.20e-01 0.088700 6.50e-01 1.71e-01 0.580000
Cell-cell junction organization 154 5.59e-07 4.20e-06 0.2480 0.022800 2.45e-01 -0.023200 6.26e-01 1.56e-07 0.619000
Signaling by FGFR2 in disease 26 2.13e-01 2.82e-01 0.2470 0.201000 1.44e-01 -0.001970 7.56e-02 2.05e-01 0.986000
Plasma lipoprotein assembly, remodeling, and clearance 51 1.09e-02 2.55e-02 0.2470 0.085100 2.80e-02 -0.230000 2.94e-01 7.30e-01 0.004430
Purine ribonucleoside monophosphate biosynthesis 11 5.52e-01 6.08e-01 0.2470 -0.242000 3.04e-02 -0.036000 1.64e-01 8.61e-01 0.836000
Transcriptional regulation by small RNAs 41 2.38e-02 4.89e-02 0.2470 0.069100 6.56e-02 -0.228000 4.44e-01 4.68e-01 0.011700
mRNA 3’-end processing 47 1.02e-02 2.43e-02 0.2470 -0.126000 1.87e-01 -0.100000 1.36e-01 2.67e-02 0.235000
Mitotic Anaphase 162 3.92e-07 3.20e-06 0.2460 -0.004480 2.46e-01 -0.004090 9.22e-01 6.65e-08 0.929000
Cell junction organization 177 1.24e-07 1.07e-06 0.2450 0.058700 2.37e-01 -0.025200 1.79e-01 5.80e-08 0.564000
Signaling by NOTCH 145 5.52e-07 4.17e-06 0.2450 0.109000 1.96e-01 -0.099900 2.44e-02 4.73e-05 0.038400
Mitotic Metaphase and Anaphase 163 5.39e-07 4.14e-06 0.2450 -0.001510 2.45e-01 0.000902 9.74e-01 7.31e-08 0.984000
SUMO E3 ligases SUMOylate target proteins 142 4.74e-06 2.99e-05 0.2450 0.168000 1.67e-01 -0.060900 5.48e-04 6.16e-04 0.211000
Telomere C-strand synthesis initiation 10 5.17e-01 5.75e-01 0.2440 -0.132000 1.98e-01 -0.055500 4.71e-01 2.78e-01 0.761000
Mitophagy 32 7.47e-02 1.22e-01 0.2440 -0.042800 2.38e-01 -0.031900 6.76e-01 1.99e-02 0.755000
RNA Polymerase III Transcription Initiation From Type 1 Promoter 22 1.42e-01 2.02e-01 0.2440 -0.057300 1.67e-01 -0.168000 6.42e-01 1.75e-01 0.172000
Antigen Presentation: Folding, assembly and peptide loading of class I MHC 24 2.01e-01 2.69e-01 0.2440 0.160000 1.75e-01 -0.056400 1.74e-01 1.39e-01 0.632000
Fcgamma receptor (FCGR) dependent phagocytosis 69 2.79e-03 8.37e-03 0.2440 0.194000 9.28e-02 -0.114000 5.35e-03 1.83e-01 0.102000
RAC3 GTPase cycle 72 7.11e-03 1.80e-02 0.2420 0.222000 9.61e-02 -0.003670 1.12e-03 1.59e-01 0.957000
Global Genome Nucleotide Excision Repair (GG-NER) 75 1.04e-03 3.61e-03 0.2420 -0.170000 1.67e-01 -0.045700 1.12e-02 1.27e-02 0.494000
Listeria monocytogenes entry into host cells 16 4.06e-01 4.73e-01 0.2420 0.120000 2.09e-01 -0.022200 4.07e-01 1.48e-01 0.878000
MITF-M-dependent gene expression 84 1.50e-03 4.89e-03 0.2420 0.146000 1.89e-01 -0.038300 2.09e-02 2.83e-03 0.545000
SARS-CoV-2 activates/modulates innate and adaptive immune responses 90 2.56e-04 1.06e-03 0.2420 0.156000 1.29e-01 -0.131000 1.04e-02 3.41e-02 0.031900
JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 21 2.75e-01 3.48e-01 0.2410 0.176000 1.56e-01 -0.052000 1.62e-01 2.16e-01 0.680000
RAC1 GTPase cycle 143 7.38e-06 4.46e-05 0.2410 0.235000 -2.69e-02 -0.047200 1.31e-06 5.79e-01 0.331000
Disorders of transmembrane transporters 112 2.44e-05 1.32e-04 0.2410 -0.133000 1.98e-01 -0.033500 1.48e-02 3.05e-04 0.541000
Hyaluronan degradation 11 5.01e-01 5.61e-01 0.2410 -0.124000 -5.10e-02 0.200000 4.77e-01 7.70e-01 0.250000
Removal of the Flap Intermediate 14 4.74e-01 5.33e-01 0.2400 -0.204000 3.01e-02 -0.123000 1.86e-01 8.45e-01 0.425000
Signal Transduction 1665 4.28e-56 6.11e-53 0.2400 0.196000 1.33e-01 -0.040700 2.15e-38 1.45e-18 0.007200
L1CAM interactions 80 2.50e-03 7.64e-03 0.2400 0.219000 8.56e-02 -0.050300 7.30e-04 1.86e-01 0.437000
Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks 39 4.05e-02 7.49e-02 0.2400 0.125000 1.74e-01 -0.109000 1.78e-01 6.03e-02 0.239000
TBC/RABGAPs 38 3.33e-02 6.45e-02 0.2400 0.070700 1.10e-01 -0.201000 4.51e-01 2.41e-01 0.032100
rRNA modification in the nucleus and cytosol 45 1.99e-02 4.23e-02 0.2400 -0.073200 9.18e-02 -0.209000 3.96e-01 2.87e-01 0.015400
Senescence-Associated Secretory Phenotype (SASP) 41 3.93e-02 7.31e-02 0.2400 0.031000 2.33e-01 -0.045400 7.31e-01 9.83e-03 0.615000
Defective pyroptosis 11 4.60e-01 5.22e-01 0.2390 -0.079400 1.83e-01 -0.131000 6.49e-01 2.92e-01 0.453000
Insulin processing 15 4.23e-01 4.89e-01 0.2390 0.221000 -5.07e-02 -0.076300 1.39e-01 7.34e-01 0.609000
Signaling by Rho GTPases 493 4.85e-19 4.08e-17 0.2390 0.190000 1.27e-01 -0.069000 7.54e-13 1.57e-06 0.009240
Lagging Strand Synthesis 20 3.42e-01 4.13e-01 0.2390 -0.232000 -8.26e-03 -0.054900 7.23e-02 9.49e-01 0.671000
Sensory processing of sound by inner hair cells of the cochlea 41 5.54e-02 9.64e-02 0.2380 0.225000 -3.83e-02 -0.068000 1.26e-02 6.71e-01 0.452000
Signaling by ERBB2 TMD/JMD mutants 17 3.36e-01 4.07e-01 0.2380 0.109000 1.99e-01 -0.071100 4.35e-01 1.55e-01 0.612000
Signaling by Non-Receptor Tyrosine Kinases 43 3.48e-02 6.66e-02 0.2380 0.112000 1.96e-01 -0.077100 2.03e-01 2.66e-02 0.382000
Signaling by PTK6 43 3.48e-02 6.66e-02 0.2380 0.112000 1.96e-01 -0.077100 2.03e-01 2.66e-02 0.382000
Signaling by Receptor Tyrosine Kinases 383 4.71e-14 1.43e-12 0.2380 0.199000 1.21e-01 -0.044500 2.69e-11 5.07e-05 0.137000
DNA Damage/Telomere Stress Induced Senescence 19 4.25e-01 4.90e-01 0.2370 0.159000 1.73e-01 0.035000 2.32e-01 1.92e-01 0.792000
RAC2 GTPase cycle 67 7.47e-03 1.87e-02 0.2370 0.210000 8.86e-02 -0.064400 2.98e-03 2.10e-01 0.363000
TP53 Regulates Transcription of Cell Cycle Genes 37 3.95e-02 7.32e-02 0.2370 0.083200 1.35e-01 -0.176000 3.81e-01 1.56e-01 0.064100
Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase 17 3.36e-01 4.07e-01 0.2370 -0.118000 2.06e-01 0.000933 4.01e-01 1.42e-01 0.995000
Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) 15 4.13e-01 4.80e-01 0.2370 0.184000 1.16e-01 -0.094400 2.18e-01 4.39e-01 0.527000
Metabolism of cofactors 20 3.52e-01 4.23e-01 0.2370 -0.025400 2.26e-01 0.063700 8.44e-01 7.96e-02 0.622000
Glyoxylate metabolism and glycine degradation 13 4.42e-01 5.05e-01 0.2370 -0.136000 1.91e-01 -0.028200 3.95e-01 2.33e-01 0.861000
Kinesins 32 1.53e-01 2.15e-01 0.2360 0.118000 -1.56e-01 -0.132000 2.47e-01 1.27e-01 0.195000
Signaling by Rho GTPases, Miro GTPases and RHOBTB3 509 6.09e-19 4.73e-17 0.2360 0.188000 1.30e-01 -0.060700 6.37e-13 6.29e-07 0.020200
Signaling by Insulin receptor 50 2.63e-02 5.30e-02 0.2360 0.137000 1.83e-01 -0.058500 9.43e-02 2.53e-02 0.475000
TCR signaling 84 2.60e-03 7.91e-03 0.2360 -0.026100 2.30e-01 0.042700 6.79e-01 2.69e-04 0.499000
Late endosomal microautophagy 26 2.56e-01 3.28e-01 0.2350 -0.034400 2.17e-01 0.085600 7.62e-01 5.59e-02 0.450000
Base Excision Repair 39 9.76e-02 1.52e-01 0.2350 -0.227000 -3.69e-03 -0.059500 1.43e-02 9.68e-01 0.521000
Interleukin-1 signaling 87 1.53e-03 4.99e-03 0.2350 -0.043400 2.29e-01 0.027800 4.85e-01 2.29e-04 0.654000
Hyaluronan metabolism 13 4.96e-01 5.55e-01 0.2340 -0.205000 2.44e-03 0.113000 2.00e-01 9.88e-01 0.480000
Arachidonate metabolism 24 3.57e-01 4.29e-01 0.2340 -0.171000 -1.48e-01 -0.061400 1.47e-01 2.11e-01 0.603000
tRNA Aminoacylation 21 2.78e-01 3.51e-01 0.2340 -0.185000 6.24e-02 -0.129000 1.42e-01 6.21e-01 0.307000
RNA polymerase II transcribes snRNA genes 62 1.14e-02 2.64e-02 0.2340 0.128000 1.90e-01 -0.046400 8.10e-02 9.60e-03 0.528000
Cell-Cell communication 202 6.96e-08 6.22e-07 0.2340 0.091200 2.12e-01 -0.037500 2.60e-02 2.16e-07 0.360000
Glucose metabolism 63 3.03e-03 8.79e-03 0.2320 -0.083400 1.79e-01 -0.122000 2.53e-01 1.40e-02 0.093700
Cell Cycle Checkpoints 181 1.04e-06 7.52e-06 0.2320 -0.009530 2.31e-01 0.021100 8.25e-01 8.88e-08 0.626000
Nonhomologous End-Joining (NHEJ) 30 1.60e-01 2.22e-01 0.2310 0.185000 1.24e-01 -0.061800 7.91e-02 2.40e-01 0.558000
O-linked glycosylation 68 2.60e-02 5.25e-02 0.2310 0.034400 -1.79e-01 -0.142000 6.24e-01 1.07e-02 0.043200
Phosphorylation of the APC/C 17 3.70e-01 4.40e-01 0.2310 -0.173000 1.52e-01 0.017600 2.18e-01 2.77e-01 0.900000
Transport of Mature Transcript to Cytoplasm 69 2.93e-03 8.52e-03 0.2310 -0.115000 1.07e-01 -0.169000 9.91e-02 1.25e-01 0.015400
Synthesis of PIPs at the plasma membrane 46 5.31e-02 9.32e-02 0.2300 0.156000 1.64e-01 -0.042100 6.81e-02 5.38e-02 0.622000
Cellular responses to stress 563 3.89e-20 5.55e-18 0.2300 -0.006740 2.30e-01 0.008260 7.86e-01 2.07e-20 0.740000
Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy 14 5.96e-01 6.52e-01 0.2290 0.002590 2.05e-01 0.103000 9.87e-01 1.85e-01 0.504000
RHO GTPase cycle 359 1.55e-12 4.09e-11 0.2290 0.200000 9.53e-02 -0.056100 8.78e-11 2.04e-03 0.069300
Vpr-mediated nuclear import of PICs 32 8.88e-02 1.41e-01 0.2290 -0.020400 8.72e-02 -0.210000 8.42e-01 3.94e-01 0.039500
Metabolism of steroid hormones 16 4.24e-01 4.90e-01 0.2290 -0.203000 9.88e-02 0.037000 1.60e-01 4.94e-01 0.798000
RNA Polymerase III Transcription Initiation From Type 3 Promoter 22 2.15e-01 2.83e-01 0.2280 0.102000 1.36e-01 -0.151000 4.07e-01 2.70e-01 0.220000
cGMP effects 10 6.49e-01 7.00e-01 0.2270 -0.205000 -7.95e-02 0.058400 2.62e-01 6.63e-01 0.749000
Biotin transport and metabolism 10 5.79e-01 6.35e-01 0.2270 0.111000 7.70e-02 -0.183000 5.42e-01 6.73e-01 0.318000
Formation of the Early Elongation Complex 25 2.87e-01 3.60e-01 0.2270 -0.165000 2.39e-03 -0.156000 1.53e-01 9.83e-01 0.178000
Formation of the HIV-1 Early Elongation Complex 25 2.87e-01 3.60e-01 0.2270 -0.165000 2.39e-03 -0.156000 1.53e-01 9.83e-01 0.178000
Anti-inflammatory response favouring Leishmania parasite infection 52 3.63e-02 6.84e-02 0.2270 0.152000 -6.93e-02 -0.153000 5.85e-02 3.87e-01 0.055800
Leishmania parasite growth and survival 52 3.63e-02 6.84e-02 0.2270 0.152000 -6.93e-02 -0.153000 5.85e-02 3.87e-01 0.055800
PKR-mediated signaling 54 3.20e-02 6.24e-02 0.2260 0.109000 1.95e-01 -0.032700 1.67e-01 1.34e-02 0.678000
Interactions of Rev with host cellular proteins 35 6.96e-02 1.14e-01 0.2250 -0.008300 9.67e-02 -0.203000 9.32e-01 3.22e-01 0.037300
RNA Polymerase III Transcription Initiation From Type 2 Promoter 21 2.16e-01 2.85e-01 0.2250 -0.014500 1.43e-01 -0.173000 9.09e-01 2.56e-01 0.169000
G2/M Checkpoints 93 1.02e-03 3.56e-03 0.2250 -0.106000 1.98e-01 0.014000 7.73e-02 9.85e-04 0.815000
RHOG GTPase cycle 62 1.70e-02 3.71e-02 0.2240 0.206000 -2.16e-02 -0.084800 5.02e-03 7.69e-01 0.249000
FCERI mediated Ca+2 mobilization 21 4.70e-01 5.30e-01 0.2240 0.133000 1.67e-01 0.068400 2.92e-01 1.86e-01 0.587000
Membrane Trafficking 485 2.56e-17 1.22e-15 0.2240 0.114000 1.83e-01 -0.061000 1.98e-05 7.67e-12 0.022500
Metabolism of nitric oxide: NOS3 activation and regulation 16 3.93e-01 4.63e-01 0.2240 0.103000 1.71e-01 -0.101000 4.77e-01 2.37e-01 0.482000
Signaling by Interleukins 295 1.41e-08 1.55e-07 0.2230 0.179000 1.32e-01 0.011300 1.29e-07 1.05e-04 0.740000
Nuclear Pore Complex (NPC) Disassembly 32 1.09e-01 1.66e-01 0.2230 0.073800 6.34e-02 -0.200000 4.70e-01 5.35e-01 0.049800
MicroRNA (miRNA) biogenesis 20 3.05e-01 3.80e-01 0.2230 0.065800 3.67e-02 -0.209000 6.10e-01 7.76e-01 0.105000
DCC mediated attractive signaling 12 5.50e-01 6.07e-01 0.2220 0.161000 3.98e-02 -0.149000 3.35e-01 8.11e-01 0.373000
Complement cascade 19 3.20e-01 3.93e-01 0.2220 0.006760 -2.15e-01 0.054400 9.59e-01 1.05e-01 0.682000
Regulation of TP53 Activity through Methylation 16 6.26e-01 6.80e-01 0.2220 -0.135000 -1.33e-01 -0.115000 3.49e-01 3.58e-01 0.427000
Glycolysis 57 9.70e-03 2.34e-02 0.2220 -0.045800 1.90e-01 -0.104000 5.50e-01 1.30e-02 0.177000
Deposition of new CENPA-containing nucleosomes at the centromere 16 4.40e-01 5.03e-01 0.2210 -0.172000 -1.22e-02 0.139000 2.33e-01 9.33e-01 0.337000
Nucleosome assembly 16 4.40e-01 5.03e-01 0.2210 -0.172000 -1.22e-02 0.139000 2.33e-01 9.33e-01 0.337000
Rev-mediated nuclear export of HIV RNA 33 1.02e-01 1.58e-01 0.2210 -0.028400 7.88e-02 -0.205000 7.78e-01 4.34e-01 0.041900
Transport of Ribonucleoproteins into the Host Nucleus 30 1.21e-01 1.80e-01 0.2210 0.063700 9.15e-02 -0.191000 5.46e-01 3.86e-01 0.070200
HCMV Infection 83 1.67e-03 5.36e-03 0.2210 0.056200 1.98e-01 -0.080800 3.77e-01 1.85e-03 0.204000
Metabolism of folate and pterines 13 6.18e-01 6.72e-01 0.2200 0.063800 -1.85e-01 -0.101000 6.90e-01 2.48e-01 0.527000
Death Receptor Signaling 125 2.49e-04 1.04e-03 0.2200 0.181000 1.12e-01 -0.055900 4.82e-04 3.08e-02 0.281000
Synthesis of bile acids and bile salts 23 4.45e-01 5.08e-01 0.2200 -0.002610 1.60e-01 0.150000 9.83e-01 1.83e-01 0.212000
Cell surface interactions at the vascular wall 77 6.59e-03 1.70e-02 0.2200 0.189000 -3.21e-02 -0.107000 4.11e-03 6.27e-01 0.106000
RND3 GTPase cycle 35 1.12e-01 1.69e-01 0.2190 0.100000 2.26e-02 -0.193000 3.06e-01 8.17e-01 0.047900
Constitutive Signaling by Aberrant PI3K in Cancer 45 1.22e-01 1.81e-01 0.2190 0.182000 1.19e-01 0.019200 3.43e-02 1.68e-01 0.823000
Regulation of T cell activation by CD28 family 47 6.45e-02 1.08e-01 0.2190 0.175000 1.15e-01 -0.060700 3.76e-02 1.72e-01 0.472000
Leishmania infection 118 2.92e-04 1.19e-03 0.2180 0.189000 2.75e-02 -0.105000 3.93e-04 6.06e-01 0.048400
Parasitic Infection Pathways 118 2.92e-04 1.19e-03 0.2180 0.189000 2.75e-02 -0.105000 3.93e-04 6.06e-01 0.048400
Telomere Maintenance 50 3.72e-02 6.97e-02 0.2180 -0.143000 7.82e-02 -0.145000 8.08e-02 3.39e-01 0.076000
SUMOylation of ubiquitinylation proteins 37 7.50e-02 1.22e-01 0.2180 0.066600 8.45e-02 -0.190000 4.84e-01 3.74e-01 0.046000
SARS-CoV-1 Infection 108 5.01e-04 1.90e-03 0.2180 0.002450 2.17e-01 -0.021800 9.65e-01 1.01e-04 0.696000
Nuclear import of Rev protein 32 1.16e-01 1.74e-01 0.2180 0.015800 7.62e-02 -0.204000 8.77e-01 4.56e-01 0.046300
Growth hormone receptor signaling 15 4.30e-01 4.95e-01 0.2180 0.044600 1.93e-01 -0.091500 7.65e-01 1.96e-01 0.540000
RHOA GTPase cycle 116 2.53e-04 1.05e-03 0.2180 0.170000 7.01e-02 -0.117000 1.60e-03 1.93e-01 0.030200
Glycosphingolipid catabolism 25 4.59e-01 5.22e-01 0.2180 -0.077800 -1.45e-01 -0.142000 5.01e-01 2.09e-01 0.218000
Gap-filling DNA repair synthesis and ligation in GG-NER 23 3.74e-01 4.44e-01 0.2170 -0.213000 -3.15e-02 -0.032000 7.77e-02 7.94e-01 0.791000
tRNA processing 84 3.72e-03 1.05e-02 0.2170 -0.194000 8.54e-02 -0.045000 2.10e-03 1.77e-01 0.477000
Netrin-1 signaling 32 2.17e-01 2.85e-01 0.2170 0.209000 5.83e-02 -0.010500 4.11e-02 5.68e-01 0.918000
Pyroptosis 18 5.32e-01 5.91e-01 0.2170 0.145000 1.57e-01 0.033700 2.86e-01 2.48e-01 0.805000
G alpha (s) signalling events 69 3.50e-02 6.66e-02 0.2170 0.052800 -1.23e-01 -0.170000 4.49e-01 7.65e-02 0.014700
Viral Messenger RNA Synthesis 38 9.05e-02 1.43e-01 0.2170 0.005030 4.23e-02 -0.212000 9.57e-01 6.52e-01 0.023500
Golgi-to-ER retrograde transport 95 5.46e-04 2.06e-03 0.2160 0.077400 1.01e-01 -0.175000 1.93e-01 9.01e-02 0.003260
Regulation of TP53 Activity 129 1.44e-04 6.53e-04 0.2160 0.146000 1.41e-01 -0.073900 4.27e-03 5.76e-03 0.148000
Cellular responses to stimuli 644 4.79e-20 5.70e-18 0.2160 0.025100 2.14e-01 -0.003100 2.82e-01 3.43e-20 0.894000
SARS-CoV Infections 317 3.04e-11 6.29e-10 0.2160 0.077400 1.90e-01 -0.066300 1.84e-02 6.64e-09 0.043300
Sensory processing of sound by outer hair cells of the cochlea 34 1.62e-01 2.23e-01 0.2160 0.208000 -3.21e-02 -0.049200 3.62e-02 7.46e-01 0.620000
G1/S-Specific Transcription 17 4.61e-01 5.23e-01 0.2160 0.123000 -3.89e-02 -0.173000 3.82e-01 7.82e-01 0.217000
Synthesis of substrates in N-glycan biosythesis 51 1.50e-01 2.11e-01 0.2160 -0.058900 -1.25e-01 -0.166000 4.67e-01 1.24e-01 0.040800
Transport of vitamins, nucleosides, and related molecules 25 2.88e-01 3.61e-01 0.2160 -0.198000 -5.05e-02 0.068400 8.66e-02 6.62e-01 0.554000
Glutamate and glutamine metabolism 11 6.49e-01 7.00e-01 0.2150 0.204000 2.73e-02 -0.063900 2.42e-01 8.75e-01 0.714000
Ca-dependent events 31 1.90e-01 2.56e-01 0.2150 0.077800 -1.60e-02 -0.200000 4.54e-01 8.77e-01 0.054200
Viral Infection Pathways 581 9.97e-21 1.58e-18 0.2150 -0.001270 2.08e-01 -0.054200 9.59e-01 2.16e-17 0.027100
Ca2+ pathway 46 6.48e-02 1.09e-01 0.2140 0.144000 1.38e-01 -0.077400 9.17e-02 1.04e-01 0.364000
Diseases of programmed cell death 36 8.05e-02 1.30e-01 0.2130 0.017800 1.74e-01 -0.123000 8.53e-01 7.16e-02 0.202000
Aberrant regulation of mitotic exit in cancer due to RB1 defects 17 4.47e-01 5.10e-01 0.2130 -0.120000 1.75e-01 0.021600 3.91e-01 2.12e-01 0.878000
HCMV Early Events 64 1.22e-02 2.79e-02 0.2130 0.056300 1.90e-01 -0.079200 4.36e-01 8.71e-03 0.274000
Interferon alpha/beta signaling 48 4.13e-02 7.59e-02 0.2130 0.113000 7.41e-02 -0.164000 1.75e-01 3.75e-01 0.048800
Cytochrome P450 - arranged by substrate type 25 3.09e-01 3.82e-01 0.2120 0.080700 -1.90e-01 -0.047700 4.85e-01 9.94e-02 0.680000
Protein-protein interactions at synapses 46 1.07e-01 1.63e-01 0.2120 0.089700 -1.67e-01 -0.095800 2.93e-01 5.07e-02 0.262000
Glutamate binding, activation of AMPA receptors and synaptic plasticity 22 3.18e-01 3.90e-01 0.2120 -0.119000 1.75e-01 -0.002530 3.34e-01 1.55e-01 0.984000
Trafficking of AMPA receptors 22 3.18e-01 3.90e-01 0.2120 -0.119000 1.75e-01 -0.002530 3.34e-01 1.55e-01 0.984000
Integration of energy metabolism 75 5.82e-03 1.56e-02 0.2120 0.127000 7.49e-02 -0.152000 5.77e-02 2.63e-01 0.023200
Reduction of cytosolic Ca++ levels 10 6.88e-01 7.34e-01 0.2110 0.157000 -1.30e-01 -0.056100 3.91e-01 4.76e-01 0.759000
Autophagy 124 4.19e-04 1.64e-03 0.2110 0.055500 2.02e-01 -0.023400 2.87e-01 1.06e-04 0.654000
Vesicle-mediated transport 508 6.89e-16 2.62e-14 0.2100 0.120000 1.63e-01 -0.059700 4.71e-06 4.87e-10 0.022300
p75 NTR receptor-mediated signalling 73 1.66e-02 3.66e-02 0.2100 0.195000 5.63e-02 -0.055800 4.04e-03 4.06e-01 0.410000
Lysosome Vesicle Biogenesis 26 1.99e-01 2.67e-01 0.2100 0.041000 1.04e-01 -0.178000 7.17e-01 3.57e-01 0.117000
Role of phospholipids in phagocytosis 16 6.50e-01 7.00e-01 0.2100 0.156000 1.02e-01 0.096200 2.81e-01 4.79e-01 0.505000
RHOF GTPase cycle 33 2.15e-01 2.83e-01 0.2090 0.165000 1.24e-01 -0.037300 1.01e-01 2.19e-01 0.711000
Activation of AMPK downstream of NMDARs 18 3.64e-01 4.35e-01 0.2090 0.062500 1.18e-01 -0.161000 6.46e-01 3.87e-01 0.238000
Selective autophagy 66 2.48e-02 5.05e-02 0.2080 0.065900 1.96e-01 -0.023100 3.55e-01 5.83e-03 0.745000
Intra-Golgi and retrograde Golgi-to-ER traffic 152 2.07e-05 1.13e-04 0.2080 0.065400 1.82e-01 -0.078300 1.65e-01 1.16e-04 0.096500
HCMV Late Events 49 3.12e-02 6.12e-02 0.2080 -0.002660 1.59e-01 -0.134000 9.74e-01 5.40e-02 0.105000
Termination of translesion DNA synthesis 27 3.30e-01 4.02e-01 0.2070 -0.187000 6.10e-03 -0.090400 9.34e-02 9.56e-01 0.416000
SUMOylation of chromatin organization proteins 55 2.88e-02 5.72e-02 0.2070 0.109000 8.55e-02 -0.155000 1.64e-01 2.73e-01 0.047600
G2/M DNA damage checkpoint 47 1.48e-01 2.09e-01 0.2070 0.142000 1.49e-01 0.023100 9.17e-02 7.81e-02 0.784000
Aberrant regulation of mitotic cell cycle due to RB1 defects 29 3.07e-01 3.81e-01 0.2070 0.137000 1.55e-01 -0.007160 2.01e-01 1.50e-01 0.947000
RNA Polymerase III Transcription Initiation 29 1.61e-01 2.23e-01 0.2060 -0.006050 1.37e-01 -0.154000 9.55e-01 2.01e-01 0.152000
Regulation of NF-kappa B signaling 17 4.11e-01 4.78e-01 0.2060 -0.067200 1.06e-01 -0.164000 6.32e-01 4.51e-01 0.243000
G alpha (q) signalling events 78 1.45e-02 3.24e-02 0.2060 0.192000 4.73e-02 -0.057900 3.45e-03 4.71e-01 0.377000
Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template 34 1.89e-01 2.56e-01 0.2060 -0.147000 4.70e-02 -0.136000 1.39e-01 6.36e-01 0.170000
Activation of ATR in response to replication stress 26 3.07e-01 3.81e-01 0.2050 -0.170000 3.89e-02 0.109000 1.35e-01 7.31e-01 0.337000
Regulation of CDH1 posttranslational processing and trafficking to plasma membrane 28 1.92e-01 2.59e-01 0.2050 -0.090200 1.53e-01 -0.102000 4.09e-01 1.62e-01 0.352000
Reproduction 51 1.76e-01 2.41e-01 0.2050 0.084400 1.65e-01 0.085600 2.97e-01 4.11e-02 0.291000
Nuclear Envelope Breakdown 47 6.11e-02 1.05e-01 0.2050 0.106000 5.78e-02 -0.165000 2.09e-01 4.93e-01 0.050300
Diseases of mitotic cell cycle 31 2.56e-01 3.28e-01 0.2040 0.100000 1.77e-01 -0.020100 3.36e-01 8.79e-02 0.847000
Extension of Telomeres 40 1.26e-01 1.84e-01 0.2040 -0.171000 7.26e-02 -0.084600 6.12e-02 4.27e-01 0.355000
CaM pathway 30 2.61e-01 3.33e-01 0.2040 0.084000 -3.68e-02 -0.182000 4.26e-01 7.27e-01 0.083800
Calmodulin induced events 30 2.61e-01 3.33e-01 0.2040 0.084000 -3.68e-02 -0.182000 4.26e-01 7.27e-01 0.083800
Muscle contraction 140 7.12e-04 2.64e-03 0.2040 0.023500 2.00e-01 0.031200 6.32e-01 4.43e-05 0.525000
Ion transport by P-type ATPases 36 1.84e-01 2.51e-01 0.2040 0.148000 1.30e-01 -0.052200 1.26e-01 1.76e-01 0.588000
Miscellaneous transport and binding events 19 6.14e-01 6.69e-01 0.2040 0.099400 9.01e-02 0.153000 4.53e-01 4.97e-01 0.248000
NS1 Mediated Effects on Host Pathways 38 1.16e-01 1.74e-01 0.2040 0.074400 4.93e-02 -0.183000 4.27e-01 5.99e-01 0.051200
Regulation of HSF1-mediated heat shock response 68 1.75e-02 3.79e-02 0.2030 0.082300 1.72e-01 -0.070700 2.41e-01 1.44e-02 0.314000
Adaptive Immune System 520 3.96e-13 1.18e-11 0.2030 0.092500 1.80e-01 0.001300 3.45e-04 2.88e-12 0.960000
Mismatch Repair 13 6.48e-01 7.00e-01 0.2030 0.012800 -2.00e-01 -0.029200 9.36e-01 2.12e-01 0.855000
CDC42 GTPase cycle 131 6.16e-04 2.30e-03 0.2030 0.192000 1.30e-02 -0.063100 1.51e-04 7.97e-01 0.214000
Nuclear signaling by ERBB4 21 4.82e-01 5.41e-01 0.2020 0.047700 1.95e-01 0.028800 7.05e-01 1.23e-01 0.819000
IRAK1 recruits IKK complex 14 5.48e-01 6.06e-01 0.2020 0.109000 1.41e-01 -0.095900 4.80e-01 3.62e-01 0.534000
IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation 14 5.48e-01 6.06e-01 0.2020 0.109000 1.41e-01 -0.095900 4.80e-01 3.62e-01 0.534000
Defective homologous recombination repair (HRR) due to BRCA2 loss of function 30 2.23e-01 2.91e-01 0.2020 -0.039300 -2.58e-02 0.197000 7.09e-01 8.07e-01 0.062500
Diseases of DNA Double-Strand Break Repair 30 2.23e-01 2.91e-01 0.2020 -0.039300 -2.58e-02 0.197000 7.09e-01 8.07e-01 0.062500
Nucleotide Excision Repair 95 1.88e-03 5.98e-03 0.2020 -0.125000 1.27e-01 -0.095400 3.61e-02 3.26e-02 0.109000
Negative regulation of the PI3K/AKT network 77 2.95e-02 5.83e-02 0.2020 0.155000 1.29e-01 -0.007100 1.88e-02 5.03e-02 0.914000
Translation of Replicase and Assembly of the Replication Transcription Complex 9694676 10 6.58e-01 7.06e-01 0.2020 0.031100 7.72e-02 -0.184000 8.65e-01 6.73e-01 0.314000
Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 11 6.99e-01 7.42e-01 0.2020 0.102000 -4.52e-02 -0.168000 5.59e-01 7.95e-01 0.334000
RSV-host interactions 62 2.53e-02 5.13e-02 0.2020 0.125000 1.08e-01 -0.116000 8.92e-02 1.43e-01 0.115000
Transcription of E2F targets under negative control by DREAM complex 15 5.44e-01 6.02e-01 0.2010 0.132000 1.44e-02 -0.152000 3.78e-01 9.23e-01 0.309000
Platelet activation, signaling and aggregation 170 3.47e-05 1.78e-04 0.2010 0.168000 5.76e-02 -0.095500 1.69e-04 1.97e-01 0.032100
ADP signalling through P2Y purinoceptor 12 12 6.67e-01 7.14e-01 0.2010 0.087200 -3.46e-02 -0.178000 6.01e-01 8.36e-01 0.285000
Synthesis of PE 10 6.87e-01 7.34e-01 0.2010 -0.086500 6.50e-02 -0.170000 6.36e-01 7.22e-01 0.353000
Formation of HIV-1 elongation complex containing HIV-1 Tat 31 2.29e-01 2.99e-01 0.2010 -0.101000 4.72e-02 -0.167000 3.29e-01 6.49e-01 0.108000
HIV Transcription Elongation 31 2.29e-01 2.99e-01 0.2010 -0.101000 4.72e-02 -0.167000 3.29e-01 6.49e-01 0.108000
Tat-mediated elongation of the HIV-1 transcript 31 2.29e-01 2.99e-01 0.2010 -0.101000 4.72e-02 -0.167000 3.29e-01 6.49e-01 0.108000
SUMOylation of DNA replication proteins 39 1.05e-01 1.61e-01 0.2010 0.015700 7.47e-02 -0.185000 8.65e-01 4.20e-01 0.045200
Resolution of AP sites via the multiple-nucleotide patch replacement pathway 21 4.83e-01 5.41e-01 0.2000 -0.194000 -5.15e-02 0.000416 1.25e-01 6.83e-01 0.997000
Non-integrin membrane-ECM interactions 63 4.33e-02 7.82e-02 0.2000 0.165000 -4.09e-02 0.106000 2.37e-02 5.75e-01 0.146000
Interactions of Vpr with host cellular proteins 34 1.29e-01 1.89e-01 0.2000 -0.030900 1.33e-01 -0.146000 7.55e-01 1.80e-01 0.141000
Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) 12 7.73e-01 8.12e-01 0.2000 -0.036800 -1.65e-01 -0.105000 8.25e-01 3.21e-01 0.528000
Dual incision in TC-NER 54 6.33e-02 1.07e-01 0.1980 -0.162000 6.98e-02 -0.090600 4.00e-02 3.75e-01 0.250000
Gap-filling DNA repair synthesis and ligation in TC-NER 53 1.11e-01 1.68e-01 0.1980 -0.152000 1.11e-03 -0.126000 5.56e-02 9.89e-01 0.113000
SUMOylation of SUMOylation proteins 32 1.87e-01 2.54e-01 0.1970 -0.000842 6.85e-02 -0.185000 9.93e-01 5.03e-01 0.070700
Clathrin-mediated endocytosis 112 1.24e-03 4.22e-03 0.1970 0.126000 1.06e-01 -0.107000 2.14e-02 5.24e-02 0.049900
Cytokine Signaling in Immune system 504 7.13e-12 1.66e-10 0.1970 0.160000 1.13e-01 -0.013400 9.76e-10 1.53e-05 0.610000
Transcriptional Regulation by TP53 288 2.16e-08 2.25e-07 0.1970 0.062100 1.80e-01 -0.049800 7.10e-02 1.74e-07 0.148000
Macroautophagy 112 1.38e-03 4.58e-03 0.1960 0.042900 1.84e-01 -0.053500 4.34e-01 7.88e-04 0.329000
DNA Damage Bypass 42 9.46e-02 1.47e-01 0.1950 -0.089500 1.16e-01 -0.129000 3.16e-01 1.93e-01 0.149000
Presynaptic phase of homologous DNA pairing and strand exchange 30 2.95e-01 3.68e-01 0.1950 -0.015100 7.91e-03 0.194000 8.86e-01 9.40e-01 0.065600
Transcription-Coupled Nucleotide Excision Repair (TC-NER) 66 3.50e-02 6.66e-02 0.1940 -0.161000 7.30e-02 -0.080200 2.36e-02 3.06e-01 0.260000
InlB-mediated entry of Listeria monocytogenes into host cell 13 6.53e-01 7.01e-01 0.1940 -0.020300 1.93e-01 0.005970 8.99e-01 2.28e-01 0.970000
Calnexin/calreticulin cycle 22 4.81e-01 5.40e-01 0.1940 0.006540 1.91e-01 0.031600 9.58e-01 1.21e-01 0.798000
RNA Polymerase II Pre-transcription Events 59 3.44e-02 6.61e-02 0.1940 0.061300 1.56e-01 -0.097700 4.16e-01 3.85e-02 0.195000
Developmental Biology 785 7.11e-20 7.81e-18 0.1940 0.112000 1.51e-01 -0.047100 1.38e-07 1.24e-12 0.026800
Mitotic Prophase 73 1.69e-02 3.69e-02 0.1940 0.118000 9.31e-02 -0.122000 8.06e-02 1.69e-01 0.072800
TAK1-dependent IKK and NF-kappa-B activation 36 3.22e-01 3.94e-01 0.1930 0.104000 1.59e-01 0.035300 2.79e-01 9.91e-02 0.714000
DDX58/IFIH1-mediated induction of interferon-alpha/beta 57 7.95e-02 1.28e-01 0.1930 0.095800 1.66e-01 -0.026700 2.11e-01 3.07e-02 0.728000
G0 and Early G1 17 5.15e-01 5.73e-01 0.1930 0.129000 4.08e-02 -0.138000 3.57e-01 7.71e-01 0.326000
G-protein beta:gamma signalling 20 5.09e-01 5.67e-01 0.1930 -0.021500 -1.12e-02 -0.191000 8.68e-01 9.31e-01 0.138000
PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases 13 7.10e-01 7.53e-01 0.1920 0.175000 8.00e-02 -0.005410 2.76e-01 6.17e-01 0.973000
PI Metabolism 71 2.42e-02 4.94e-02 0.1920 0.130000 9.76e-02 -0.101000 5.78e-02 1.55e-01 0.140000
Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) 28 2.69e-01 3.41e-01 0.1910 0.023500 5.83e-02 -0.181000 8.29e-01 5.94e-01 0.097700
Regulation of Glucokinase by Glucokinase Regulatory Protein 28 2.69e-01 3.41e-01 0.1910 0.023500 5.83e-02 -0.181000 8.29e-01 5.94e-01 0.097700
Signaling by MET 66 1.27e-01 1.87e-01 0.1900 0.139000 1.15e-01 0.061500 5.13e-02 1.08e-01 0.388000
Nicotinate metabolism 23 4.02e-01 4.70e-01 0.1900 -0.145000 -4.39e-02 0.115000 2.29e-01 7.16e-01 0.341000
Mitochondrial tRNA aminoacylation 17 5.67e-01 6.24e-01 0.1890 -0.142000 4.67e-02 -0.115000 3.10e-01 7.39e-01 0.410000
Sensory processing of sound 46 1.46e-01 2.08e-01 0.1890 0.165000 -5.98e-02 -0.070600 5.34e-02 4.83e-01 0.408000
Triglyceride metabolism 23 4.66e-01 5.26e-01 0.1890 -0.078300 1.62e-01 0.057300 5.16e-01 1.79e-01 0.635000
MET activates PTK2 signaling 24 3.98e-01 4.67e-01 0.1880 0.022800 -1.86e-01 0.010900 8.47e-01 1.14e-01 0.926000
Neurotransmitter release cycle 26 4.59e-01 5.22e-01 0.1870 0.035900 -6.55e-02 -0.172000 7.52e-01 5.64e-01 0.129000
GPCR downstream signalling 250 2.55e-06 1.74e-05 0.1870 0.138000 -2.26e-02 -0.124000 1.79e-04 5.40e-01 0.000766
Telomere C-strand (Lagging Strand) Synthesis 30 3.83e-01 4.51e-01 0.1870 -0.173000 3.72e-04 -0.071300 1.02e-01 9.97e-01 0.499000
Mitotic G2-G2/M phases 146 2.17e-04 9.35e-04 0.1870 -0.052400 1.73e-01 -0.048200 2.75e-01 3.26e-04 0.316000
G2/M Transition 145 2.38e-04 9.98e-04 0.1860 -0.056800 1.70e-01 -0.050000 2.39e-01 4.23e-04 0.300000
Infectious disease 742 1.21e-19 1.16e-17 0.1860 0.043400 1.69e-01 -0.065200 4.66e-02 1.06e-14 0.002830
Rab regulation of trafficking 102 5.35e-03 1.45e-02 0.1850 0.099700 1.34e-01 -0.080800 8.25e-02 1.99e-02 0.159000
Antiviral mechanism by IFN-stimulated genes 122 2.00e-03 6.24e-03 0.1850 0.113000 1.25e-01 -0.077500 3.15e-02 1.77e-02 0.140000
Factors involved in megakaryocyte development and platelet production 93 2.10e-02 4.43e-02 0.1850 0.185000 1.86e-03 -0.000480 2.07e-03 9.75e-01 0.994000
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling 71 6.34e-02 1.07e-01 0.1850 0.144000 1.14e-01 -0.022400 3.55e-02 9.86e-02 0.744000
Export of Viral Ribonucleoproteins from Nucleus 30 2.46e-01 3.17e-01 0.1850 0.025900 8.74e-02 -0.161000 8.06e-01 4.08e-01 0.127000
NEP/NS2 Interacts with the Cellular Export Machinery 30 2.46e-01 3.17e-01 0.1850 0.025900 8.74e-02 -0.161000 8.06e-01 4.08e-01 0.127000
SUMOylation of DNA methylation proteins 15 6.46e-01 6.98e-01 0.1850 0.107000 -3.81e-02 -0.146000 4.73e-01 7.98e-01 0.329000
Metabolism of nucleotides 75 3.53e-02 6.72e-02 0.1840 -0.169000 7.40e-02 -0.005120 1.16e-02 2.68e-01 0.939000
CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling 22 4.92e-01 5.51e-01 0.1840 0.022700 1.82e-01 -0.002620 8.54e-01 1.39e-01 0.983000
Inactivation, recovery and regulation of the phototransduction cascade 15 6.90e-01 7.35e-01 0.1830 -0.061300 1.55e-01 0.075800 6.81e-01 2.99e-01 0.611000
COPI-dependent Golgi-to-ER retrograde traffic 67 6.93e-02 1.14e-01 0.1830 -0.015500 -6.62e-03 -0.182000 8.27e-01 9.25e-01 0.010000
Nuclear Envelope (NE) Reassembly 59 6.33e-02 1.07e-01 0.1820 0.079800 1.44e-01 -0.078400 2.89e-01 5.57e-02 0.298000
Cargo recognition for clathrin-mediated endocytosis 76 3.42e-02 6.58e-02 0.1820 0.107000 1.34e-01 -0.061300 1.09e-01 4.40e-02 0.356000
Ras activation upon Ca2+ influx through NMDA receptor 15 7.32e-01 7.74e-01 0.1820 -0.023600 1.52e-01 0.096300 8.74e-01 3.08e-01 0.519000
Gene expression (Transcription) 1193 4.03e-27 1.15e-24 0.1810 0.069600 1.59e-01 -0.051400 7.17e-05 1.27e-19 0.003390
G-protein mediated events 45 1.70e-01 2.34e-01 0.1800 0.107000 -4.16e-03 -0.145000 2.16e-01 9.62e-01 0.091600
Signaling by GPCR 275 2.48e-06 1.70e-05 0.1800 0.126000 -3.60e-02 -0.124000 3.58e-04 3.07e-01 0.000412
Opioid Signalling 69 3.54e-02 6.73e-02 0.1800 0.091700 1.05e-01 -0.113000 1.88e-01 1.31e-01 0.104000
Signaling by NTRK3 (TRKC) 15 6.27e-01 6.80e-01 0.1790 0.119000 4.81e-02 -0.124000 4.24e-01 7.47e-01 0.406000
RAB geranylgeranylation 41 3.54e-01 4.26e-01 0.1780 0.040500 1.61e-01 0.066000 6.54e-01 7.50e-02 0.465000
Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) 12 7.87e-01 8.24e-01 0.1780 -0.022100 -1.71e-01 -0.043700 8.94e-01 3.04e-01 0.794000
Recognition of DNA damage by PCNA-containing replication complex 27 3.76e-01 4.44e-01 0.1780 -0.134000 1.13e-01 -0.030200 2.28e-01 3.11e-01 0.786000
tRNA processing in the nucleus 50 1.11e-01 1.68e-01 0.1780 -0.113000 9.91e-02 -0.094200 1.65e-01 2.26e-01 0.250000
CREB1 phosphorylation through the activation of Adenylate Cyclase 10 8.58e-01 8.87e-01 0.1780 0.140000 6.31e-02 0.089800 4.45e-01 7.30e-01 0.623000
Bile acid and bile salt metabolism 24 6.07e-01 6.63e-01 0.1780 -0.006680 1.29e-01 0.121000 9.55e-01 2.73e-01 0.303000
Interleukin-1 family signaling 108 1.56e-02 3.47e-02 0.1770 0.001080 1.76e-01 0.022300 9.85e-01 1.60e-03 0.689000
Formation of RNA Pol II elongation complex 42 1.37e-01 1.97e-01 0.1770 -0.016200 1.20e-01 -0.130000 8.56e-01 1.80e-01 0.146000
RNA Polymerase II Transcription Elongation 42 1.37e-01 1.97e-01 0.1770 -0.016200 1.20e-01 -0.130000 8.56e-01 1.80e-01 0.146000
Diseases of DNA repair 38 1.93e-01 2.60e-01 0.1770 -0.071500 -8.90e-02 0.135000 4.46e-01 3.42e-01 0.149000
SUMOylation of RNA binding proteins 45 1.30e-01 1.90e-01 0.1770 0.056800 9.81e-02 -0.135000 5.10e-01 2.55e-01 0.117000
MHC class II antigen presentation 84 2.00e-02 4.24e-02 0.1760 0.101000 6.94e-02 -0.127000 1.09e-01 2.72e-01 0.045100
Regulation of PLK1 Activity at G2/M Transition 72 3.86e-02 7.18e-02 0.1760 0.069500 1.43e-01 -0.076700 3.09e-01 3.64e-02 0.261000
Platelet degranulation 83 4.16e-02 7.63e-02 0.1760 0.171000 8.01e-03 -0.043800 7.28e-03 9.00e-01 0.491000
Disease 1294 5.64e-28 2.68e-25 0.1760 0.073600 1.50e-01 -0.056700 1.34e-05 8.28e-19 0.000797
HIV Life Cycle 123 1.22e-03 4.16e-03 0.1760 -0.010000 1.27e-01 -0.121000 8.48e-01 1.51e-02 0.020700
Synthesis of very long-chain fatty acyl-CoAs 12 7.73e-01 8.12e-01 0.1750 -0.038300 1.65e-01 0.045700 8.18e-01 3.22e-01 0.784000
Gene Silencing by RNA 62 4.99e-02 8.83e-02 0.1750 0.039400 1.13e-01 -0.129000 5.92e-01 1.26e-01 0.080100
ISG15 antiviral mechanism 69 5.95e-02 1.02e-01 0.1750 0.132000 7.14e-02 -0.090000 5.82e-02 3.06e-01 0.197000
Formation of HIV elongation complex in the absence of HIV Tat 33 3.32e-01 4.04e-01 0.1750 -0.071200 3.01e-02 -0.157000 4.79e-01 7.65e-01 0.119000
O-linked glycosylation of mucins 29 4.04e-01 4.71e-01 0.1740 0.142000 -9.05e-02 -0.043400 1.85e-01 3.99e-01 0.686000
Hedgehog ‘off’ state 89 1.45e-02 3.25e-02 0.1740 -0.099300 1.23e-01 -0.072400 1.06e-01 4.44e-02 0.239000
Maturation of spike protein 9694548 39 1.89e-01 2.55e-01 0.1740 0.056100 1.11e-01 -0.122000 5.45e-01 2.31e-01 0.188000
Protein folding 66 6.96e-02 1.14e-01 0.1740 -0.007830 2.87e-02 -0.171000 9.13e-01 6.88e-01 0.016200
Late Phase of HIV Life Cycle 111 3.14e-03 9.03e-03 0.1740 0.005230 1.39e-01 -0.104000 9.24e-01 1.17e-02 0.057700
WNT ligand biogenesis and trafficking 12 6.83e-01 7.31e-01 0.1740 -0.014400 1.45e-01 -0.093900 9.31e-01 3.84e-01 0.574000
AURKA Activation by TPX2 59 7.09e-02 1.16e-01 0.1730 0.068300 8.86e-02 -0.132000 3.64e-01 2.39e-01 0.078700
Chromosome Maintenance 65 8.52e-02 1.36e-01 0.1730 -0.146000 5.65e-02 -0.074600 4.21e-02 4.31e-01 0.298000
Unfolded Protein Response (UPR) 69 5.86e-02 1.01e-01 0.1730 0.071100 1.46e-01 -0.060400 3.08e-01 3.64e-02 0.386000
Bacterial Infection Pathways 77 6.06e-02 1.04e-01 0.1720 0.154000 5.39e-02 -0.055500 1.98e-02 4.14e-01 0.400000
Post NMDA receptor activation events 54 1.13e-01 1.70e-01 0.1720 0.089800 1.17e-01 -0.088300 2.54e-01 1.37e-01 0.262000
Loss of Nlp from mitotic centrosomes 58 8.14e-02 1.31e-01 0.1720 0.074700 8.38e-02 -0.130000 3.26e-01 2.70e-01 0.086800
Loss of proteins required for interphase microtubule organization from the centrosome 58 8.14e-02 1.31e-01 0.1720 0.074700 8.38e-02 -0.130000 3.26e-01 2.70e-01 0.086800
SARS-CoV-2-host interactions 145 7.75e-04 2.84e-03 0.1720 0.007530 1.55e-01 -0.072600 8.76e-01 1.28e-03 0.132000
Metabolic disorders of biological oxidation enzymes 16 7.72e-01 8.12e-01 0.1710 0.027600 8.71e-02 0.145000 8.48e-01 5.46e-01 0.315000
Postmitotic nuclear pore complex (NPC) reformation 26 4.25e-01 4.90e-01 0.1710 -0.022200 1.68e-01 -0.027600 8.45e-01 1.39e-01 0.808000
Regulation of insulin secretion 49 1.62e-01 2.23e-01 0.1710 0.108000 2.90e-02 -0.129000 1.91e-01 7.25e-01 0.118000
MET promotes cell motility 34 4.12e-01 4.79e-01 0.1700 0.134000 -1.40e-03 0.105000 1.78e-01 9.89e-01 0.288000
Metal ion SLC transporters 13 7.64e-01 8.05e-01 0.1700 0.098200 -1.13e-01 -0.080200 5.40e-01 4.80e-01 0.617000
Transport of Mature mRNA Derived from an Intronless Transcript 40 3.74e-01 4.44e-01 0.1700 -0.037200 -4.24e-02 -0.160000 6.84e-01 6.43e-01 0.079800
Transport of Mature mRNAs Derived from Intronless Transcripts 40 3.74e-01 4.44e-01 0.1700 -0.037200 -4.24e-02 -0.160000 6.84e-01 6.43e-01 0.079800
Hemostasis 376 1.24e-07 1.07e-06 0.1690 0.152000 8.32e-03 -0.073900 4.61e-07 7.83e-01 0.014500
M Phase 261 3.13e-06 2.05e-05 0.1690 0.013100 1.58e-01 -0.059400 7.16e-01 1.20e-05 0.100000
Heme biosynthesis 10 7.98e-01 8.35e-01 0.1690 -0.117000 6.05e-02 -0.106000 5.21e-01 7.40e-01 0.562000
RAB GEFs exchange GTP for GDP on RABs 76 8.02e-02 1.29e-01 0.1680 0.122000 1.11e-01 -0.032800 6.65e-02 9.35e-02 0.621000
Maturation of nucleoprotein 9683610 11 8.17e-01 8.52e-01 0.1680 -0.137000 -9.45e-02 0.021400 4.31e-01 5.87e-01 0.902000
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) 12 8.06e-01 8.42e-01 0.1670 0.081400 1.46e-01 0.003520 6.25e-01 3.80e-01 0.983000
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) 70 1.31e-01 1.91e-01 0.1670 0.074800 -9.07e-02 -0.119000 2.80e-01 1.90e-01 0.085500
Stimuli-sensing channels 56 1.21e-01 1.79e-01 0.1670 -0.087900 1.40e-01 -0.023000 2.55e-01 6.94e-02 0.766000
TP53 Regulates Transcription of DNA Repair Genes 48 1.35e-01 1.95e-01 0.1670 0.017000 1.20e-01 -0.115000 8.38e-01 1.51e-01 0.169000
Regulated Necrosis 46 2.53e-01 3.25e-01 0.1660 0.131000 9.28e-02 -0.043100 1.24e-01 2.77e-01 0.614000
Regulation of FZD by ubiquitination 14 8.24e-01 8.58e-01 0.1660 0.064000 1.37e-01 0.069000 6.78e-01 3.74e-01 0.655000
Homologous DNA Pairing and Strand Exchange 32 3.77e-01 4.45e-01 0.1660 -0.009880 -1.90e-02 0.165000 9.23e-01 8.52e-01 0.107000
G alpha (i) signalling events 120 1.94e-02 4.14e-02 0.1650 0.087900 -6.50e-02 -0.124000 9.71e-02 2.20e-01 0.019400
Post-translational protein modification 1054 4.31e-20 5.60e-18 0.1650 0.058700 1.47e-01 -0.044800 1.55e-03 2.02e-15 0.015700
TP53 Regulates Transcription of Genes Involved in Cytochrome C Release 15 6.65e-01 7.12e-01 0.1640 0.078500 7.89e-02 -0.121000 5.99e-01 5.97e-01 0.418000
Response to elevated platelet cytosolic Ca2+ 86 6.85e-02 1.14e-01 0.1640 0.159000 2.84e-02 -0.025800 1.08e-02 6.49e-01 0.680000
RNA Polymerase II Transcription 1014 2.12e-19 1.90e-17 0.1640 0.062700 1.42e-01 -0.051100 8.97e-04 4.74e-14 0.006870
Plasma lipoprotein assembly 12 7.51e-01 7.92e-01 0.1630 -0.095800 8.06e-02 -0.104000 5.66e-01 6.29e-01 0.532000
Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol 14 7.56e-01 7.97e-01 0.1630 -0.121000 8.06e-02 0.074000 4.35e-01 6.02e-01 0.632000
Mitotic Prometaphase 139 7.97e-03 1.98e-02 0.1630 0.093700 1.29e-01 -0.032300 5.70e-02 8.79e-03 0.512000
RIPK1-mediated regulated necrosis 28 4.62e-01 5.23e-01 0.1610 0.122000 5.09e-02 -0.092300 2.65e-01 6.41e-01 0.398000
Regulation of necroptotic cell death 28 4.62e-01 5.23e-01 0.1610 0.122000 5.09e-02 -0.092300 2.65e-01 6.41e-01 0.398000
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein 64 2.97e-01 3.70e-01 0.1610 -0.100000 -8.69e-02 -0.091200 1.66e-01 2.29e-01 0.208000
Glucagon-like Peptide-1 (GLP1) regulates insulin secretion 27 4.76e-01 5.35e-01 0.1610 0.114000 3.63e-02 -0.108000 3.06e-01 7.44e-01 0.334000
Asparagine N-linked glycosylation 247 2.16e-05 1.18e-04 0.1610 0.032000 1.42e-01 -0.067500 3.88e-01 1.26e-04 0.068800
Centrosome maturation 66 1.05e-01 1.61e-01 0.1610 0.011400 2.87e-02 -0.158000 8.73e-01 6.87e-01 0.027000
Recruitment of mitotic centrosome proteins and complexes 66 1.05e-01 1.61e-01 0.1610 0.011400 2.87e-02 -0.158000 8.73e-01 6.87e-01 0.027000
Carboxyterminal post-translational modifications of tubulin 27 6.62e-01 7.10e-01 0.1600 -0.022800 -1.18e-01 -0.106000 8.37e-01 2.89e-01 0.339000
IRE1alpha activates chaperones 39 2.90e-01 3.63e-01 0.1600 0.070300 4.38e-02 -0.136000 4.48e-01 6.36e-01 0.140000
Sphingolipid metabolism 72 7.47e-02 1.22e-01 0.1600 0.080200 4.95e-02 -0.129000 2.40e-01 4.68e-01 0.059100
RNA Pol II CTD phosphorylation and interaction with CE 20 6.27e-01 6.80e-01 0.1590 -0.136000 6.09e-02 -0.055800 2.93e-01 6.37e-01 0.666000
RNA Pol II CTD phosphorylation and interaction with CE during HIV infection 20 6.27e-01 6.80e-01 0.1590 -0.136000 6.09e-02 -0.055800 2.93e-01 6.37e-01 0.666000
Signaling by Hedgehog 115 7.95e-03 1.97e-02 0.1590 -0.053400 1.05e-01 -0.106000 3.23e-01 5.11e-02 0.049900
Immune System 1256 8.12e-20 8.28e-18 0.1580 0.111000 1.06e-01 -0.038000 1.04e-10 5.93e-10 0.026500
SARS-CoV-2 Infection 224 7.55e-05 3.62e-04 0.1580 0.038300 1.32e-01 -0.078000 3.25e-01 7.11e-04 0.044900
XBP1(S) activates chaperone genes 38 3.08e-01 3.81e-01 0.1580 0.056400 4.72e-02 -0.139000 5.48e-01 6.15e-01 0.137000
Degradation of cysteine and homocysteine 11 8.27e-01 8.60e-01 0.1560 -0.139000 -3.39e-02 0.062500 4.24e-01 8.46e-01 0.720000
Association of TriC/CCT with target proteins during biosynthesis 30 4.73e-01 5.33e-01 0.1560 0.126000 6.04e-02 -0.069700 2.32e-01 5.67e-01 0.509000
TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain 11 8.97e-01 9.19e-01 0.1560 0.038100 1.09e-01 0.105000 8.27e-01 5.30e-01 0.548000
Cell Cycle 455 1.38e-08 1.54e-07 0.1560 0.024300 1.48e-01 -0.042500 3.78e-01 7.39e-08 0.123000
PLC beta mediated events 41 3.49e-01 4.20e-01 0.1560 0.060700 -1.36e-02 -0.143000 5.02e-01 8.80e-01 0.114000
Metabolism of proteins 1427 3.98e-26 9.47e-24 0.1560 -0.019600 1.45e-01 -0.052500 2.27e-01 3.06e-19 0.001180
Generic Transcription Pathway 914 8.30e-16 3.04e-14 0.1550 0.069000 1.29e-01 -0.052200 4.95e-04 8.04e-11 0.008400
Post-translational protein phosphorylation 64 2.01e-01 2.69e-01 0.1550 0.088900 -8.05e-02 -0.098000 2.19e-01 2.66e-01 0.176000
HIV Transcription Initiation 34 3.65e-01 4.35e-01 0.1550 0.014000 1.42e-01 -0.060500 8.88e-01 1.53e-01 0.542000
RNA Polymerase II HIV Promoter Escape 34 3.65e-01 4.35e-01 0.1550 0.014000 1.42e-01 -0.060500 8.88e-01 1.53e-01 0.542000
RNA Polymerase II Promoter Escape 34 3.65e-01 4.35e-01 0.1550 0.014000 1.42e-01 -0.060500 8.88e-01 1.53e-01 0.542000
RNA Polymerase II Transcription Initiation 34 3.65e-01 4.35e-01 0.1550 0.014000 1.42e-01 -0.060500 8.88e-01 1.53e-01 0.542000
RNA Polymerase II Transcription Initiation And Promoter Clearance 34 3.65e-01 4.35e-01 0.1550 0.014000 1.42e-01 -0.060500 8.88e-01 1.53e-01 0.542000
RNA Polymerase II Transcription Pre-Initiation And Promoter Opening 34 3.65e-01 4.35e-01 0.1550 0.014000 1.42e-01 -0.060500 8.88e-01 1.53e-01 0.542000
p75NTR signals via NF-kB 14 8.64e-01 8.92e-01 0.1550 0.071300 8.76e-02 0.106000 6.44e-01 5.71e-01 0.493000
Transport of the SLBP Dependant Mature mRNA 33 4.64e-01 5.24e-01 0.1540 -0.010300 2.67e-03 -0.154000 9.18e-01 9.79e-01 0.127000
Transport of the SLBP independent Mature mRNA 33 4.64e-01 5.24e-01 0.1540 -0.010300 2.67e-03 -0.154000 9.18e-01 9.79e-01 0.127000
Chaperonin-mediated protein folding 60 1.60e-01 2.22e-01 0.1500 0.033800 4.29e-02 -0.140000 6.51e-01 5.66e-01 0.060700
Platelet homeostasis 60 2.76e-01 3.49e-01 0.1500 0.045600 -5.83e-02 -0.130000 5.41e-01 4.35e-01 0.080900
PIWI-interacting RNA (piRNA) biogenesis 15 7.66e-01 8.06e-01 0.1500 0.051400 -1.60e-03 -0.141000 7.31e-01 9.91e-01 0.346000
Recruitment of NuMA to mitotic centrosomes 71 1.05e-01 1.61e-01 0.1500 0.048400 5.08e-02 -0.132000 4.81e-01 4.60e-01 0.054200
Processive synthesis on the C-strand of the telomere 17 7.76e-01 8.14e-01 0.1490 -0.129000 7.24e-04 -0.075100 3.57e-01 9.96e-01 0.592000
Metabolism of non-coding RNA 46 2.42e-01 3.13e-01 0.1490 -0.040700 8.90e-02 -0.113000 6.33e-01 2.97e-01 0.186000
snRNP Assembly 46 2.42e-01 3.13e-01 0.1490 -0.040700 8.90e-02 -0.113000 6.33e-01 2.97e-01 0.186000
Interferon Signaling 200 1.92e-03 6.07e-03 0.1490 0.089800 1.10e-01 -0.045300 2.91e-02 7.62e-03 0.271000
Impaired BRCA2 binding to RAD51 26 6.40e-01 6.92e-01 0.1470 0.016500 1.85e-02 0.145000 8.84e-01 8.71e-01 0.200000
Potassium Channels 36 5.74e-01 6.30e-01 0.1460 0.029200 -1.12e-01 -0.088600 7.62e-01 2.46e-01 0.358000
Diseases of metabolism 172 3.83e-02 7.15e-02 0.1450 -0.042000 -6.69e-02 -0.122000 3.43e-01 1.31e-01 0.006050
The phototransduction cascade 16 8.11e-01 8.47e-01 0.1450 -0.063500 8.74e-02 0.096100 6.60e-01 5.45e-01 0.506000
Metabolism of steroids 102 9.06e-02 1.43e-01 0.1440 0.081700 1.18e-01 -0.013600 1.54e-01 3.95e-02 0.812000
Late SARS-CoV-2 Infection Events 65 1.54e-01 2.16e-01 0.1440 0.045400 1.14e-01 -0.074200 5.27e-01 1.11e-01 0.301000
Cell Cycle, Mitotic 365 5.43e-06 3.40e-05 0.1430 0.010300 1.38e-01 -0.037200 7.37e-01 6.49e-06 0.225000
Translation of Structural Proteins 9694635 59 1.78e-01 2.43e-01 0.1430 0.010600 1.19e-01 -0.077700 8.88e-01 1.13e-01 0.303000
Regulation of TP53 Activity through Phosphorylation 71 1.82e-01 2.49e-01 0.1430 0.096800 9.42e-02 -0.045900 1.59e-01 1.70e-01 0.504000
Transcription of the HIV genome 52 2.58e-01 3.31e-01 0.1420 0.063000 9.98e-02 -0.078600 4.33e-01 2.14e-01 0.327000
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers 22 6.99e-01 7.42e-01 0.1420 -0.131000 -2.72e-02 0.045900 2.87e-01 8.26e-01 0.710000
Signaling by FGFR2 IIIa TM 13 8.95e-01 9.18e-01 0.1390 -0.017200 -7.20e-02 -0.118000 9.14e-01 6.53e-01 0.461000
RNA Polymerase I Transcription Initiation 38 4.03e-01 4.71e-01 0.1390 0.018800 6.16e-02 -0.123000 8.41e-01 5.11e-01 0.191000
HDR through Single Strand Annealing (SSA) 30 7.17e-01 7.60e-01 0.1380 0.005560 9.30e-02 0.102000 9.58e-01 3.78e-01 0.334000
Processing of Capped Intronless Pre-mRNA 25 6.35e-01 6.88e-01 0.1380 -0.098000 9.65e-02 -0.008650 3.97e-01 4.04e-01 0.940000
Innate Immune System 635 3.36e-09 4.75e-08 0.1370 0.078200 8.76e-02 -0.071000 8.70e-04 1.94e-04 0.002500
Cardiac conduction 77 3.35e-01 4.07e-01 0.1360 0.041000 1.17e-01 0.054200 5.35e-01 7.53e-02 0.411000
Vitamin B5 (pantothenate) metabolism 16 8.74e-01 9.01e-01 0.1350 -0.017400 -6.86e-02 -0.115000 9.04e-01 6.35e-01 0.428000
Biological oxidations 101 1.20e-01 1.78e-01 0.1340 -0.090800 8.90e-02 0.041100 1.15e-01 1.23e-01 0.476000
Synthesis of IP3 and IP4 in the cytosol 22 7.50e-01 7.92e-01 0.1330 0.034400 -1.25e-01 -0.031300 7.80e-01 3.10e-01 0.799000
DNA Repair 230 1.02e-03 3.56e-03 0.1330 -0.057000 9.61e-02 -0.071800 1.38e-01 1.23e-02 0.061700
Polymerase switching on the C-strand of the telomere 23 7.42e-01 7.85e-01 0.1310 -0.106000 2.09e-02 -0.073800 3.79e-01 8.62e-01 0.540000
Defects in cobalamin (B12) metabolism 10 8.93e-01 9.16e-01 0.1300 0.093000 -5.46e-02 0.073200 6.11e-01 7.65e-01 0.689000
Synthesis of PC 21 6.94e-01 7.39e-01 0.1290 0.007640 7.14e-02 -0.108000 9.52e-01 5.71e-01 0.393000
Formation of tubulin folding intermediates by CCT/TriC 16 8.56e-01 8.86e-01 0.1290 0.059500 -8.18e-02 -0.080400 6.80e-01 5.71e-01 0.578000
Amyloid fiber formation 32 6.04e-01 6.59e-01 0.1290 0.082300 8.51e-02 -0.050300 4.21e-01 4.05e-01 0.622000
Metabolism 1433 4.36e-17 2.01e-15 0.1280 -0.086900 8.73e-02 -0.035600 7.67e-08 6.63e-08 0.027700
Axon guidance 379 1.54e-05 8.75e-05 0.1280 0.013900 9.18e-02 -0.087500 6.44e-01 2.28e-03 0.003660
SUMOylation of DNA damage response and repair proteins 70 2.14e-01 2.83e-01 0.1270 0.048700 8.77e-02 -0.078300 4.81e-01 2.05e-01 0.258000
Transport of bile salts and organic acids, metal ions and amine compounds 31 5.71e-01 6.27e-01 0.1270 -0.035900 -9.73e-02 0.073700 7.29e-01 3.49e-01 0.478000
Intraflagellar transport 38 6.38e-01 6.91e-01 0.1270 0.020800 -4.87e-02 -0.115000 8.24e-01 6.04e-01 0.219000
Branched-chain amino acid catabolism 17 8.46e-01 8.77e-01 0.1270 0.101000 -6.48e-03 0.076400 4.72e-01 9.63e-01 0.586000
Synthesis of IP2, IP, and Ins in the cytosol 13 8.78e-01 9.04e-01 0.1260 0.108000 -5.35e-02 -0.037400 5.02e-01 7.38e-01 0.815000
Cobalamin (Cbl, vitamin B12) transport and metabolism 12 8.99e-01 9.20e-01 0.1250 0.110000 5.29e-02 -0.027900 5.10e-01 7.51e-01 0.867000
Nervous system development 394 2.71e-05 1.46e-04 0.1250 0.035900 9.78e-02 -0.069100 2.24e-01 9.24e-04 0.019400
RNA Polymerase I Promoter Clearance 41 5.15e-01 5.73e-01 0.1230 -0.014700 3.32e-02 -0.117000 8.71e-01 7.13e-01 0.194000
Activation of NMDA receptors and postsynaptic events 62 3.36e-01 4.07e-01 0.1220 0.079500 6.53e-02 -0.066300 2.79e-01 3.75e-01 0.367000
HDR through Homologous Recombination (HRR) 50 4.49e-01 5.12e-01 0.1220 -0.084300 -1.81e-02 0.086600 3.03e-01 8.25e-01 0.290000
Organelle biogenesis and maintenance 222 1.06e-02 2.50e-02 0.1220 0.048900 1.08e-01 -0.029200 2.11e-01 5.73e-03 0.455000
Platelet calcium homeostasis 19 8.52e-01 8.83e-01 0.1220 0.023800 -1.08e-01 -0.050400 8.57e-01 4.14e-01 0.704000
Cholesterol biosynthesis 21 8.15e-01 8.51e-01 0.1210 0.118000 1.93e-02 -0.014400 3.47e-01 8.79e-01 0.909000
DAG and IP3 signaling 36 6.01e-01 6.57e-01 0.1190 0.080900 3.95e-02 -0.078000 4.01e-01 6.82e-01 0.418000
Sulfur amino acid metabolism 21 8.26e-01 8.59e-01 0.1190 -0.086900 -7.94e-02 0.015500 4.91e-01 5.29e-01 0.902000
Ion channel transport 105 1.37e-01 1.98e-01 0.1170 -0.004940 1.11e-01 -0.037200 9.30e-01 5.01e-02 0.511000
Transcriptional Regulation by VENTX 34 6.16e-01 6.71e-01 0.1150 0.018000 4.72e-02 -0.104000 8.56e-01 6.34e-01 0.296000
Fatty acid metabolism 104 2.18e-01 2.86e-01 0.1130 -0.077100 2.61e-02 -0.078900 1.75e-01 6.46e-01 0.165000
Removal of the Flap Intermediate from the C-strand 16 8.69e-01 8.96e-01 0.1130 -0.097200 5.16e-02 -0.027100 5.01e-01 7.21e-01 0.851000
Maturation of nucleoprotein 9694631 15 9.09e-01 9.28e-01 0.1120 -0.051700 6.72e-02 0.073500 7.29e-01 6.52e-01 0.622000
Iron uptake and transport 41 5.92e-01 6.49e-01 0.1120 0.031100 1.01e-01 -0.038100 7.30e-01 2.65e-01 0.673000
SLC transporter disorders 58 3.95e-01 4.64e-01 0.1120 -0.032200 8.95e-02 -0.058800 6.72e-01 2.39e-01 0.439000
Glycosaminoglycan metabolism 88 3.13e-01 3.87e-01 0.1120 0.092200 -4.34e-02 -0.045800 1.35e-01 4.83e-01 0.459000
Amino acids regulate mTORC1 39 6.02e-01 6.58e-01 0.1110 -0.061000 8.81e-02 -0.030400 5.10e-01 3.42e-01 0.743000
Neuronal System 204 4.82e-02 8.59e-02 0.1110 0.045000 -2.22e-02 -0.099300 2.69e-01 5.86e-01 0.014800
Caspase activation via Death Receptors in the presence of ligand 13 9.06e-01 9.26e-01 0.1110 0.052300 -9.78e-02 -0.005850 7.44e-01 5.42e-01 0.971000
RNA Polymerase I Transcription Termination 22 8.39e-01 8.72e-01 0.1110 -0.058800 8.45e-02 0.041200 6.33e-01 4.93e-01 0.738000
Leading Strand Synthesis 14 9.14e-01 9.31e-01 0.1100 -0.109000 -1.32e-02 0.008940 4.79e-01 9.32e-01 0.954000
Polymerase switching 14 9.14e-01 9.31e-01 0.1100 -0.109000 -1.32e-02 0.008940 4.79e-01 9.32e-01 0.954000
Neutrophil degranulation 306 1.88e-03 5.98e-03 0.1100 0.019600 6.30e-02 -0.088100 5.58e-01 5.92e-02 0.008310
Negative regulators of DDX58/IFIH1 signaling 33 6.53e-01 7.01e-01 0.1090 -0.003380 9.10e-02 -0.060400 9.73e-01 3.66e-01 0.548000
Metabolism of carbohydrates and carbohydrate derivatives 203 2.06e-02 4.37e-02 0.1080 0.010800 8.29e-02 -0.069000 7.91e-01 4.23e-02 0.091000
Acyl chain remodelling of PC 13 9.23e-01 9.37e-01 0.1080 -0.106000 -7.85e-03 0.020100 5.08e-01 9.61e-01 0.900000
Processing of DNA double-strand break ends 50 5.15e-01 5.73e-01 0.1080 -0.001460 9.88e-02 -0.042700 9.86e-01 2.27e-01 0.602000
RNA Polymerase I Transcription 42 5.91e-01 6.48e-01 0.1070 0.001630 4.31e-02 -0.098300 9.85e-01 6.29e-01 0.271000
Acyl chain remodelling of PE 11 9.57e-01 9.66e-01 0.1070 -0.083900 -2.78e-02 -0.060400 6.30e-01 8.73e-01 0.729000
Visual phototransduction 45 6.97e-01 7.41e-01 0.1070 -0.027500 -1.02e-01 -0.016800 7.50e-01 2.39e-01 0.846000
Synthesis of PA 21 8.85e-01 9.09e-01 0.1060 -0.009200 9.75e-02 0.041800 9.42e-01 4.39e-01 0.740000
Peptide hormone metabolism 42 6.90e-01 7.35e-01 0.1050 0.053900 -8.40e-02 -0.034300 5.46e-01 3.47e-01 0.701000
Transmission across Chemical Synapses 148 1.41e-01 2.02e-01 0.1050 0.021600 -1.08e-03 -0.103000 6.50e-01 9.82e-01 0.031000
mRNA Capping 22 8.60e-01 8.89e-01 0.1050 -0.104000 7.53e-03 0.002840 3.98e-01 9.51e-01 0.982000
Transport of inorganic cations/anions and amino acids/oligopeptides 66 5.51e-01 6.07e-01 0.1040 -0.051500 6.74e-02 0.060900 4.70e-01 3.44e-01 0.393000
G beta:gamma signalling through CDC42 12 9.34e-01 9.45e-01 0.1040 -0.084100 2.73e-02 -0.054700 6.14e-01 8.70e-01 0.743000
Sensory Perception 106 4.36e-01 5.01e-01 0.1030 0.003150 -7.61e-02 -0.069900 9.55e-01 1.77e-01 0.214000
RA biosynthesis pathway 13 9.29e-01 9.42e-01 0.1030 -0.092800 1.16e-02 0.042500 5.62e-01 9.42e-01 0.791000
Chondroitin sulfate/dermatan sulfate metabolism 26 8.54e-01 8.84e-01 0.1030 0.021900 -9.26e-02 -0.038600 8.47e-01 4.14e-01 0.733000
Phospholipid metabolism 154 9.36e-02 1.47e-01 0.1020 0.038500 6.30e-02 -0.071000 4.11e-01 1.78e-01 0.129000
N-glycan antennae elongation in the medial/trans-Golgi 17 9.22e-01 9.37e-01 0.1020 0.070900 7.31e-02 0.005980 6.13e-01 6.02e-01 0.966000
Translation of Structural Proteins 9683701 29 7.50e-01 7.92e-01 0.1010 0.008780 5.44e-02 -0.084500 9.35e-01 6.12e-01 0.431000
SLC-mediated transmembrane transport 131 2.14e-01 2.83e-01 0.1010 -0.086100 -1.83e-02 0.049100 8.96e-02 7.18e-01 0.333000
Sialic acid metabolism 26 8.83e-01 9.07e-01 0.0997 -0.050500 -8.29e-02 -0.022500 6.56e-01 4.65e-01 0.842000
Metabolism of lipids 510 4.75e-04 1.82e-03 0.0986 0.032100 8.51e-02 -0.037900 2.19e-01 1.10e-03 0.146000
TP53 Regulates Transcription of Cell Death Genes 36 7.69e-01 8.09e-01 0.0979 0.056100 -1.52e-02 -0.078800 5.60e-01 8.74e-01 0.414000
Glycosphingolipid metabolism 39 7.99e-01 8.35e-01 0.0976 0.030500 -5.94e-02 -0.071100 7.42e-01 5.21e-01 0.442000
Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding 21 8.81e-01 9.05e-01 0.0974 -0.002500 9.73e-02 -0.001840 9.84e-01 4.40e-01 0.988000
Caspase activation via extrinsic apoptotic signalling pathway 21 9.10e-01 9.28e-01 0.0972 0.083400 4.93e-02 0.007400 5.08e-01 6.96e-01 0.953000
Neurotransmitter receptors and postsynaptic signal transmission 113 3.31e-01 4.03e-01 0.0970 0.026300 -1.00e-02 -0.092800 6.29e-01 8.55e-01 0.088800
Transport of small molecules 448 1.46e-03 4.81e-03 0.0940 -0.043100 6.91e-02 -0.047100 1.21e-01 1.29e-02 0.089900
Defects in vitamin and cofactor metabolism 18 9.23e-01 9.37e-01 0.0927 0.088000 2.25e-02 -0.018400 5.18e-01 8.69e-01 0.893000
IL-6-type cytokine receptor ligand interactions 12 9.65e-01 9.73e-01 0.0919 -0.017800 7.62e-02 0.048200 9.15e-01 6.48e-01 0.773000
Inwardly rectifying K+ channels 18 9.29e-01 9.42e-01 0.0906 -0.062600 -6.42e-02 0.013100 6.46e-01 6.38e-01 0.924000
Negative regulation of FLT3 12 9.65e-01 9.73e-01 0.0887 0.054000 7.03e-02 -0.001060 7.46e-01 6.73e-01 0.995000
Homology Directed Repair 79 5.43e-01 6.02e-01 0.0850 -0.056900 5.86e-02 -0.023400 3.83e-01 3.68e-01 0.719000
Prefoldin mediated transfer of substrate to CCT/TriC 20 9.02e-01 9.23e-01 0.0830 -0.004180 6.74e-02 -0.048300 9.74e-01 6.02e-01 0.709000
Cargo trafficking to the periciliary membrane 38 8.76e-01 9.03e-01 0.0769 -0.035600 2.47e-02 0.063600 7.04e-01 7.92e-01 0.498000
Purine catabolism 13 9.79e-01 9.85e-01 0.0763 -0.005720 6.28e-02 0.042900 9.72e-01 6.95e-01 0.789000
FGFR2 mutant receptor activation 16 9.61e-01 9.70e-01 0.0741 0.052200 -9.12e-03 -0.051800 7.18e-01 9.50e-01 0.720000
DNA Double-Strand Break Repair 107 5.26e-01 5.84e-01 0.0741 -0.015400 7.01e-02 -0.018300 7.84e-01 2.11e-01 0.745000
Negative epigenetic regulation of rRNA expression 38 8.46e-01 8.77e-01 0.0732 0.020900 3.44e-02 -0.061200 8.24e-01 7.14e-01 0.514000
N-Glycan antennae elongation 11 9.73e-01 9.79e-01 0.0727 -0.019000 -2.85e-02 0.064200 9.13e-01 8.70e-01 0.713000
Fatty acyl-CoA biosynthesis 19 9.40e-01 9.52e-01 0.0712 -0.007710 4.17e-02 -0.057200 9.54e-01 7.53e-01 0.666000
HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) 74 7.12e-01 7.55e-01 0.0701 -0.041200 5.43e-02 -0.016100 5.40e-01 4.20e-01 0.811000
RNA Polymerase I Promoter Escape 22 9.50e-01 9.60e-01 0.0700 -0.062700 1.90e-02 0.024800 6.11e-01 8.78e-01 0.840000
Inositol phosphate metabolism 39 9.22e-01 9.37e-01 0.0686 0.026600 1.58e-02 0.061200 7.74e-01 8.65e-01 0.509000
Anchoring of the basal body to the plasma membrane 83 7.07e-01 7.51e-01 0.0657 0.030200 3.09e-02 -0.049400 6.34e-01 6.27e-01 0.437000
Transferrin endocytosis and recycling 20 9.67e-01 9.74e-01 0.0649 -0.037100 2.40e-02 0.047600 7.74e-01 8.53e-01 0.713000
Interferon gamma signaling 65 8.81e-01 9.05e-01 0.0623 0.056700 2.30e-02 0.011900 4.30e-01 7.49e-01 0.868000
NoRC negatively regulates rRNA expression 35 9.46e-01 9.57e-01 0.0568 -0.000998 8.79e-04 -0.056800 9.92e-01 9.93e-01 0.561000
Glycerophospholipid biosynthesis 84 7.86e-01 8.23e-01 0.0566 -0.029100 3.54e-02 -0.033300 6.45e-01 5.76e-01 0.598000
Phase I - Functionalization of compounds 53 9.19e-01 9.35e-01 0.0541 0.052300 -3.75e-03 -0.013500 5.11e-01 9.62e-01 0.865000
Lysine catabolism 10 9.91e-01 9.96e-01 0.0526 -0.026600 4.46e-02 -0.007870 8.84e-01 8.07e-01 0.966000
Metabolism of water-soluble vitamins and cofactors 90 9.08e-01 9.28e-01 0.0516 -0.012700 -2.79e-02 -0.041500 8.35e-01 6.48e-01 0.497000
Metabolism of vitamins and cofactors 136 8.41e-01 8.73e-01 0.0481 0.006800 -2.14e-02 -0.042500 8.91e-01 6.67e-01 0.393000
Insulin receptor recycling 20 9.93e-01 9.96e-01 0.0456 -0.028400 -2.56e-02 -0.024900 8.26e-01 8.43e-01 0.847000
Cilium Assembly 155 7.74e-01 8.12e-01 0.0425 0.008830 2.00e-02 -0.036400 8.50e-01 6.68e-01 0.435000
Modulation of host responses by IFN-stimulated genes 16 9.93e-01 9.96e-01 0.0405 0.028900 1.94e-02 -0.020800 8.41e-01 8.93e-01 0.886000
TP53 Regulates Transcription of Caspase Activators and Caspases 11 9.97e-01 9.98e-01 0.0375 -0.033700 -9.82e-03 0.013000 8.46e-01 9.55e-01 0.940000
Nucleotide catabolism 25 9.96e-01 9.98e-01 0.0290 0.014700 -1.43e-02 -0.020500 8.99e-01 9.02e-01 0.859000
Assembly and cell surface presentation of NMDA receptors 25 9.97e-01 9.98e-01 0.0258 0.022400 -7.74e-05 -0.012700 8.46e-01 9.99e-01 0.912000
p75NTR recruits signalling complexes 11 9.99e-01 9.99e-01 0.0245 0.009820 -2.22e-02 -0.003680 9.55e-01 8.99e-01 0.983000
Processing of Intronless Pre-mRNAs 18 9.99e-01 9.99e-01 0.0230 -0.011800 1.59e-02 0.011800 9.31e-01 9.07e-01 0.931000



Detailed Gene set reports


FOXO-mediated transcription of cell cycle genes
FOXO-mediated transcription of cell cycle genes
metric value
setSize 15
pMANOVA 1.29e-05
p.adjustMANOVA 7.4e-05
s.dist 0.851
s.rna 0.508
s.k9a 0.607
s.k36a 0.312
p.rna 0.000652
p.k9a 4.66e-05
p.k36a 0.0364


Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).


Top 20 genes
Gene k9a rna
FOXO3 10263 6533
CDKN1A 9386 6599
KLF4 7477 6628
SMAD3 10284 4740
FOXO1 7377 6499
SMAD2 9007 4871
FOXO4 6500 5543
RBL2 7746 3913
CCNG2 4463 6200
CDKN1B 7451 3621
SMAD4 10401 1624
CAV1 7001 1358

Click HERE to show all gene set members

All member genes
rna k9a k36a
KLF4 6628 7477 1732.5
CDKN1A 6599 9386 3516.5
FOXO3 6533 10263 4720.5
FOXO1 6499 7377 1470.5
CCNG2 6200 4463 -4368.5
FOXO4 5543 6500 2195.5
SMAD2 4871 9007 4088.5
SMAD3 4740 10284 4696.5
PCBP4 -3986 5437 -6669.5
RBL2 3913 7746 -2326.5
CDKN1B 3621 7451 -1331.5
SMAD4 1624 10401 -918.5
CAV1 1358 7001 -3763.5
MSTN -1136 10296 4360.5
GADD45A -957 6083 -2437.5





Dectin-2 family
Dectin-2 family
metric value
setSize 10
pMANOVA 0.000725
p.adjustMANOVA 0.00268
s.dist 0.81
s.rna -0.0541
s.k9a -0.74
s.k36a -0.326
p.rna 0.767
p.k9a 5.1e-05
p.k36a 0.074


Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).


Top 20 genes
Gene k9a k36a
MUC6 -2420 -8072.5
MUC4 -2354 -7338.5
PLCG2 -2449 -6331.5
MUC3A -2407 -2391.5
CLEC10A -833 -6616.5
MUC16 -2452 -1441.5
MUC20 -577 -1364.5

Click HERE to show all gene set members

All member genes
rna k9a k36a
MUC3A 6131 -2407 -2391.5
MUC4 -5908 -2354 -7338.5
CLEC10A 4904 -833 -6616.5
MUC6 -4861 -2420 -8072.5
MUC16 -2855 -2452 -1441.5
SYK 1353 575 1694.5
PLCG2 1050 -2449 -6331.5
FYN -923 5060 -3174.5
MUC20 -577 -577 -1364.5
LYN 25 216 -2939.5





NGF-stimulated transcription
NGF-stimulated transcription
metric value
setSize 28
pMANOVA 4.63e-09
p.adjustMANOVA 6.01e-08
s.dist 0.769
s.rna 0.642
s.k9a 0.374
s.k36a 0.2
p.rna 4.12e-09
p.k9a 0.000613
p.k36a 0.0668


Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).


Top 20 genes
Gene rna k9a
ID3 6591 10184
FOS 6436 10244
TRIB1 6518 9267
FOSB 6257 8305
JUND 6607 7577
EGR1 6547 7640
SRF 6267 7611
EGR2 6451 6578
ATF1 4687 8906
MEF2D 3760 10055
EGR3 6461 5578
REST 5456 5482
CHD4 6032 4889
TCF12 3053 9304
ATF2 5664 4988
ID1 6384 4010
FOSL1 6491 3048
ID2 4841 3731
LYL1 4286 2723
CDK5R1 2173 3766

Click HERE to show all gene set members

All member genes
rna k9a k36a
JUND 6607 7577 -4586.5
ID3 6591 10184 2562.5
NAB2 6548 504 -4262.5
EGR1 6547 7640 -2536.5
TRIB1 6518 9267 4728.5
FOSL1 6491 3048 -4121.5
EGR3 6461 5578 3073.5
EGR2 6451 6578 -1312.5
FOS 6436 10244 4331.5
ID1 6384 4010 -638.5
SRF 6267 7611 2848.5
FOSB 6257 8305 2067.5
CHD4 6032 4889 -7514.5
ATF2 5664 4988 1197.5
REST 5456 5482 -4359.5
ID2 4841 3731 -1534.5
ATF1 4687 8906 -2413.5
DNM2 4489 1714 -7951.5
LYL1 4286 2723 -4977.5
SGK1 -3981 10162 4007.5
MEF2D 3760 10055 4655.5
TCF12 3053 9304 2703.5
CDK5R1 2173 3766 -6799.5
ID4 1615 3806 1320.5
CREB1 1065 6388 672.5
ELK1 -721 5674 160.5
RRAD 650 10096 4130.5
NAB1 565 7970 3512.5





NFE2L2 regulating tumorigenic genes
NFE2L2 regulating tumorigenic genes
metric value
setSize 10
pMANOVA 0.00261
p.adjustMANOVA 0.00794
s.dist 0.75
s.rna 0.626
s.k9a 0.369
s.k36a 0.182
p.rna 0.000603
p.k9a 0.0433
p.k36a 0.319


Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).


Top 20 genes
Gene rna k9a
CREBBP 5966 9533
BCL2L1 5513 10199
SP1 5448 8999
MAFK 5862 8173
BCL2 2780 8870
NFE2L2 6260 3007
PDGFA 2773 4944
AREG 5471 2319

Click HERE to show all gene set members

All member genes
rna k9a k36a
NFE2L2 6260 3007 -1506.5
CREBBP 5966 9533 -6131.5
MAFK 5862 8173 4643.5
NOTCH1 5625 -1073 -6328.5
BCL2L1 5513 10199 2314.5
AREG 5471 2319 3390.5
SP1 5448 8999 -111.5
EGF -3352 9090 -2316.5
BCL2 2780 8870 1939.5
PDGFA 2773 4944 -980.5





MET activates RAP1 and RAC1
MET activates RAP1 and RAC1
metric value
setSize 10
pMANOVA 0.00569
p.adjustMANOVA 0.0153
s.dist 0.749
s.rna 0.401
s.k9a 0.521
s.k36a 0.359
p.rna 0.0281
p.k9a 0.00431
p.k36a 0.0493


Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).


Top 20 genes
Gene k9a rna
MET 9940 5616
RAP1B 9969 5298
CRK 8154 6392
GAB1 10241 4245
RAPGEF1 6688 5685
CRKL 7678 3790
DOCK7 2303 2679

Click HERE to show all gene set members

All member genes
rna k9a k36a
CRK 6392 8154 1121.5
RAPGEF1 5685 6688 -5123.5
MET 5616 9940 3943.5
RAP1B 5298 9969 423.5
RAC1 -5304 8988 496.5
GAB1 4245 10241 4254.5
CRKL 3790 7678 -49.5
DOCK7 2679 2303 4203.5
GRB2 -592 1903 -4677.0
RAP1A -34 8045 1755.5





Regulation of localization of FOXO transcription factors
Regulation of localization of FOXO transcription factors
metric value
setSize 11
pMANOVA 0.00212
p.adjustMANOVA 0.00662
s.dist 0.729
s.rna 0.486
s.k9a 0.519
s.k36a 0.161
p.rna 0.00523
p.k9a 0.00287
p.k36a 0.355


Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).


Top 20 genes
Gene k9a rna
FOXO3 10263 6533
YWHAZ 10231 5390
YWHAQ 8761 6010
FOXO1 7377 6499
YWHAG 10069 4560
FOXO4 6500 5543
AKT2 7958 3059
AKT3 5870 3357
AKT1 795 385

Click HERE to show all gene set members

All member genes
rna k9a k36a
FOXO3 6533 10263 4720.5
FOXO1 6499 7377 1470.5
YWHAQ 6010 8761 -2792.5
FOXO4 5543 6500 2195.5
YWHAZ 5390 10231 4562.5
YWHAG 4560 10069 76.5
AKT3 3357 5870 2673.5
AKT2 3059 7958 -5506.5
YWHAB -2525 8568 351.5
FOXO6 -2200 4751 -6861.5
AKT1 385 795 -7999.5





Phosphorylation and nuclear translocation of the CRY:PER:kinase complex
Phosphorylation and nuclear translocation of the CRY:PER:kinase complex
metric value
setSize 12
pMANOVA 0.000234
p.adjustMANOVA 0.000985
s.dist 0.727
s.rna 0.462
s.k9a 0.556
s.k36a -0.0765
p.rna 0.00557
p.k9a 0.00086
p.k36a 0.646


Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).


Top 20 genes
Gene k9a rna
PER1 10434 5911
PER2 8936 6482
CSNK1D 8116 6080
PPP1CB 10194 4674
CRY2 9684 4222
CSNK1E 7541 4650
PPP1CC 9403 3653
CSNK2A1 8038 950
CSNK2A2 4923 1312
CRY1 586 5417
PER3 9224 223

Click HERE to show all gene set members

All member genes
rna k9a k36a
PER2 6482 8936 1649.5
CSNK1D 6080 8116 -6329.5
PER1 5911 10434 4402.5
PPP1CA -5505 4268 -7028.5
CRY1 5417 586 -2881.5
PPP1CB 4674 10194 4607.5
CSNK1E 4650 7541 -7144.5
CRY2 4222 9684 158.5
PPP1CC 3653 9403 -4853.5
CSNK2A2 1312 4923 -4157.5
CSNK2A1 950 8038 -4994.5
PER3 223 9224 390.5





Antigen processing: Ub, ATP-independent proteasomal degradation
Antigen processing: Ub, ATP-independent proteasomal degradation
metric value
setSize 16
pMANOVA 6.09e-06
p.adjustMANOVA 3.75e-05
s.dist 0.705
s.rna -0.646
s.k9a 0.283
s.k36a -0.0171
p.rna 7.73e-06
p.k9a 0.0499
p.k36a 0.906


Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).


Top 20 genes
Gene rna k9a
PSMA3 -5671 9619
PSMB7 -6237 8470
PSMA4 -6068 8342
PSMB2 -5288 7989
PSMB6 -4874 8136
PSMB4 -4766 8055
PSMB1 -4663 5911
PSMA7 -4440 5218
PSME1 -5795 3698
PSMA6 -2583 4000
PSMB5 -6178 1482
PSMA1 -1515 4418
PSMA5 -460 10087
PSMB9 -1933 1785

Click HERE to show all gene set members

All member genes
rna k9a k36a
PSMB7 -6237 8470 -505.5
PSMB5 -6178 1482 -1841.5
PSMA4 -6068 8342 -5116.5
PSME1 -5795 3698 -3215.5
PSMA3 -5671 9619 2807.5
PSMB2 -5288 7989 1972.5
PSMB6 -4874 8136 -4094.5
PSMB4 -4766 8055 -2320.5
PSMB1 -4663 5911 -236.5
PSMA7 -4440 5218 -6243.5
PSMB3 -4141 -919 -2157.5
PSMA6 -2583 4000 -1476.5
PSMB9 -1933 1785 -2750.5
PSMA1 -1515 4418 -1372.5
PSMA2 759 7316 -444.5
PSMA5 -460 10087 -1761.5





Signaling by FLT3 fusion proteins
Signaling by FLT3 fusion proteins
metric value
setSize 18
pMANOVA 1.17e-05
p.adjustMANOVA 6.8e-05
s.dist 0.703
s.rna 0.556
s.k9a 0.429
s.k36a -0.027
p.rna 4.42e-05
p.k9a 0.00164
p.k36a 0.843


Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).


Top 20 genes
Gene rna k9a
CDKN1A 6599 9386
GOLGB1 6395 9385
SPTBN1 6087 9583
PIM1 6560 8361
SOS1 5406 9689
KRAS 6337 6859
PIK3CA 6210 5691
GAB2 4759 7047
TRIP11 3345 9755
ZMYM2 3687 8129
MYO18A 4109 6447
NRAS 3383 3642
ETV6 944 9197
STAT5B 1273 4752
STAT5A 3518 1273
PIK3R1 291 10359

Click HERE to show all gene set members

All member genes
rna k9a k36a
CDKN1A 6599 9386 3516.5
PIM1 6560 8361 -4423.5
GOLGB1 6395 9385 -2631.5
KRAS 6337 6859 -2579.5
PIK3CA 6210 5691 -4814.5
SPTBN1 6087 9583 -1147.5
SOS1 5406 9689 -2824.5
GAB2 4759 7047 3.5
MYO18A 4109 6447 -8144.5
ZMYM2 3687 8129 1465.5
STAT5A 3518 1273 -4016.5
NRAS 3383 3642 1444.5
TRIP11 3345 9755 1709.5
STAT5B 1273 4752 -4028.5
ETV6 944 9197 1607.5
GRB2 -592 1903 -4677.0
HRAS -321 771 -7494.5
PIK3R1 291 10359 3522.5





FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
metric value
setSize 22
pMANOVA 4.97e-05
p.adjustMANOVA 0.000248
s.dist 0.684
s.rna 0.33
s.k9a 0.454
s.k36a 0.391
p.rna 0.0073
p.k9a 0.000227
p.k36a 0.0015


Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).


Top 20 genes
Gene k9a k36a
FOXO3 10263 4720.5
SMAD3 10284 4696.5
TRIM63 10442 4320.5
PPARGC1A 10489 4235.5
NR3C1 10460 4175.5
SMAD2 9007 4088.5
SOD2 9102 3977.5
SREBF1 8160 2739.5
FBXO32 10381 2125.5
FOXO4 6500 2195.5
ABCA6 5121 2775.5
FOXO1 7377 1470.5
HDAC2 938 4579.5
CAT 7371 444.5

Click HERE to show all gene set members

All member genes
rna k9a k36a
FOXO3 6533 10263 4720.5
FOXO1 6499 7377 1470.5
NR3C1 5950 10460 4175.5
SOD2 5904 9102 3977.5
FOXO4 5543 6500 2195.5
SIN3A 4900 7718 -5589.5
SMAD2 4871 9007 4088.5
ABCA6 -4936 5121 2775.5
SMAD3 4740 10284 4696.5
TRIM63 3592 10442 4320.5
SREBF1 3528 8160 2739.5
FBXO32 3110 10381 2125.5
HDAC2 2952 938 4579.5
POMC -2846 5086 -3887.5
PLXNA4 2774 142 -2755.5
FOXO6 -2200 4751 -6861.5
PPARGC1A 1930 10489 4235.5
ATXN3 -1841 6284 -1007.5
SMAD4 1624 10401 -918.5
CAT -1498 7371 444.5
SIRT3 -324 2520 -1203.5
HDAC1 207 189 -5846.5





Network diagram

Only used for one-dimensional analysis.

Here, the network diagram is used to depict the similarity between some of the top ranked gene sets. It makes separate charts for up and downregulated sets. It works best when prioritisation is done by effect size during the mitch_calc() step. By default, we only show the top 20 genes, but you can use the networkplot() command yourself with other options. See ?networkplot for more detail. There is an element of stochasticity with regard to the network projection, so if you see a lot of overlapping labels or labels getting cut off, you could repeat the chart generation until you get a nice layout. See ?networkplot for more detail.

Below the network diagrams, you will see lists of genes that make up the up and downregulated sets respectively. For upregulated genes the score needs to be >2 and for downregulated genes it needs to be < -2. This is to remove genes that have uninteresting differential expression and do not contribute enrichment.

if (d==1) {
  networkplot(eres=res,FDR=0.05,n_sets=20)
  network_genes(eres=res,FDR=0.05,n_sets=20)
} else {
 message("Network charts only generated in one-dimensional analysis.")
}
## Network charts only generated in one-dimensional analysis.

Session information

Here is the session info with all the versions of packages used.

sessionInfo()
## R version 4.6.1 (2026-06-24)
## Platform: x86_64-pc-linux-gnu
## Running under: Ubuntu 24.04.5 LTS
## 
## Matrix products: default
## BLAS:   /usr/lib/x86_64-linux-gnu/openblas-pthread/libblas.so.3 
## LAPACK: /usr/lib/x86_64-linux-gnu/openblas-pthread/libopenblasp-r0.3.26.so;  LAPACK version 3.12.0
## 
## locale:
##  [1] LC_CTYPE=en_AU.UTF-8       LC_NUMERIC=C              
##  [3] LC_TIME=en_AU.UTF-8        LC_COLLATE=en_AU.UTF-8    
##  [5] LC_MONETARY=en_AU.UTF-8    LC_MESSAGES=en_AU.UTF-8   
##  [7] LC_PAPER=en_AU.UTF-8       LC_NAME=C                 
##  [9] LC_ADDRESS=C               LC_TELEPHONE=C            
## [11] LC_MEASUREMENT=en_AU.UTF-8 LC_IDENTIFICATION=C       
## 
## time zone: Australia/Melbourne
## tzcode source: system (glibc)
## 
## attached base packages:
## [1] stats     graphics  grDevices utils     datasets  methods   base     
## 
## other attached packages:
## [1] gtools_3.9.5     kableExtra_1.4.1 eulerr_7.1.0     mitch_1.24.0    
## 
## loaded via a namespace (and not attached):
##  [1] gtable_0.3.6          beeswarm_0.4.0        bslib_0.12.0         
##  [4] xfun_0.61             ggplot2_4.0.3         htmlwidgets_1.6.4    
##  [7] caTools_1.18.4        GGally_2.4.0          lattice_0.23-1       
## [10] vctrs_0.7.3           tools_4.6.1           bitops_1.1-0         
## [13] generics_0.1.4        parallel_4.6.1        tibble_3.3.1         
## [16] pkgconfig_2.0.3       KernSmooth_2.23-27    polylabelr_1.0.0     
## [19] RColorBrewer_1.1-3    S7_0.2.2              lifecycle_1.0.5      
## [22] compiler_4.6.1        farver_2.1.2          stringr_1.6.0        
## [25] textshaping_1.0.5     gplots_3.3.0          httpuv_1.6.17        
## [28] sass_0.4.10           htmltools_0.5.9       yaml_2.3.12          
## [31] jquerylib_0.1.4       later_1.4.8           pillar_1.11.1        
## [34] tidyr_1.3.2           MASS_7.3-66           cachem_1.1.0         
## [37] mime_0.13             ggstats_0.14.0        network_1.20.0       
## [40] tidyselect_1.2.1      digest_0.6.39         stringi_1.8.9        
## [43] dplyr_1.2.1           reshape2_1.4.5        purrr_1.2.2          
## [46] labeling_0.4.3        polyclip_1.10-7       fastmap_1.2.0        
## [49] grid_4.6.1            cli_3.6.6             magrittr_2.0.5       
## [52] dichromat_2.0-1       withr_3.0.3           scales_1.4.0         
## [55] promises_1.5.0        rmarkdown_2.32        otel_0.2.0           
## [58] gridExtra_2.3.1       coda_0.19-4.1         shiny_1.14.0         
## [61] evaluate_1.0.5        knitr_1.52            viridisLite_0.4.3    
## [64] rlang_1.3.0           Rcpp_1.1.2            xtable_1.8-8         
## [67] glue_1.8.1            echarts4r_0.5.0       xml2_1.6.0           
## [70] jsonlite_2.0.0        svglite_2.2.2         rstudioapi_0.19.0    
## [73] R6_2.6.1              plyr_1.8.9            statnet.common_4.13.0
## [76] systemfonts_1.3.2

END of report